var title_f2_12_2240="Full thickness burn PI";
var content_f2_12_2240=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F63587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F63587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Full-thickness burn",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 303px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Full-thickness burns are white, gray, or black, and do not turn pale when touched. The burned skin cannot feel anything, so it does not hurt when you touch it.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eric D Morgan, MD and William F Miser, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2240=[""].join("\n");
var outline_f2_12_2240=null;
var title_f2_12_2241="Knee extension test";
var content_f2_12_2241=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Knee extension test",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With the patient supine and the knee at 90 degrees of flexion, the examiner forces the patella medially while simultaneously internally rotating and slowly extending the knee. A positive test consists of pain and popping when the knee is between 45 and 60 degrees of flexion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2241=[""].join("\n");
var outline_f2_12_2241=null;
var title_f2_12_2242="Management of acute epicondylitis algorithm";
var content_f2_12_2242=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Management of acute epicondylitis algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 721px; background-image: url(data:image/gif;base64,R0lGODlhFALRAtUAAP///wAAAICAgEBAQMDAwIiIiLu7u0RERAAzmSIiIhEREZmZmd3d3TMzM2ZmZszMzFVVVe7u7oigz7vJ5ERptHd3dyJOp6qqqpmt1t3k8WaFwjNcrczW6xFBoO7x+FV3u3eSyaq73aCgoNDQ0ODg4GBgYCAgIBAQEFBQUHBwcPDw8JCQkLCwsDAwMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAUAtECAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaancASqq6ytrq+wsbKztLW2t7i5uru8vb6sI6jCgQEDxsfIycrLzM3Oz9DR0tPU1dbX2Nnaxi0Dw999AeDjZgTe5Oh04unsXebt8G3r8fRU7/X4ZPP5/Ev3/QC37AtIUMi/ggilDEzY7yDDh0sWQqzncKJFIhIvtquo0WJGPRIQILiCYEISCRTQTBhpBOUgChKWlIzCsSPEjBZEIviQAcDK/y8wn3iYSXLCz5YpoRCdcrSIy6Azm0ZZOoUqkqBKrDKpaZMhTgwAMlCw4EEOB5ZFTyY1I3WIyyFa72BNElcJ164Ivw7pEOInBp0awm7QOUGChZwbyoZEsIGDBwoiOwCA+ThyEcgIKHjIiSCwkJU5O3wQCUKwyMAZBos0OvLvaQBvh4xm7GHlYAscAMycLRmzZt2qwU7gPNJCTA98n0rQoPMvAAwdRMYMWYSD6g+6Tc5GEJOxSLAgdOaGy3pwh9zDpcPMMBODBdOrAcxODBttkbt4CeoVAlPqXw8fbCBESYZlgBwGZ+WmAQUrlcWfBA22RJYHG0Bon08zWZCScx+gdv/eB0mV5B8CHsQGG30VrpTbB9gRaEFPsE1YoW7TvddBTH695x5sKUFl0k8UlObWhRIISJ4EHfQEVY26hXCEiDNRENiNQ6zX3nsgDlgYitNdOAR++QG0HwB8+aUaAhlYAFZ2b6m5o0/vhUdlUHLGNIQGni3X1lFB/UQcAu6tCeVzZ2ZgInOAHWVYdnjemWdgV7LX00/ITbABWMplh6FPg1EwnhEZjHYpo575+Nx7hnXmoJZH4SlplRKwZ9KOamqJ6Gt2nRPmTUjUKtZ7fpYWAposAnBWYUmpmaB8a50llp3GounWhMbtyVKfI3VIRLHHBgvAsIaudeKqR20AaWEvCmH/mAebdTerjV2qu4FkPE7WnZNSaQvuEYu6yK5xmr4pRAdrsspSo1Q+qBtYY8mH3bFFrlofEmDumg9OOn1Q1k+L5ZQBBznlhKwQtS7W2Eqv9QfYZSJpZq3CP6Wm08eIDdoxmibK1xzKjPUUpWW+lXXlcyINJsRQdmaKqHOY4QYACJ4N+V12FIoE8JXIFS3xoAA0OkF03AVl8nsge6ddcxMfUbHF9XwkhbOVtLXF1xJDsYFJQtXax9psx+O2EzxDO4ncWmwg5Bg6ibsH332383fjojAOOTqPT/6J5JaDU3nmnGDOuTCbf56J56KbEnrplpCO+iinrz6J6q6D0nrskMBO/3sns9/eiO26a5I7GAUcIEYABiQRPBoGSHT8Kbz3jsnvSSwQwPTUP7E8GMQnf8T1ThBfhfZGcE9K885bAv0SBxQQhfhdeI8E+2KAXwT8oZBfPiXQR9BAAMIbkT4ADNhfABwAgAIkIAEBaEAECkg94RVgegl4AAACsIAEEFAIyUOgAiAwvQoAUIAEDCD1DKA96U2PgOLjYAIjkLz9RXCCxVOhAhiYQAkmcHoLAIABEDg9ACRAfRFQwAWOt0McRk5X9xsG9B44vQv4T30QCKECHmBABgRxAQ/wXvAeMEUAVAACEwQjEZJXvAQIT3oAiCIApwiB/mVvH9KLAPcKoEAANP+gAMmTIATASLwqCiGLEnSA8AKgPgMCQAHqK2ECAFDBAgpPATm8wAzrh8QkomKJ1HNiEf7HQxwuLwELaKQjTQhBGBYBfP/TXicpCEohvJGRAgwAA7jnAOoNEHyGJJ4DLsjIRepwkd6rIANkqUNxBNEADchh8IZpSwZQ0pLfyN/++rdJKPLSkUIAJSDTeAAuSnAI7hsCKhMpDjUOYY8AyCIJxZEAD15AlnOsIwbX0QAC9jEBzkxnAPQ4yOI1EpEMFAIdJ3k8SJbCftB8xPmU8D8RTm+W/WtlLRPoQOrZs3hjXEcqxeFQWT4AgftbJw0RCNEiqJCCyZteA5zpvQNMb4b/TGyADf25SBPuTwgRIKRAhVfEAPgSFAhNaCMWegn5dcEACljgN4Iq1EUQ1RJG5UIDPAgOpjY1EU+9qh6sqlVDZLWrd+AqWAfx1bHSQaxmBURZ0xoHtLI1HG9dhFvjqoe10pUNc73rHeyq1zTkta/qAGwh/irYOPDVDFFlK2EL+wa7MjEAYqzmFF5ZzC/8bwuJTSwTwgkF+gFisYyVhxcMyYAfHnUdmvVDapXA2dFVMrQKrYL++Dc/X0ZxohQEwP9umNshSJIIWcxpTxPQwgB0cQgGVMAKmbnCBwgQAhFwqXF1W4AFELQBaVSpUgGQ028KQYjBeyAarTs9A5ZSnDxc/0BpPViBelJvlhC0oQBzWAHqUZGnyjXoAUDIB9DCVg2YbCIRDMnFHArBAdjdbSF/yt19CrMAfBRpMYt3gGsaMAIRMK0QhjlE7M5zu+m74iEXQMcF3pEIdywtFmFK3MoegKqVLYJBf8uADeLTlN70Ih8XPEFNYhOg1o0uT4m51df+lxEBDoCPaTjAAirXp9Q1pSiHcMdkOgAC6qMs+HY54P5V+AHSpSADOJhMLxpXff8L3gUWidsmD+GLDlgzhLFZWWTy7wFRZe5DGalkV/rTlsCkaQER6AA5HmCY+ZRlQ4mcB/8e+QzSpO2Af8phLy5yt4IesAIIqIAuvnGBW7aw8P9qvAAEN9jAgx5CFhmwaNOW+AhcXCQEALo8o0Yxedv9LqrXCIEb9znH4My0rgtayKQuOp+NNvKjsTpaBkv3gFEOJoP1WbwK+JJ4syXuOriMXOqBEak+peBjF5DSJl/WAUkVwkl3fUj1vdOZtRbHsx+Q7THyEJ+mhYACJwrfE0o5AUHULhHzm8NjL07Zyz7EYd/g2fs5OuFjWLgbGl6+h0M8DBK/+BUsrnEvZLzj9kA4yNU68jpwvORZ+DjKn3DylVtB5S7fishjngeY0zwJLb95FGyucyPkvOfdA/oafi70iBRitWSguBVc6lKMPrPoe3Cst49w2Z1LGOndc3qwl6D/9CK01pREkOQCv24ErCuC6FBHgmMXWVr1cQF8ZqcC2buccq3Tee6bQHvajRBpagrUtrukXsGzPN+wT/KPARDuvYt73J0+sN8RdO70Iix5yOIW8hJ8rN+/OOAGkJGCxKt8FN+7YcF7T4UKLIACGEBq7TnUgwYEaa4Jofe9Y6QKj10ygQ164ARnmcdD6O6DIwz3llq4xTn+Ih0xYoDlbz35EFAnnYXwW0GmEY86haHz/Tw/Nza/jidu74m1h04uNh+fIj5E7W3vStxncsAWdXIpMd3LIlS51FiGYfEPLGohkNKnY5ZAOUQ8AVhmwQRoosQ9OXUBL2ZdeDYPBEhmA2h3/8ujS7Z0QQngYapkYAdAYhHFboOwfuzXd7U1BJVmbdEmbAK1aYfkaesEatvWf+nUeMgVaDXYYzPoXdvURiYFSVw0Q/ITTrm0ZHf3fblWAQdgWuQHRur0SSAoCCJoe2tHBM92aVmmgtRmaX6WbaFGdwJlUeOmfYIHAPz2WAQ0UQ3gd05mYgQUhM03hvyGXN6XXZ4EcFlEbhwlQLD3gYgQhXvHc1Dnh2kHiEUniFBHiEJniEWHiECniELHiD3niEAHiToniT1HiTdniTqHiTSniTfHiTHniTQHii4nijFHiitnii6HioaAW24XZpGFD6q4cqxICNYmQUiFZlJEhPEwi/8oV4uDIETIlWAEtE354IslB4yBMExO10jSBVD8gIwjp4yBIIwCRYz6A2OyOHPsxwbUCAgO8EK5qFtS9IQbwY3dCGD84IpCUGHzZHfwII0g940XJ48dR48QZ48ah48Jp48Xx4/L5o8QB5CPJpAJR5BHZpDLhpD/pZCPxpCw5ZBHBpGhJZH/RZGMZZGwRZGLMQSEQwU5MwaEE5J9QJJEUBf+gI7piAYYIxI8sSleMBdMMBR48xleUi9RYJJ0UZNSMJI94i5aMgUyKQVDyS+KYwQomSsrGVhH4CtjUTdtcBZF4JNSoJNfQJXkUZJHWQRJiXMquZRlMCZl0horIzOrYRj/iKEYReMYmNEbElAZCEAvVdIym4Erm+IancEep2GWgYESIYGXfak481Eb3uE0u2EZJpMb3gEocKITAAAwyBECynErsmIdLokhPAmXblkfLQMcUwMd0kEEUBEcjckdLgEwkmKWh0kbaUMxXwmWEdcrBaMyRPAfAaIlBXIgy7IgEfIgvUkE60IhFjKV9vEfb6EtGXAehsGTxikuEQMAKYIAK9Ii6AIju5kS3BEjZIIjraEjqPKTmsImRmKTPPmbMHEWTuIS2bkoQXIES6KdCVMvqEksIbIlZTEj1OGVsGlYsrkXfdEahaI3BJIsGPAmw/E0cRkTdJKgRNAosKEBL4MB/4XSJjoBKG8hoTNzKBUKoSzRLxPgoKfyGe8RKdJCKR1gKZgCnkRREqHCGAVjBHViL2+inu/CKZnxKfYSMC8iLeqSEvOZJoLyoRvaBBoZWnrxK5tiAcJCLA8zoCSDINLJLEPgLHMBN+pCLcNJBN4CLkUiBNriFsmypOECnPRhk0JgLmySLtGyIthZo1SSn0VCL5mCAE4Snto5FC86pWhynlGaJUMjG1GTo0MTn0/Rl0waLfYJnDf5Ja+5n9jTKxmzMSNxMzSDACLTJpiyljwTGCpjl/xBly9DqRwQHRqgmmPKmR6TM9uBATyzAT5jEm3JmY2ho0TjHUeTnfUSFIgiK/+LwZgh8B5aujK6ajVtGqJNg6OmsiNfIx0ugTKDUamDcTZTk5+u6aiNtQVWGgkfiQV0QwUgIDhN8KV+UKSMRVSBQwnbegWGUwaY4aqf1ajW2j7xqgXkWlgYWVj1Klj3Klj5Clj7Clj92lf/2lcBq1cDq1cFe1cHe1cJS1cLS1cNG1eo2HUxlgUUKxDweLF5B6/zqgVr9X895AQUq1kau1NW93IZq4YHxbEdiwWHVXUiq7JIQLIyy3U1i3EpOwwR+1Yk+EQf5G+xt0JMVlE+ZUMVxEslZFHM5QAOhULpA3pAq4aox0I39EKn91I0JFMTVHgdZQDWp1sVQETpNT4s27L/L+d+AiZZalRjVIR+PqhF3dRFnAdZpwRHibc8aztFBqR1cRRPJoZ9ehRhfqRPgTRIPMaDMIRoiFZQkXR4T2e2kIa2fSZZq+SB2RRKvhQ8/2eDGQVL7/VJtmS5nvtQtHSBuBRo3FZ/v/RvPmRgLVUAFeC0esZoQFW2kDtZsjVNVGdNXqhN+8RNwMZ9ndtOAPBuzmdOJutD7gRPfvdq8yQE9aR9N0a43MS65ec9O9RFjMs8tnu7OwcGDRVLJdW6ZKhSRNtkraU9TERSXDRAHTW+68u8JiV45bZSpvSMWTtT9fdRN4RRaWiyw0W23msGDxs/h3VM5LCzbFXAYRB3U9Be/+igwGnFwIrVvQMcdBcMBRJsVhScVhs8Vh1sVh8MViE8ViPcVSUMViesVSncVSt8VS2sVS/cVPvqwH9QWoQUw1Mww0IldZO3u5N1dXwFs1iQWQuBhBXLUG5XCTycUFPYdqf1vISQWPlnw5fQxNDUszeYRoFnRLtVeL7luMFFPIt3QzSYXMtFPQoketGFteljXddIh/LUYN51SEP0tOP1ZOYFZf5nej9rbtglSWBWSColX0Z0dhacwUZHBbk3aTOIaqamYKkWfA6GT3OmZcY3aRimYQCkZNuHa0MQYgYFSa92YlRWACrGRYNWPNrzYuK0EBvFxWskQQ0waxRWANtkff86ZUiIrMjDI7m6F3+qN39XqLqnbGX5h8n854VfFmbqJYFmBlBpdgBrVr7x92ZRJGdgFG86NE0P6LOqFLqdTFVv7Es7xLq97MuPSgWzpYa83MlOhIL0N2UryGkuCMpdKIdrVGrYlVOo9s6r1mqFNMfApQCyRmv9Y2sOAMpUSE6yjGIcdMs72E/G3IeJrM5HMIWhDEFWiM6q5j0oCENcGIPw98PghkAkRr/xd27pRoe9NQQA9W501srxVW+h7NDvewDbPEVpVsgebdEY/QUhXLKug8WWNNQ363AXHdS3x9T66dQCAdXVKtUpR9U+t9RQrcNNZdRJpNVCxdX349UJBdb/5SPW0ETWzmPWloTWvVPDkEjU22jVLjtaU+ezCiHELguPeJe8T/B1e709SZ0EVmwHbK07T8zJWrB/Qg2P3Vd36xPYtYPVTq3Ff6duXZxbX3zI1CfGiUfGEMR4dRxe8BRfogdDond565t5DUQEnDeMnyc9BnDapLdh/LVfxTtFFtVTBcdf5EVIrqeHxbQ/NGhyks3USaZ7i1RgQxDJvzfJOFXJs0R8qJXJNVg80Ld92udh3Ad90sc91Sc8WJY8btdH2g125yRFtGzLdDZjM3QAQ8ZqMLaEM7hOFHZNxC3XV3DcJd1kwwxl8zxt93dlV6jYqUtnm1uAE4jgUoaAmet3/wvYgFPkhgreWpU7ziY7u6ymPohmZ920ge2Ih8uMB4V9O5Tt3CfY0dI2PyzYaTOFzyStzzkYPpybar/WeBPdgysGhBDodENoUvZdy1rkYbzXjhrOaLdWTkxIWQV+3/hdBRrdjhydghWdhSGNbS6Uz3xthmHYR3BIuvGHhu6cbtHrhmEYh7T9XjrtZA/Qvgt9b1GGaPP22x0UY0t+VsUd1GqdRCNOO3mu1E3u5H8OAHseO31ecXeO0YXuPIPuOoneO4u+Oo2uO4+OOpF+O5NeOpVOO5cuOgHwC57+6aAe6qI+6qRe6rSwAoeuztuw6qze6q5+DCfQDa8+67Re68yQAv+BDjkDQAC53utRsOu+HuxNAOzCXuxIQOzGnuxDgOzKnuzM3uzF/uzQnuskYEvFMO3B3gK2JADY7uspYEu83u25zgK2JO69rgLUgwLm3usDMD0rsO65LgDTEwzw/ucEEAAnUO+5fgIloO+BjgIi4O9/vgIkIPAGf/AIn/CooAKm3vAO//AQvwv0rvCNdgK2fvEYn/EaXw3dQPFFxq+p7vFYsOmBQPK2Z/J/gPJpp/J7E/IibwUs318u//IhB/I0T9gzzzkxn4g5nzk734hf+U6xSAhZNPSudfNMbgQnpVNC3wUPtMRGkEX2dQRNr1wLVF9Q/9FGPwgPpI1O8PORqGz/HORELnUBTa8FOVVeSpBTjpsEVr8ERZ8IXS8FYF+JYt9nWP9ODbA/a2xL6lN5+xQBKpQAvPj0iDf0bC8E9XUAypXke0Q9YatTT0a3cf9m/KNcV2ZcEjT5YKT3fL9AnA9ALtVpiSf4EORE+6NCwSO0j6U+i9/4Uj89cpR9KYn0do4EY29H+/ROwuNSS5xFM7Q/qDb2wzRtDOR2lU/Jk4T1h7RPcf/2hj8ECBTbdGv56qNcDCA91zT9vK9btO9DxMNB1594xA9lIZVB5ZvSHkRSzK9cVBQAVBX9tW/7clATJ9VKTY/1AUg9EQAEi8CwEVEMkRHAclkIFJhRZiSgWFae/4BG4PEIQABHpROKRV68YCYWKr58Aebh5Q1mx5GBy/ERDhjz/ra6AhrwCiACL+4GnSqkICMJBiIrLS8xMzU3OTs9P0FDRUdJS01PMScrEy+i6g4T2/6YthYSFyzJltKkqKwOtbh4jxgAyJwOAFh517LcvpCV9V7ZolkP9PwibqMGvQyrAxyiGLmcxo2zMlVR293f4ePl5+nrTdkhWV3h2B6OGsQcGTJuG5JfS6gYBMBsV54H5QiBcRKgApkIWxRsQQOnmawIdS5W0UjtSciMeh5sAfin4BAr3goBmzjkYZZBIf/oWkfJXk+fP4EGFTq0Ez6iR+0ZCJAAKSSjTaFGlf86leq8p1WxbnpDpM/Uq1nBhhU7luhXsmfBmkW7lm1bt5XUvpULNO5cu3fxluUZiYGCZEF94RUD9JylunkRJ1bcTi1AJb0qPFqILeapwEL1mRr8Sd/lTYm6Ot27mHRp06HMKpXM5EGiBK2MFHHnGWjmUps92fbkBZ3o07+BB5c0OooTA0wWYGuAq8nSIavTjcNmQKmhmVBavg6MrUAEyuqWLBCowInEJ1gOHHGQSEEflXNmgkNSJkB6cexDA/BeRcwdPm8aCNCL+eILw4qUhjigmC0SAS+Bg6Q4TLgJKXzLLAcCKEa/56TQZ4vjGkqAgSoKwLAARwBIIENWRkzAFxP/8ehtiio0NEKBCB4EhhghxhmkLyv0QRGbRZzJkMcoYtHGPy62qmyhKqRpxcAUb6wuGOqgXCKRxyIkrsIvwWzrwgyRU445ADDE5Q5anlDAgQNUZKDBMwRKwqBiHlCxivwwHAKMRBJ5ZMmP4BhEG330wSKyIglVYwlD+yvygVcAkDOPgqRUoL2YEgrpAc+2HC7MUUk9yyzjpGhtqVbeSMZQJpxwU7z6okMygDN9AZAccSABhIEByRz0lUGUYoobIfUQlqMlhlSSIj8m5ShJMbiZ8sEIrLwpSyrh8rLUb8FFKrVne42suaXOXGLEW9eFIh0kPp3zRigxXA8JBVkzyF0G/69gdNgqlurDn5jMIE/HPyhVV8WVImBARfuiVWNghieeEsH6FuTiMt66Ddfjj4dq7Ea3PtTk1cRA6xjklVm2ylt1/WrLSpO5UKwwlVvOWedSJNzZrZ59DlpooIU29eWikR766KTZIprpp791GuqqpJ7aagqrvhqqrLXuujSu2Srgr3PDBNvrs/MyOwoqmIpEbGbdlSIALOF5e24qjjsgbkv0hvsutdEO3MKlPSkAIBCleDsTpeoe24tO+kYMcMEpR8vpPMFjIoES0TFAz5neLEC8JgyZW88E3mQWOufEIYLZBMe4FwDTB+p7pgf6vFWIIZKDYqIG+iiEdwBmzTyqyf8rTz4sp+fkEgClsB3Z4Cb+0tsIXBTAZW7GK81wRA2XyMIBEUc0oAAXLyrAi+PsphsAvdeHxAFDIoe/5tSzOP996KhCXvn/+0e4fCQhCrljF5mo5zexXaBt2wsAE/RWARnNjn1/mZsD0FGiBbStfdzT2waLIxCm1E90bfMcBYnHFANs4QD5OZ4AARjDtVxORXszgpQMF4a45fB9UGiRuxz4GM+1R24VDJ/50Lc5L/QBAslwINzi171WVGCEkrEfE514HBAyAQIT3BoMZRhGsQBudOriggEEoj71RM4BI6NgSNrWgLExYW7GsGDeYIcmImTRg76DF2USwJTd9e5dwEP/IQgB6cIvipGRgwuLERB3Nv81kpL1mKQ7KmAIwV2ykp18Byc9uQlQhpKUoxhlKQ0DRlSu0mWs9MkpXRlLnMlSHrCk5S0BYEtZ6hKXseSlK3/Zy1UGc5iqFOYxNUFMUzjMeKDgXoWUicxOIm8mEABfJ+qIiQrMcRTPxJoxpRlO35iCin1gwAEiyYlsXgICe+vmA78UTXEykobGU4CUmIDGKuAidSlaQHX2lDsGTCQBwdtgHs4JO6UoZQG389zw8im8gs5ug+MbwkQdqqd0GW2eHS0KOJsXBQQywWDiiUA/E/DPOh5gHHX0Rx8qAAaO2A59DSiAUqAQxTDgYg9RUAoT/2XqqCUkoAI6zR4Aeto0cHo0nMwjIEnT9b3wMQClKl0CBg+ZB6Zks29YNYYDuLfF7iE0ok3Y6nFOigQHiHVdSLgmWeTJVADW051UPM450ei7G+kPjVZFU0tb8VKRgoimEcDRTeFp1I0ugXsNaKkWZ+FYxcolrnJVHvJy5wAG6POozASIX7Hap4GqFYU9fF19sAXPd53xdD5FQgOKUUcGbGEp48joRcW0VMsKs7LT1O1ucdnbSgoXuGgjbiOPW9yuJVeMzFWu1Zwrw+g+92nTnetvqctK6/5vu9lVmnd3Al6mdjd55BVvzrbrzU6oF3LulMf06ILd83oScAak1SXYC/+J/Gpiv5qIXHPUsDniCaSF/WIOZRbQVnL5w3mvlO98h/vgIqKiv5ioMCb+awxN4WJzVIANBHBhhAOMrW9SXaFE+OdgCIuTrpGQLW0fcb5/pLZStLXma2kchdMFj7a4eOgQEseVHsIpd7jI8PkKcKMOG088UjWtk73wmIsJlR7mXfHHnDqEBqMQAmDwBxINuznGNRESI7rAfok6O98xxWDeXCKaknEA2BaQfns7nxHGB4XkDEQJB3gECbsHvmzy8CdWvnK4sjyLCaeUWQ2tHlgfyOhdfMevCMnsIUVEJm9u8YSRSzJuj8yUidiwARVQcNtKjMAoqysRy1HxoY/ZYkj/1LHLTzJfMvpiVTJf1RBUqDTxIvvYFOowHVF4M5lTPcUR2rltNTRAgdPHwxs+WdOOhYT+emJoWJfKfy/mUDWf98DZ+kmfKvr1uGuLaWALL8iF6EP9Lrrs4rRNCAWwlJ9SFLf1IFjBdkbCYmsp4W1f1x6KQ6W2B142gWfC4KVEeMLjuXAWSxzim6S4NB9e8QllfLkX17jXOK61kH/8NCOHrsdJfjWTT23lKVdMy6uLcpdDDeZMq/nM/yZzvEyENDfH+Vwm9x33YqLhUcFbKLhX9EX+PJRBH8dP7/I4pKsWKz5n+s/AiTl3snQJ2SsyHmgihweIbUR9gN6P07XQW+EY/6BEnEky0C4FyhwARwOJqIoU0KBHoPsRp3sbZ3FxvoVtuco6v3rQEu08rgsBfPObHT6zkUCud3GnSIUQTqNg5oW+zwFeaMXbjppUsxrWpurdfAKSIQRleFkB7gO9nvcqouvF9/C+zc1TT3srDeP2fOKIQO8d8Hu4K+B7Ch4p9x5Aae5hcItkD0TjMwhpKfQx3P5sdNIVhMAMKU7Sr649crNeQ7n3xsxxaFvXz5Q97qMe/ZFYfq9vtfzO14zMR712EhE7fXj2bcxeDqIdiS3JhG+oAK6Vvg/8ToHrICjeAKEQGrAIFEcIQOTHzq/6nucIzE3+9Ggp4K61omDucqysTP+LcfhOP7Zgc4ZvnwDQ+grN8A6wZazOEigP0VzwBVcmBuWOCN6KVHDQBtOiBncJCH2QBhOuB4eQaoTwJ9YJBpPwCHlw4TLMxdJpvajuEpYwE65wE5SOo5yQu5IwC+EBDC1BDE3DCLvwhRIQCoRH95hAoAjqAdROCPSkTwyBcQTPAVPkooInktDOYQTFsdzqDWenx8DOHFLwqOTM7qquCc8w4tJQzYyhAlFIsGIK8yBxfBigfOxQ9uxvqB5hCUPPCvoCAkRkEokopiBRfyIPAEvqRkYs3HZw6RqRcoJODbVIEutody7qmepIcZ6I+xYgrexunYyvGIRASnJRq9QN+IT/z8kyJNVisSnMcBaPohbVTaQCi4gYS7V68Y7s8C9SSgiUwNpAMaryrhSzQbDo6BajQP2SwWAEEBoXkRppEQptcdgKaAhGayB40Ygo6BsJEN1Qp7QY63QcBgogoAhEC3Qw7QEHEPCoLRrFhRHpMTimkQkrMnAukmU2MiO9D9Y60iPtISSxjCJF8msoMgqxYTqOQgzJ8MIC6CQ7LigybA+UgAxhhZtC4W0ixyXdR/8mLCtIUibjQZmO7I5oEoim8IgsQb1wciKJUuUW7uvuUDbmJG7aSgKlwQGTLBPd8QJVsCq5hAry457ERheFgBAHiwRpy4EwAnfcah6jkuUuzvHO/4cBrucuTSsnj8hwxrEMAsR33hH2fo8T08WmHGYB/AEAe3LNimjMNMmB8kbYhNIk5zJtFu7TlmIFU8qrjvKIDAgdEkCTnE9Dtg8c0yWmHICBEIExlRIf15FxJO2J/oogkfAyaU7gyo+KOLOh8K847sgvyQFOBDMA9wo1jU0BjAUe40wychEX6abW1kcDV/E2cdPmoDDeetMkBIwvuezf7swLHA0sjwoYpcBg3qAY3maQnvMxHwhzVMR9Qksf5fI6kWYo3cELJPIH7TNp8NMUlGIIhm4s/rM/RaFAuc0yDRTrilBBF1SphGYLHelBfWa6sjAKrXApPQH7PAFD0ZBCd//GQjVUnUaUEzgUM0E0RBcu7n7M3mxsK4ug7eBSH28FdWwHXljDxopsbuJPowZxeNCNdpZCLN+loGTUtNbQx/SkCj8yRW9w4UKR2LRkbISz9FaKMmdKfbKQ0FDIEqM0f4wlMl3PMCkRAjaP6/oGTMPgEWCyKB3UScdIN59vpLovNKkTRLiqhPii1bTnOLinGNtzNl0PNXVxKTQwTW/RxJg0294UTvlTM9IFvnbNGGRjG68KsJiyh3Tq/h7PAitvHYdNOv8PGNXRArEKUYcNHhd1JBvVUeuTFCgQLJ8A3f7k3zRQtPJ0tUJjJviJd1QrVtsTPu/mBM0TdA71HkFod1T/JGRa1VVjcmX0kx6wLSgQ1Fln6VsCtJlQYSJaj1mttSQb9Fs9plpHhVzFlQnMFUzS9VzXFZqa9VyhcuDa9VvndePeFV7LogUIYF/5tV/99V8BNmAFdmAJtmAN9mARNmEVdmETdgXuFV+FYgQGYGIptmIt9mIxNmM1dmM5tmM9lmJPoAU+dmRJtmRN1mNTAGIrbgAIQGVdVh5Y9mVl1h1idmZtthRq9mZ1FhRydmd9dhN69meF1hKCdmiNNgqK9mgriQQEoGmd9mmhNmqldmqptmqt9mqxNmu1VgBMoAS29mvBNmzFdmynVgSU9h5MgGzVdm3Ztm3d9m3hNm6jtgQe/zZF65WS7lZe61Zvz5Zn9nbb8hZw/xYkB3dBA7e5CtdADzeMFvfKGjeGHve8REAASiBtBYAEUnRyK7dpMbdvPSEFAkEFUhR080B0PbcTWCAPWsBJUxcJVvd0PSEPUjZFVSAPBAB2PWEAkKBlnVR3h4B3cXcTBAAJHHV4gSx4OWEEhiBx54sAhgAFkLcTTiAAVsBVp7d6o3cTUCAARsBVt7d7s1cTROAEnHUFyDd8NYEEoNdVSaAE0FeUrBV433d+6bd+7fd+8Td/9Xd/vSIQ/Pd/ATiABXiACbiADfiAETiBFfiALdN3F/iBITiCJXiCKbiCLRiA5ddes0uekvYIO//4NyIXQoXig32QhMuQebFzKEz4BVe451DYPxs4g7uwhRcjhGcohumRhl/uhe8Th6lRhxPDhi3Hh2cRiCWHh4uGg2XYCY0YRalLiRlJAhAAAXxCAjRgHpoYL6JrAqg4CrgYASYAK7jYK4i4EjDAAqZ4A8IYE8YYANo4EyhAAtwCjDvBA+j4E+74jjXBAtYYE/S4E7I45yrhiy0gKN54CTZAjj8hjpeAkeHhkDXBkeEBii0hBBAAA5ZAAxT5EiD5Yzigi/G4jzlhAgoZi5cYONSik+0BkjtAlDlBkuVBlfVChU95CT4ABKQgAzZginFZAiwAjTfAA9AYAfiYin0ZmD3/IAPo+IwBgJERYJcv2Y2HGZSXQIqfmQMA4JIt4IqXIAQ6IAo+2QOseQOwOY4pwAIwoAOmWAJ0eYqv+Jif2QOyeQK4eJc7AJutGQEoIAqGWQMsQI6VOQPgOZgBIJ8pYIoRQJnD+KD12QPqGQHuOZPl+KEtAJuHuaLn+aEjmotdGWlrueSOpo3PeYpHugMyIJuhGZPN2QLaGQFw+Z8BwAM6IARIeYoxuaanOAo0YIq3eZ8BAJ01Gp8ROp8xgJHHGZuf2aal4KKROqWlGaGlIKmjeaeV2pmdOps3GTXKGBIoAJOj4AM+AAA4oJV9OQNkGgPaeIzL+qwVGgCY2Znl2JcB/6ADcPmQPxmbNWCfESCso8COOeCMBfoD7hoA8rqZN+CkKQCXbfmKM+Ce17oDMBmMObqZNeCTQ6CgfXoJ2himA/qxMeCT+ziPJ8CXPcADEnmyKeCK7VieuRibwZqfcVmy6Ti13fiPpSCQ7SKVu5gC9hkD6BimESCuv5kCDhsAXnusR7uQ5RqyAcCb53qiqXmeCdungXq2K1uPHTmOB7uwg7ugSxkSLCC247qQOwC6o1q4dXoDmlmOu1uusZoUKLkSPoCbmQCdGxkDJIC60bqL1Vq/2/qt2TuMATuhazsKmFmapVsKEnkDMEADPkACDpyU11uzd5kCOGCaLzm/l8C+Zf87kzXgwDWcCTYboBM6xNH5wJdAtDWAm624jVe8oPm6jUmbqhHgijucsOn7EnAb6EJ6t817wumYizPAke27mTFApieAwZUZoROawCGZjgv7p/fbw1F8wtc7wgt5mb87pmncxgWcpZ08uoO8xNWZmIH8y1EhviPBkhVZk48bjE18v1nbmPU7m1W6kJ0Zzcu7oKl5sD9ArztaAjrgijvgnv18n2HZuB08x+M8o7t4xQ/di3f7nUtcv0GbCRDgsueZtIVZAlz8ijdA09t4Az4cAeSZ1B3dw2u7o5lgxymrxxv5x/McAEAAzxX5zcPYnztAnpmbCfZciqM6jOV6AiD70y//vZEVW7sRwLUB3a233LdP3cud/bn5PNhpHcwvu9bPfNrf25S2GhIEnaQnoKV7Wb9Nm5j7e8MxeZxtXbqZ2beJObqPOsHBmY61nc+v2coZuqJbutLVPdVxnLB5OrMLvLaTWqDrPJ85gKrbmqEpwKEfvbK/WbMR+rBbepsB/sUnuxJcfUIhgZAnXKTZm6cXWpHJfQmUWZFxupDhfZetPQOAudgjHt+XHd6LOq7TGKnRnAkuXtrfPY3FnOSbmafbXctTPKtBQc3Bwr3ZYr6HAgQUu+DfoeMZdBRsG1yuvkl9gurlwZpbeS0YuribQpZx9qNPmBSyvlTSnlVpOYfNHiU3//jbmfjtXTju2/6H6b6Gkfi7Rjjva4/rRfi5lH6G/T6I9x7x5N6DC/+I7b7vPSFhSA7wb7jxg4KEZ+ILGgUVcOI1OqQ6OwE3SAH0w0Xyh5jygcLyn8URIJ8UWkM/NKXz8ckTRF8UZv9bSJ8LpdWLsoLnEkcnK/PuKwFF6gBAVEIJ6gQM9kNAsyP2maAvFG21GoD4rWM+thJj5mRR7MNeiCj5EoQBiN8Br58hSuX24eriTkgKEkBDs1Vb4SG/ju7afH8M8XQKGcdDvR343eZZTKRV3gcIAgUAEZAIGCoBRxESuDACiWKR0QhAqADnBXAJgBuFQMUYYDSFAEUgAlAO2f+MxdKoiNAd3wPgoGa7PWBpERYaHiImKi4yFg0QNEZKTlISEgxUHhpMUW1qngEUKGSSUgkaFvA1Ii0eDJVqXcJWPiKOgal9ZcG94T49HAUoPLD5uhXRBTQcp3XpEjn5XhQEk6219ca16Qr6NjzzAs6Ok8PWlqOnF8lKJhsUelI5vMKDVmSljkWFuUWP3iZ4QIUam2X7lEUwECBUgiPLgjlIMCQKg1RUDi7bAkaBA1xRDDjI0qeCwmQBFmwCs6AXGIGN2KlLdA6VtSLghIzhw6WIkpAnC906wCzNymeh6hAR9M+anGzXIjxLoAANkZva0AgSGXOruplcv1KC2ahYAy3/1cAMiYAtGSciCnE5iEDtXZUn1KgSE3hvYIIIESTWvaCQIYMIClAuNDLxjEVCUaYloAqA1WQDChkIYjDYFZHDXkY9CYsJbCGvhMaUsTkIToQrCq5ciBbgQGHZo4rcwkUPADFlRo/iehDtSplbFcJtG/TADxgIVoFXyEp6einT1K8XEsuILLy2obTWQ/O3QuPluBY4YELEpJSBqg44MK9ycOMEiIkAptg4KfOT6alQxoorFTCx2WK+VHREXJFoR5112EEYoYQOQjLhhA0q4k53VHyDyGUA/FVAYw6UpdYCdyU1DFB8MHAYiSCeRJ8q9g3WBxP67AfAiyaiSERolQGw/4ACCryzWWqeEYIkIxiS9qCFT0IZ5SROSrkVk5nEw9ttn+ACgVyqGMDGESsxtxQY6hGRWxZhShHjQvXdB8BbV1Skilti/lSmjmB8hB+YCyWDUjB9kTWUIld+RWWVizIqpaKNkoMoLMdFmCOkXEm61aOXctqpphV6mk6moa5IakyjdgWqqauyWp2qrZKCKqyzRjoahJvSmiusuOpqiKy9AsugrdjxGqyxjRZ7LAC/KttsLMNelyykFnHmbKjSGsustc5qOw62HuJi5yGUkULtbttC+i2w3aKbLbQUqtNiF2CZ2y6n6vbKrr35vjuduiwMIIAhmV0UgEAKqfXOcBHshf9bWVVcUQe1ETNhBRhliEEFBKkBwEACZVSQEW6unASXYiAqcIESLe1LBL666tsyrTGT8i0JuIhAyBFDsGXjFkwgUUBGYlwwigM67QZBxcNQm4UgwjlN5F7wreESES1CENlBCdK1XhsLTAH2ZPPKDMDLudJcNqtp0/IqIyPgskIhf63UyVSgINERXGpdcEAFQlptxnn1TgZ23QcsUPSJ32yJzI/urRfxGYYZ0MBK1CxhKLpnz9wvrdWqnZ3nYKmbQgADqCDPRAqca0QCqgQtMjSHEdP4z5Bz9gUDEDjNypAVKQBex8FHpkV9ZegeSgO2K2kv57OyTUQEsnGMSLWgV4L/PaPkfhX9lG6TAnZzhdBBFyuyXX4HAA2gebXkdfahW8cRpwYBHyZeBBgEsoeiCkCgqCUthZLZ82DlvQZkpHKtaF0mtBe6dYwuUeB7ICnCpLmyFbBV2tJQEQRhqFs0QCDKUIlJFsCZEf7kaPhZycKocACKze9iDAlDxLqQkp9ojB+iYECLFmAxiZFsdxupzAMihg8wBCQCesqE9ySRQQqur3oPfOKqtMWdImQpKQbTER/UQI0+vOKEQ/iiCo2wODdkrAgH4MNleKclA9wlCkNQoWeKNpChDSFkGVPa8B4wF8IUIXYdVNE9EAaLJkaCilBcpNkmaC8rhsEUoEAGJzzB/wqxXW8Il5xCGe2jtzO5cDEeO9yJYPeOVByET0X4JFIS8LCzlJII/wmkAYRoOfZMQQmsi1UEuaJIRlLwl6HaIBi6RgQEoqFyT9tCF9+BydSc0JlT+GKYzlgIzlDEjYKAoyn7t4a6GY9/FTiA/trXmB4BKU0BUZEWCFYJRDZCmMBUmzw75T0GlKk4YRChNIOkkmgGaQoeU4Zn0BfKjp3hh8XppkVu6B2NqIQaERCED9+3Hz0F7TzAWcJbkPLOXn5qniKtmSPbBc+RWuiki6gnStvF0kuptKUQiqlMSirTm7rMptuiKU5Jw9NDvBQW3LOFuAoxVDklJko1IlVQG/XTnv9iCqQxeWJu1DCLo6KiqITgHhJkBEZDZPKqlknMUrniQEvVlIJPheqppJqqcnwRHVgtFSKOWlYHEgGvsKhRWbei10Tq1FprZauo3JqOfwXMeN4BoQjBdrRgkFMYaBgUP0NJzh/eqCEIEVxAJhOxlXT1TYg7zycXUELOMNazKqGCHTvYBiQMSiGuCRxmYzgIfwCnsyg07XlcQc6GBoOBjggstwxL2EUNVgs2w9lAfLFMFQ6iD3wo38mK8LF05rUBaOBji/wYGcOA0whl8CJoxupN7b0ok8/t4hi9o5YHgK0iWQitWwTUPu4Ow364KZ6W9DLf9n61D9r15i4V0VRGJff/uONI8HApATcwyG2/lHTLFCjDmRq5IgKfBJoxqwVLOGnYZKy4DH0JJwokBtgVYpNThfvJIaGhBwKaNC9SZdk+WNpnlWjCJZAwGcZXoHKSaX0ggxVciiI3shKmQx1fXCsQ/Vp4CBguAB3QyOGD3m5kK6zy+q5cgRZ71W8I7cKXR5LXAiwTyi7GDUfWoKLQuqFGs4TGfe3Uo7wAqJ9iDrBFCjzk0CHZyB+VEFUXu890XjgxrvhhAq6sxlf8kDEzqigSgYbEd5R4uv9EYtj+OcZDb7KdrChzZVojBTm3L9I8NGL8hLHRK4stUNVqaDGEm1O1GlfQaKUOkg8s6Fb5ukrR/3vLQ61rawudU6uV2LUiRpzUSfSauL8OXbCl5L2+korZ5VJ2s4056AhVe9rXkrayiDlUDMNwZ33yMTkBYxiyqTZPqYhMugUomGCQiWIHmQcb2eCZF4KyE/jeKB/yAwrcUra0C1EoUmfrq1yTI9zi7pTEnwRJZWgBw2wExaJD/UI0xPqh5BXwdpfmXYZ88zPSRSr8CMyzO6yR5VSo4zBYYRGDJ0gy1h1vkRaiTSIp5B1UEx2hyQ2lv14ni/TiNpQqnlKIXxGLihYlGNc9hWpRznJacDY+XwHLrPvQF2fApqTTRJtJjp3qVxP7im8uyjmHGJTONmNe4zTnZxV9K9imRP9jkG5Ub08CcVqYxyH8fmZGaFsSif8erifBQakfniJfzdPV6SE02wGpzNXiozyk4obmkb0iD+vzGGGu9s6AM818oBqO+Mtl9o2txtqkr47aR4Vo6/3Zmej7sWMi+CIYRufZ672W02V0d42D2F+VPGrDUHngWxVAlw6wqhH6Cocu/wy94bec/E2m07MYxXprwMZHiIYyMZoJeqODbcuA6ofnnRxCQktskXASgDxAtsI4WDX2DXCkLIz+vdlYOVxuMF3dUYEJWc+nKYMIfVYJscm/wRA1OIQbpNZJNNoNrcTKGIxFcGDgMB6RQVwl+JkmqM/WAR5U4R457FmNIdUQ4Fn/IdnXGrifaOXVxokeGhVA0PlMaAldfIQGs7EHGBzTvAzco63XZABYteySkChR73hXYdDOFkGXSNBc7JkdFrpK431FRwxYIjSAFPlICvbUCibfFRxA/pFVYuASqkmeV2UfA7CSA7wf7aVH2x1gH6Qe5mmBilVSiwVUHPpI1/lILJnRilnSO6QSYyjIl8zQgmSC013ICE7cdZhhOSiNIdUIntWXja3BpylP5DGG7NQhjaWH6vEGVv3eG4hhH6LZFqlZIO7ZLomCEg2B7sAJKlJG8xTBYeQILzrR8QVLoFXiIlwiLDBHEl1BAixVbtBhYvwHWyzE9oUeRLmJJ9qh+iER/x8w2yqyU+ExYAj1WKfFiPe1mhdNGnCII2U4lGHokFAMUCQK47pQYjH6VD1u4aXEFVfwUQOQIWs9zFcYnqPMI7/YI0zhI0k1yi0QiV+FgfBFyUBGiSRKCDEe5CEc40VOUUHCTEJqZGHF30cGE0eijUeKZK2E5EnSE0l2jkpGSUa6pPOwJPSYZEzyUkrapExy4SycBUQqXh7m2awsnmjgZE5uzkwaUE3S3TgMJS0JJVBCm1IGo9rkyFv8Y6vMVUiJoOMVk1mAk8eAzDL8X8XA0A/JhgOYRGZV4CdJRmTNxhFMBWc54GqlpW2djw4FAwKBgQ0N3FjuWznAZCnQCV3tGv9AoUO9ZMxQJhuU9FVWThVSahDURRIV9CTWFM8BQCF+CYedFVWV3QV4YdcN+tM7AMbOKSHKOc70PEzs6GAcqQEdFcUoxNxlNKUkBCaWvAYD1aZjLpu4NCTiQaWF8OZhQebaSCbGUWZ4+dO8VAsG+oLhFN8CWFQ6DlWinVnc1UGoSadH5FhlzGFj2NzZIUjo1aawFCUjAIzADB4EIGJwwUWQHUwbuMInxZyZqRFkwSUapJYBgpHeSAQbBVda7hutCUO+BRxugJpjUSYSPUBI5FUZMIdQDEak1RIuLIMACkRu5N8RAtZONsLjrdBFEM/53eIZcB402NkrIU/Z0d3jHN7/lL0erE3BdenO7MGR7IDnKfEB6ImS0IAkuAnjzYBBzgBfylDOJxYftTABHwEURUieGmkaab6iQBzNNp3XjLkcIXim/+zoyykRDjoZF02G8FAmSWgfI/qFGAyGfmHXY/AgfFgp6qncVG7lOPSk/oil/KiaWW7f/7RcjulNW0rZ1KXfOOaW9h3BESjM4DAUgKJY6G0fYEplh07CgwVAhHkNXDypN3lTmDAfloIRgbiiC/ohheHh5Onopm4nnyTbk6YdQklGe4YmiGxYqKqfehTAMy4lEsjHNdbeiiEUgtApoE3qAuqKO9lTsTJC6ZxO6qhRaiCMn/kopzbEe2jSvGzC/ze+6NSpHioCFOmZJi6OXpeGgunBapjGYgJiA+wJSUNKVIisae+ARIn46imSCzDGU3FWkbKCFfFBSkf5K5Tc5iREgdVIBJsIQZ+qAnV9VaCuj1ZZ51el1vitHpYSKE4gkfaxAfdF4PedK4I24KwWqhHYSYQmxDQ6RFfhid3dSHBg37CqjUXG5MBKyZEapTx66M3yGr8amL6qQ8joLM7WadDu7HkSrbFQZITIrEvS7NHmStLOFM86Ld4BKTr0EN9pldJlgsfAm0ZCLXYsrUo2rSQ4QCsuAloRHpYklQWd5NdaotROLQQZbSVEwQWdbVEFXwU9m9aJpNsWbdx2D9wCVf9xSmdVNI4HdSwY/dZ0MWOQ3I+ejGX79U9VcULDfKTfTgcBiN3mcm7neu7ngm7oiu7okm7pmu7pkq7gGgJVqcd7xVcBZEETwtyApYJ0UkWHGFJeZWbUwFHjlpUC9q3PAu7wUgHrFoEYWE5IFICrEmK5/ggx8IQwDEFzQqceNsbvBqeRYS7x2uMTFW6atNmQCAQtmqvyUBelSBIh1qi8Xi82EIHleq3wcu/wPlHdatE7kFrizpqmAU59gVJ/TAT9cKqpcQLfXq78zm/cUlHZzsIFBCQhSGTGneABJ3AFm4O+Xq1ZBWz+dO1Fbq8F/9oHg3DPjnAJU6oJr4oIozBUqfD/CisXArtwTLZwDN8aDdtwkt3wvcBwDscvD1/KDPvwIgFxIQzUBtfVVY7DcO7KDgdxMVKR+CgDEverIowTOShxKVwxI+wdsTBxE0/cE31B3aStJBiejFmxFAsVGgNbF3vxtCGWejaBFDFcJyHGbEHgwDmnR1ygY93Q8sIQgHyW4jaaRvVxbRGx5IDEe5ipw1HWZEBEJE0oq3FxG5fwcg2pCynnzyXyCr0pEzBhbI7p4SVhdPmZZgJI6ZGcPJRFKZtcIbApEjjpGXRymZ5mRPAQfbFp1VIyCH+LpWJqllkXKdHx+5EdgkRZILIYkGwqLAXlZcxaMUSGkDGzztSNgBSA/6iiGnZeWY4ORnfq8i5XMLMymWq8wjzYKDUdBjEfSXgdsy7SBSsbwqg932O8wRTA88wljbyymIqgWowCCTf7XPYSJzhbMBWd2GzUkgAP1PKwrD/FyKAgGpCBGl0grB97hPSdWopxWvehhaoRw1AAwwjRBfl1Yu0VaniOYSSPzyQTdAIPsamQhyLYLLC8dEsfZdwCLdKysU2z8E7z9Av/NPHWNAoPdVAfS1EnsRrHRHkmAlOjA1IbNU37dAR3gu6l8d5tMTk49SEQzqg+ZlQr8FQbMVdkZVYzpUATlbF+NVg7bf3C0At9Rm4IympF7vwJgUpbAwVuFjLUmv7plnnp9f9DoNg1gYFQFE6jrZJI+A3DWURpCTLwQe4EVmy88dZqDTRbH+0TmXIDQEBDfrLKzebYcUy8vtFngt5ow+J8AfZ3pbNV71eaapLwXEZmaHKOpNcX1hczYGYq+tFke9HzrTVmB+0TMXMUQNOBeEToVc5sqOFSIg6cdAIaNjfKZRonu7YnhoKjhZKodudzcyM0BxgV6NL0vsL9+baejfUJC/fNarbtcbaArPNBbWom+hz7piMh0PcxcRgc0oj75jJD+AVgHFW7Kox907PmCVdm5E7ZAdQzaeV6s3dxqtpuiwJ8zQdEh14yNjdj33deMWhHDVh1mxEBr4G3meys+on7yBD/tWy09nSUJ8tPvWinZT+1T0M4FEG1JJg1IvQNo1C1BN14hLfMjrPKj/uSjQc5tSF5UOd4ko+bk182lKtkk4fzkku5Tl65t1h5lm8Llbv0lnO5s3j5/I55mE8kmC8QTPMPIeQtdcByAnTwLJS5mT/JE+elUjvlo2nxdZdRWnNqI7SIzq3iegTnVjdmkUxwxKE5nQcLGOPQGDdQevdmJjAwJvehcnI1WsfzSGP6BTP6Qb6xFmyMFjC2Zi1DEY3PXaJFbjUWYndiYIeYo/5EH79nvxWogB0ofnTtoLeI3QZJrWmqZOuDyeI1ZcCvln969wYpc6lRJvOuaS9OnqGIK8Tg/3zJ9puw9uXsKChLK5ciqROGts5N0hAmBvpyqH1yqmb+0buqaUCPIaFHebKLWy/HjcbYXncbon3YEmiBhHqomC8AYlVTq7Yv4qa2KtoR4qZOhvANurYSwnKnYX0854jgqq52J2UAbznMubyz9CQsmbNWhVWZs32HqDpVxrtKBCe+u8BDd5+Fl7SOK5LWYjVa166DkwMzgtJM64lyKsrvYH2nIl0cu5wvOsfPikEXwwEk9IpPmlyXmmsAhjPOKn9re/i1R0UrLEf/G/hVerM3Qe9p+Pap2kUV9snyRspyerwbvfYWPVi4EVcEuiGoha+TBtvW+Nq7cdtvBR38JleEDP/dTwjXvhXeC9rGA67hE/6RJz4JL/5xIf7UPn7j373kr67eU77xXX5pWH7mL0rkZ/bmcz5BdgqzWaXxTLbOen7oCy05LPd1/6QhpJHph7dRpr7qU0L9ehQsMFvf446kzzvo276FhLp4K9t7zRwUlKVkB1TX+CeHS+w+tZYWMQP71R5l41TtB796N4KQBgCR5hVZ6JwYjBL0aqa6Iw5uv3ttV+x6uW5kwK66YiMq3xT2Z/+yCqMva8wrwB5PKA0QXBIFCCARQAYWx+SioAhcAFNqwGBcTA/OA+BQWE4NCUCj0Fg4IAUqYBGYOhwAK8AQYLT1e37f/wcMFBykGiAgREz/VFxkbHR8hIyUnKQMNGRMCRhQaTuLKKtoe1Agg1Bgg5ijSu1Eq2urgyh6sCro+qJ9AIDoeppTUNClumNgaJirqyCrZG62PHSOlp6mrra+prykhEA6+Gw7BbjAAzBOKm44t3VTgr0yDwhd/wIoQGrQpb1S3jsIUDhGB0mCK9gMNtJ2UOFChg0dLkz4UCKfVxMtFoJ2UeNGjh0NRvTYsGJIhiBJnkSZUiXGlS1dMjL5UuZMmtFi1sTZ8mZOnj198tn5U6jFoEONHlVZFOnSa0qZPoXa0GlUqpOmVsWatdJVrV0JcfUaVuyzsWVhZjSbVu2fASUEvIUbV+5cunXt3sWb/1fvXgElTPAFHFjwYMJvTaBdm1ixiMKNHT8O7BfyZMqV35JQnFmzZgIDNn8GHVpsZ9GlTZ82Shr1atatVap2HVv27Iawad/GnbuSbd29ff8OxBv4cOK+hRdHLohAEubNnT+HHl36dOrVrV/Hnl37du7dvX8HH148dc/Jox03j+1temno2T9y/37aevnM4tdXdB8/M/r7Jen3T7nyAqSmPwIdAfBAPxJUsBEDG8xvQAgRYXDCRB60cJAKM9wwQ0Ew9BCQDhtkTDIBMAvRkbcGGADEFNso8a8TX+QjE+Y4oXGRFphrIcc+SmjORz1Y4FFIRWxEIgUj9RCBOQmNZE7JJf8JWS4JFqakQgXmBMASgAGSQKxLP24UE4AdkRihSwGSKFMQFJB4ckobTxBzBDjbDGQFJLgsk8gAUCjzhABWwBMQOwMIc0okRCjzzTQL/eMEOvH8EsUuRZgUUj9KABTPFUxok4RONe1DBELxHKEEPBMldQoSLG3z0VZnpbVWW2/NiQTLduW1V18LY7QNAn4ltlhjj30LMcaQZbbZXmEFgAAZnaW2WmpLeFKAFq3ltttmW9SjLW/HJTeuw/QY0UPeXCz0QbCKAyldDrPlk1Z3WcUv3jjFXLfeWe+FUF9N+7UV4AYFhpTgWg1WEOFCFbbXXy/xrc/hVektWOJ3ibO4TYj/e5MAAQQaYvjAjiWaYOQ2UkZgAo5SvujjNjz4QGQEQBCkZQBgDoRnlSSgABEPdE4E6CkokOCRkgk8eQqWLTjI5yk2SFoRpI+umhmpBbnaGZmp2GADD3beIGeX0+JA5aKDlmTpAJt2Wm1stu7g7ES6lmZrh74GIO2x2wgZgQ04SHkDBDrgQAObMRhZAgssENwDDdi2AAOYHYdc7AwMF9luAAIfHAAEMLBAA7CzBuADEDYXGWekKai8A5ElYB0B0yng3HSjBRcZg50hF7kN4CnQmXQAcBfZ9NprTv5q0AnnHfGdidbDbUCMXiQDyFEnhPpm8OZDb5sQc49n2EU+v4MM/0Tn3PfXLagdZwuS9qCDECYA3nf8bW5DcQRKp5zloseBz9kscKNznshCx7vR6QF4FiAgA/UHPLmxr3cA8F8DrybBKSCAexGqnsScBrU2pI2Ak0uZyyhgOp1dDn71w8DkplA5F2YAhh8om+jsZkIMBg0BH9ADCIC4QgAg7gNA5EDdcLc+CuBsCh9QHuIoELSUZWB3SXNcEXEmNZhloHhQm+L0MvABtn2ObUjjIQp1RsQU8sF6Uwic6aiAveuxzWggKOMguuY9SWAPfHsQnzPgNr2jBY1xLpuf6LDYgeNtYH1H7FvdspjFDvguBIzsQNK2pjMZAoCGa9RA2uzWNTQi4P+EPsQiCfdgAZx58HNQyyQh2+BKCTCSChoo2wZT2cEPJoJvaVsfFYz3O55pgIUuu1wAO/lJM86QdL7ToTBJiL9otuGSGJDABi7pSWhSAANdm4DhKMABCiIwaV60og9dRjp0yjJuAPDiOsF4TgRoD5rNPJ4Ehom/YsrRD2+EYx7xWUc9fKCXf9ij5/p4xoO+0xqDNJ8mVbZBZNaza5U7GgbqF04MeNFm9aynOzvosmUKcArGHCbWsLZPqH1xZhk8JgDYGdJNVtSKsvtfPqOZUkjwDQBhW184eUjGfoouBITEXuWyOIFKJtOZkBQlFYaqzj10QH21BCJUW/ZHKEKxDVf/Q+fu5FlELMqNZxqcJzzrScY55rCUBCSqyow5PYVOAaD4PCAV89fI5HnUdkBjHPrO6EQ4KpADgR0dB2unO6SF9Gi5k6nNNODXyUH2eOjzQBc5h7PatayTTSxgIiA6UYmqVGcgSGvqkMhJC3RgbJVsQyxDpgedLbWpcg0l9UCbz6nuVJWRHdsGYmo82VbwtPBDwFFRq1OXKhI+GONDBoh3OJw9r6j+Yxw+K6c9wd1Wuxgg5/+897xqtoGtQ/Nd/HR62f9xoLPSpWc6fRtZ8a5MZaBLKzqXl0TbJVBw0Dup6dq4h7saLapGg+02w1hF7BkNrPVs5xTSGLQ97tKrGUCc/+MUSoHVEnAKjPOAH6lYT8d5wANUgxlU64bDkeo3pLNFBNyeptOIik5kFlBh1dSr1qrtL6eBNRxtXcbdDXgXg7qz2WF7598FjpUKtSvdfIFs3Bur8MZpba4rEQRdjgBzJVnUSIENSUKg+VVk8FWrfJtJSgmAwJ8ynWZqXVpObAp0vaPDAOdIzNA0z/VzGoAZRo/3zJHm080IId++EMHHsTD6Gj5tCMu0fJLA1W0jYu6bKVMXNNhS4cFWzKGDe9xaD0tY02zdrUu9Okc7Xy0E9WQlAF4NapWG1QImnl+KVzsBrSKT1IUVbaIf4eiwELsakMYTQOOIQQXq9cY6RSd/Nf8garDZmbyBPSSc4alnNX/VgAUUbwak/Wn2UiCzI1NveCF3tg2UEcZfEXbCuPwvjVEsGhulxh+j4WV8IxpdisYSsiVhbEogLZDRoCNH7hoNEORwGvquhKSr1vBHDHJKPqXgB4I5iANqnOB/SDggDF7BuzW0D2JNxMEnsfD3WHxJGE8v7P4WCNQSULoDfrgEVB4IiIPczhdhOXtcbiSYU8F+tcwAht0nUPvRtn35hB1TD+c+yBrtgKVebD4L115wD06IgHM4YrF5Y+gZTnp51eHWpTddc3OAcx+AGQZwanJGBD09QxdS0VXacKoVkrYb5+UrG7m+WMrdAwvec1QLGkX/Dowcrh+Y8DZlaNCvJi2JBBRiG1d4YHVqftq3PrEEskkFmO22GXY3D959pPciHtWTDudDp6ngUnKLDs1h9eZvqUDnkcOxcnEeWgiaKPdS6xSx/+vnMMXaTz9LYLI124BJw4mAcfKn3gGL98PmLbyYkxCPiTyeQFE7ZAq00Xhdk61rPw00xZv3zb3/aW7hGrQPVDKJtvQ0zi5Petz2tmX9LDEPAL9XkppVowTUSw7Ve4QCUIWTsAc40IN1QAmMs5kPGJsSS5ul2wOYiidtAyfZga31C5qrezJuGzkFWh/yqqXgejP6Grvkua5mSzvcKrcQW5zSIzvrCxd7a7nsk4Qx/9gDguiDO0gCNqiGO+CDCBgJKpDAQXiFJbQDOGjC/9g+UkFA5FDAQQDCNthCPiCGelAAh6CFPpjCQIBCPijDnqpCTbnCl6CHlcjCKXiDM+zCODBCLySHCigCW7AHBkiCBvgEbviHehgIYZiCAkgAKABEP7yHCEBCRDwCQGQCBxiCcsCDKWTEAADEXUACBXCAc7ACNdCCCiCGJHCAMUCCLKiAJDBEAQmhjNlBScjEJCgIQXjDZqCHM1zALtgKHxwEKNBEPWCCIgQAJfyEOVwGMWAOB4gARKxFS7wARMwDABgFXdDDTkiACIiASpwCP7yAR0wABogABVgAJDQCNvBDBv9IQ2iUxiooCCsgBlpggEfkRXIUhzCMgkUQuDJpQ0BYR0C4RWYISJSIQwAAxgbwwmSshyLwgy/cxgqQwAfwh1SUAyqYw4HoBF48AAeQyCagxylIgHKEwEpMxynsSIpsQDp4xyv4ggqYg4+cxUs8AmakkDWElH78xHDcAwlUggQ4RSbIgk9MxYvMAmVMh2AgxABIgAe4gDCkAlr4hikQxABgAyvIxE2cygK4g6PUBQOAAntcRSR4gHUIywBoxbP4N0WYw2ccBoVsACloSHLYxgKQQAdASCV0Ap2kRqTcyS5gAHK0y2JUgo/EAnPcSEJUR16Mg7tUgnacgnxUSTcAhiv/eESENMii1AN7pBKbbJfrSwRaQIJQiEBeDACGtMembIPAHMg7YEmOREo9VMIHWAJ1ZMhD1MlcrEVvfII8+ALW9IJfYIMFUAAlhMt66ALIjISCBIQuHIXlZA4IaEZe9EqlbIeJDMMHDICUxM4imM4jEEnjBMnvjEJNvETFtAMo8E4v6EQAEEo/LIgEkE44GIXsREWlHMdGrMlXXBjPRATQjIe+fMx3aA51BEYyWE0IlIOLVMoyOIM0WIPUVAXcPEklqEgv0EoEdYB0fEx1nMnorIcOhQTlJIQKEE2D+Men2EcxwUmlnMaMDNAp0ExoBAB+OIASVcY4cM1W9AWD5Evb/9TGSgxFxszLH71QHDVINniCqCTHKYxRfxMWgKOJE2WKFFUT/pQEniyI+jTQgSCDOcRMc6xI7JwDfZhRhSzGowRSA+hOJYiAdFDKImXPl/zKBbhPTYzOOt3EivPFMqFSntBFPTDHnOjHodhGzHQIEZ0X/WwE5rhDj/hTLhzJRiVD8wwzK9WKJKBUqdhTfuFMJ8yCcYjKjnjUYYDAQZBShxhU4EBUC6FSFeAUWXnMLHgCqWzEq4yAB3BT6LROOwDKGWVF4USCRmWCpaQDN80CeBgJoWyH+oSDIwADDPVVsTRFhbPUt9nULqFSIAkAUIGFe7gCT2BQKtBNy4xCJf1UfP8szhr9gwQIBar80F0gTbZczCONQi14ViNFzlMlmWr1j1WdECp9kwDIlFgdBSlQ1uyc0AVgAG5AA189hZjk0Ox0xHQ4AEOMAGVFhisIg5B8USYsUA01zHuN0w+VWH1liFT9DX+FECodARM4gWCpgnMdyzxlTyFlwmSUxyalghhlBTkMgE8IiDoIA1mgxorwxjKlV3uwV2IwhpRcUnK9NH7dD5VtkD7tg3b40IX1SPRsTI+cVi3F0wiYSGLtRjf1ycgMgweIxJEY2y69BwikB38ACGY8yFuFgpS0CJT1DaqdiIHUCqvNinCgCb3tDb4txqm0UT94Q79NBMadiFGdBMD/pYpPbIAWlQnC1Q3DbYBNNACoVVxJdQTHrQrJFRLMRQR/yNRBEF2fKMi1FIWfjcB70AXyVAKizEVjZU9e5FhBpFkvcNM5gAd5YILNRQIpqE9D5UQ73c2/VNjfNc4+FER8NABcRYI9LESxXc9GIF0fMd3xVEp5vcdQbdxGNVlrWMfVBYpr/YOD5EIzzYXcpQMkNVAjzEX5hV8sAFczaIMD6AJiINpRMABp9EM2cIAuOE2nPMRN1N8K2FxUAN5gcMasdcczeMrXhIA7EF997NRHWN1AhdTb6N4vZGA0TF1CCMjybQj03YOCZN+nJAeLXAYgFNr5tVe0JYMCDs+DTUl6/0hHjvUCLnhRW4BYKtBhkLTMYWxMXqzQANVaNFBQMlhFwWWE7bVF0P1gd/hIx31C8B2LFdVLZcwDooWHDG2CByTWnixgW/DJJrBQcTXF4BXGQizWVPRdJJgDPsSDifSGOW4HNF4HZV0AojTjs4zFJ1VLJGDLzc2Dzn1fXrBhLxBN3HQDMkDE83SC3qUCHsaD/62FeAVPnU3gUK2AA6jEnj1EXnTMyLTNatwDedTeDQ5dKyZVPNxfWYZcsWhD/7RRIgyAAwjjBx7LLmDlayxNLajc1ETIE+bF/1UA8GXX+AVDL5gFs4xgRNRG/XXXWS1m8CTiZGaDYa7N9E1LWbROef+Q3Uf2UkkOAwaIRHucSkPVZHQITW6ug3XQUj14Z2umheZVB8Xc1VpgYzHlZbz1JVgGBDQe4zrOTktsxK1UytlVUyncgiYY1gdQVvdUz152RPLs0ShMhzNeglOcU15lEzy+yDseXjctToXI5STYZTwQzjxAYiB+YlV+wyfASGUOTy3AzIud1joghjdMYiOth4yNQowGT5xeUHqoaT8wXAKh4sdkSFb4S4ns3xeGxjvQBaKFR4lu4zZ45i225ja90NaE1K0ugm0OB+Ecx1AAx2d8g2YMxwG+34XwYssVYUA0ZfBkZXes4aOlUfK1TE6uxbguA6MObHEoTx+dy8jkh1f/EOJ8pNFQ6GtAeOoAiWpVnul4TlhzrOSuBk968Gk7VuVQVAUGBNOU9GwyqAMNpQOQ9Wo3cNPFjkwUPj2pXYQv9AJfnu3EPMSfLojF5dKvnoL5zFA3tVF4ONskEMKJzGZ/7oZPYO4rgOxbGG4vFVO2UN+LM+g/eIW9jufAxEtzDNqIDu1QMOyghctayMa5TO0rLm8YRdLhDAellcBnHgffru0StobuVQm2lWWK4OJs2O6X6+4xKQhkZYB4XlORvIc8AO118FKznYP2rAM93miiVsYHV+XptEdkjG0zpu165u9q8O+UAHBCuGU9HWftU9Sq8GBTNVOUOPHZuGz/yOyZ/4jxP3jAZnaJGpeNG9+PHA8RIKcEFRYKIccPIvcQI1eE861KttxxnlDy+mDyDHFySXDcKc+JKpePK7eQ7qXeYqbdLDhekqbKP2ZjCc3VYU3yAl8N296NA5+S7qXgKpjvy7xHej1lZG7jWiBXLscJviXCGQfJAG8ICZRzP1j0yBT04KBza1hxd9jfXibCAWeK7m3iLABqPBhQrF4HpaZhq2RY8XzzFoeER++IRvfHEkdwNXzxRYgAxFWEGJ90d0TCpgRaRHdCtmT1g6jxz94HMmhSKY5sKUjsinBG2D11Q04E173iA3BeZ8XoMPgCUq7EcVzpMrdQUk7obFeAb+xVaf+340x0AHseaXJf6PalY+zsApIkh+g1gkIEZDiAY4fuaGenAnYZhM39hM6NhFvvWG728UdYwl83CDtn4+lGczKYzjS3bqUc9QBugjZd0J9g4XsAVLi9at4sgGo30GMOgzCAhTyX9l8uBwimZGI/190+akU34OAcTv49anCQWRI/R0vkUMsFyXalTDhg5og2az5gWZeF2aIV3wfEB4WeA2ClSiRE1ivg3Y2+A8yM+lJsjnB0XjzWWuVNgEgc7RfORH/4ebF13oQGdtyGBIE3i4wPxmhHR3L4ApD/6nHsXOTt9AU3wpm2ezSA2HiGedfO47hv0Zgk+XWAdwZY4rA3aiT/9OEteG+i7+6AHdg6LFpdwGGaD+oSRUJHVsn8vVBJ9fwI92SqVvlvVWC6DMdx5HRfV+IKn4MDmOYHMH1CLhC1N3hM14zWReSN/2u5r8osIGXiPgME9uvE3gW8pcTh1PNMJvw7X4f6nnnCt3kX3upbuGOZnMb0RgbjBfppNu+RlfxY3xQk4NbixupJFgMaTsfO7eUHcPyiDMVl3HEfJv0Xnem6XMb7bn0gAAiFhYPQoGAEGIBDQRhYJALU6PCKzWq3XIEAOyBwx+Sy+YxOq9fpMJYwYGsN1ETzqWQ6AQVqw74nFBHwhFWVYHAnxNBQxaRUaDAVAIi39KAQ4FAEgBSg/7CgmHclWQfg4GdEF9CoR5XUSOlwSrUQAMBIVdF5ezqrBYfldaZSgjKC1dDAZNDwEPAAAGG0NyoE4UAnDQHwbFDQEDGkjQXB7a3NCRCQiH2lDi5OZASQEBpwgQU+dNDArXhhiTs5BK8Mu+KmoMKFDBs6HJJwSLCHXBQUGoNE3hV2FDt6JDhxyEGCDA682tWHVbRqS0xSeqDtwZRG7aosIHdFJit26ehxzEWFgTppNtXZo7VkCCZNAAImalIFT6ykH7t8QSimqtatXMtEFBKyKqplZRrsysKxq9qtYQGMXAt37dBAca2CyVo3r145XwG03Qs4sMe2bwUbZsNAQT4hdP8NF+57OPLevn8lW77MhfBVzJw7j3mM17Noj5TjjD4tWTPq1ZhBs35dsDTs2XFVP2Qw5WJj2rzdbhYCubdwrG9MDz/u0LbDCvT4XUT+2jV06LKnW5ejvCGE54qur5buvXf18OTJZGeT0pmtoPxizSrSZz1ToNwg+NFY/uPjEl76+/8PYIACDkhggQYeiGCCCipoQmh+GZdfhFecp8Yz0ThADXcHnANNAYhcYUsE0wwRDwANcCehQ4WJsGCLLr4IY4wyHkhCcSne+KAwv60hxRGVYBFIFOosMBVuoQiBShW/4KjijkwKV5kck7BX0FBlpPWalQ1RmIaF0mQI5BMBCUX/TwK7jDkiEeE82VFhbPIWJRtHNaTlGFiyVudCXKaR3koaRsUHPSlNwQB9RNXyJkNuJgpbnFys99QQc+JiJgAVhNMPFbMAtWks9mkq33sJzBRBklQ1MckBUyRRTx3R7GRFqLhMVRMrEXjoRyz5lGJFppoooelDezJ63aLEruboFpmwgsWUSyQGQQJ6cPiAO4lV25yWIXrIQASgrBMpY0bYkkgCz1VKCB92DBEiBA1A8c2aJ3ILySlGfHuBAk2oskSeCg17LHTGBjxaslos++4Vkwphy2JBSlFFFJMOWaRR94SrCDlOlKokuAD0SKQjc7JjqibqcFQEsI6wRGZHABM8/9zAMHdmcBaQNnvkIgpEq4eYAi35JYkJVzqmxess5hwvjBUQoomzcNQj0QJxGK9GJyfCybdJ57EPRS/PzJvMYF9W8xnO4vaEuxG4lC5Qz3q61CZ19FtmKEkysbTSdwCVwNOJ9DjoJVNMUauQPmGtyiQ/5hG3sBD6NnaxTkbOWdkM7fbaM3h79jXlrIntuWGWL4T5aaukW/DjoIeO2uqs7zX664d1Lrtnrtde2+O4c6765LufdvvvXcUufF60L5RkNFpVgDrBwRevFfHQw3W8shGflQUd/5zxTMJpMI+iGgFtL9zz0w+m+/mz965QJuJMoTwWAWFvRvdrgD+z+eo7vv8/2eybUYxjYMF9EUiAAsQBsQBA4Bl+4AOgmAcBBWBvWfhYWx2QRoQqVIB5B8gENwKijHcxjwpP4KAHu6HAj03Ce9HxXf+4Ir0XVoV2JaCCCQZYBQVEw36oWEAfUBKAXRBqhEFUCrOIcoECHpBEKRQC/jLxgID44YdQucATofGMBdqqN/qT4b/S50Xj/a8MKKDCCXBYQCukRINU/FQVrNg8IdgPAO4zET6GYB+k4a8RUWxiHi0VxD1iUYFU5KILwzgYE8xokYxspCMfmaASjJEMIzDBCUSARjokYY4ZBCLQ8JcTSlyjgga0WhMB+QQ+jq+TVRTkA7LYPfzApouIZAP/CSCJy1zqcpcKwqRBDmmGOjLvXQkkRCHXCA1QXuFTSXRJAzDoQF24cpVOfEUJ08XHLKqwgbOhZS2/GTNgghMu3hynOVt4TsGUM53stJ0421mVdcJznpGRJz3VYM976jMv+eRKIfURx4X0IXxyUCY537nPhEqmn1ugZpWKmIWBDkJfVJyoGgbKhlUKM6BqYahCP6ofhBrmn++II0kvylE1bJSgW/EoSF/aJIUk8IOsyIQRtPkAtkVgAcvixkRNosOPvSKIfeDGQDGqAB1GzFv64ukrQgkojH4qE/kgos9CmEU3bjAAHUwhCBvhBBJSxKUwLWtBvMnDKKwSFQXQpgGV/2e/H1q0qM+wg1yTqkQHPiGpDjwLXj+xuSw8g6LGTGEeqWiSC0hRJSlcKR2hERBqREEJ64qpWS+rTpFqAZlBXOUPYXnEvjbFVp8YLQQ8W0T72AeIeyWsX/VlKvIxwI0BuBUh7JM2fPyReRWgpjYdq0rDVrC0DyErZo9rBrSG1rRQaWsK3ypHZsm1tOOjw7uoyMCkIJWwv+CrIDKxOdw+1rYFQCw+zKvYJv42KdMUbhKJa1nkynct5SxmAQKyrFngVKdOZYpFVznCRpylEf/YLgAiEAumZtciOclEA9wnUaA2oqrWZC4KjSpNbELWvRYtrmbnC2KCMNShVaHJWtIY2I7WfTjELE7DiE/5Eet2ZRCvyNnnVtziHJPBuDDlsY6R62OQBvnHlx2yQo1M5B7jWMdITrKQl5zjJjv5yFBusZSnvM8r01PLWN7yAHgJ5jCLeZdf7rKZzTPmNKt5zS9y0JnfDOc4y3nOdK6zne+M5zzrec987rOf/wzoQAt60IQutKEPjehEK3rRjG40coIAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2242=[""].join("\n");
var outline_f2_12_2242=null;
var title_f2_12_2243="Gastric attachments";
var content_f2_12_2243=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F86322&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F86322&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Gastric attachments",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 438px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2243=[""].join("\n");
var outline_f2_12_2243=null;
var title_f2_12_2244="Idiopathic granulomatous mastitis";
var content_f2_12_2244=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Idiopathic granulomatous mastitis (IGM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 307px; height: 586px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) IGM at presentation with skin ulceration.",
"    <br/>",
"    (B) IGM post resolution.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael J Dixon, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2244=[""].join("\n");
var outline_f2_12_2244=null;
var title_f2_12_2245="Enchondromatosis";
var content_f2_12_2245=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Multiple enchondromatosis (Ollier disease)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Hand. Observe the geographic, expansile, soap-bubble lesions affecting nearly every bone visualized within the hand. Slight matrix calcification is noted in the metacarpal bones.",
"    <br>",
"     B) Foot. Observe the multiple, geographic, expansile lesions scattered throughout the proximal phalanges of the foot. The first metatarsal and the diaphysis of the fourth metatarsal also contain expansile enchondromas. The expansion of bone has widened the diaphysis of most of the affected bones.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Yochum TR, Rowe LJ. Yochum and Rowe's Essentials of Skeletal Radiology, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2245=[""].join("\n");
var outline_f2_12_2245=null;
var title_f2_12_2246="EEG Subclinical rhythmic EEG discharge of adults SREDA";
var content_f2_12_2246=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F51113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F51113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 512px\">",
"   <div class=\"ttl\">",
"    Subclinical rhythmic EEG discharge of adults (SREDA)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 492px; height: 335px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Subclinical rhythmic EEG discharge of adults (SREDA) in a 52 year old woman with headaches, preceded by a widespread, moderate-to-high amplitude, biphasic waveform. This is a rare but normal variant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: BF, Westmoreland, Klass, DW. A distinctive rhythmic EEG discharge of adults. Electroencephalogr Clin Neurophysiol 1981; 51:186. Copyright &copy;1981 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2246=[""].join("\n");
var outline_f2_12_2246=null;
var title_f2_12_2247="Normal urothelium";
var content_f2_12_2247=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80375&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80375&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Normal urothelium",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6MPSjn0pR1orX0M0IB7Uo+lFFMoRhkUoGAKUUtIBuDmnY9qUUtFwEoxzS0oouA09elOx7Cl7UtADccdKX8KUdaWkA38KUD8aUD1paAuNx7UU7vS4ouFxv4Udugp2OKKLjG49hR36U4UHk0XAT8KMUvelouA31op1FFwG49aAKdimSbu1FxgOp46UvbpSr05oFFwE70v4UtFAXEx7UDpS9u1LQAzHNFPFIBRcBPwFJ+FPPWkoAbig9aeaSi4XG/hRj2p3U0GgBmPain0Y4pAMPXgUmPan96KB3G/hSGn/ypKAuNoH0p2OaTtRcVxvej8KfTaB3G0hH0qQ0lILjCPajHtTjRQAwj2pPwp9JTHcaaQ06kNA7jfam/hT8c8UlAxp47UUtFABSilGMUlWYIUUCgUoHNIYClxRSigAFFApetIAA4paPXFLQIB0ooFLQAlKBS0ooGIOtHelo+tAgFFLRSAQcUtFLQAnFFBHNLQMQdKBTu1JQAnalope1MBDR2paKBiUAc0uKB0oAKTHNOxQRxSAaKU80d6O9ACdqKWigBO9B607tSHpQAhopaKAE7UnNL3oNAxMUtL3pDQK4najvSn8aMUgGnGeKWlPWkoBCd6THNOIpKAEpKcelJQAgxiilxSUDENB60GigBD0pKdSUANpDSmgigpDO1FKRQaBjCMj3opT0opjAD9KWjvQav1MRe1A6UDpS4pDAClopQKBB3pRQKXvSuAUuOKKKBBS0Ud+lIAo70vcUvegBBSigUooAKMUUuKAEIopaD0oAKWkpaBiEUUuMik6f0oAXHFAHJoxxS/SgBO9FLRQAlFL2oI5oGJ7UtAooAQClx60Cl7UANoApe9A60AJRS0dqAExRS0lIAoxmlpKAENHtS0lABRRR2oAQ0Up6UCgBtFLRigBOtIRTqSgBpo7UtIaQCUUtFAxD0pKU0hpgJSd6dTTSKG9KSnU00xjSKKU9KKZQtL2pD1oFUYICcdqcKSl7UDFFLSDFKelIApe9ZOqaxBpsTSXEigdh3rkdT+IcbsINNi3S9S79PpgVcaUpapHTTwlWr8K0PRKHZI1Jdgq9yxwK8lvvFXiJrHerpEh+beigDH1Nc7fXWoX21bvUJJUcbuXOB+FarDPqzrp5VKXxSR7hJrGmxtiS/tgfTzBU1tqFnc8W91DIfRXBNfN6+UuW3GTBIIHTirFtvLt5TmMjkEVf1aPc6Xk8baSPpEEZpRXgOneJNW08hYr6Tg/ddtwP511Wj/EW8WXZfwxSJxyvyn/Cs3hpLZ3OSrlVWOsXc9VoxWJoXiOw1aBnhkCOpw0bnBH/ANatP7ZAePMX86xcWnZo8+VKcHaS1LB4pglQttDDIpqSJMDscH6Vyt/qsek3BeedIgJMN5nGR7UKN3Y0o0HUuup2ApRXLjxxoYAP2hiPUIas2vi/RbllVbwJuO0b1Kgn0p+zn2YPC1lq4s3zxSimqQwDKQQehHIp9Qc4neigCloAQ0CgUtAB70AZFHFN3LtzuGPWi5SQ49aKrPfW0ZG+4iXnHLCrCsrAFTkH05oY3FrdAaKq6jqFtp8Blu5VjQdzXF6p8RrSGVYdOhNzIf4m+Vf/AK9XGEp7I2pYapV+BHf0Vx9n43tPsiy3o2Mf4U5Iqhe/ERVY/ZLAsmfvSPjP4CmqM30NVgK7dlE7+iuL0Dx7aajOIbyH7K54D78pn39K7KJ0lQNG6uv95TmplBw0ZhWoVKLtNWHdqQD5aWgdakxE/OlopKQBRQaO1ABSGlooGJQaU0h60ABFJ3paKAE7UdBRSbgeM0AFJ3p3ajvSAbTS3zYp1J17UDDtSGlPWkoAKbTqQ0AJSdqU0hoKQ00lOPWkNMoY3SilNFMZX069g1CziubZ90UgyPb2+tWa89+F7PJa39uJCVilVlGfXP8AhXoQ4FazioSaQ8TSVGo4IXvQajeTb2rB8VawbCDZE2JD39KlRcnZE06UqklFGzdEnHlyAEfrUNzqcFpaSSXjiNY1ySa8nfWJZLsNPcTEgkuAT+lVfGerT6hotuiuxiSTEmO4PQ10LDNtJs9KOXO6TZl+Lddl1vUJmtyVt1OEDd/eoPD8MH2lElcgkjJ9fWsgyFjtUEqPas/S9QlutRRFJA3lQo9K7Iq+kdke24RpxUUdpeTPHdz2hf8AdKSUP8JHapdH0i81OeUW6rIU5YnoBinPCUeBSBIJ0V1yORz0rWikv9GgeW1Z1R/ldcc9eKzd7aGUpcsbR3Ej0G2t4YxIiuSeg5NQT+G5pIXvbZogoP3d3IFXdHuJp79Le6wI5CGJJ4QfWuil+yWMc0dpMDAOTuwc564z2qJOUXY55VZxdjz1LMxNIk+13U8gHlav6RbxM7q2FDjqRkA1k61q9raakwdny8pxx95cV1Gk3dvJNE7wILYrnI5OPWtJKSjc3lU08znb2RrW/wA2e5QDg471as9Xu45x5kjhT2PpXZ33hiG4sor2zcSZJ3f7NefalbzQX+W4x1/OpjNTQ6VSnW0R1UHiSfT4mkjkwTwAT3rjdQ1K81O+ka7LXMgO47uij2qdh5jbs5AIwPasmOGV9WcxoxjkO0jcemauEUrsuNOMXdLUl1bVLbT4g8zCIAbV77j9K0PDlxBr1u0OnsZtg3ErwyDuTmuK8caVdTzRTwq0kSjbsHVTmrPwlup9F1y4uGicQNCUcspAyTWvInTbW5jUqzUuVI9S8OeMbzw9ei1ut09kTlozyy+6+h9q9jsrqG9tIrm2cPDKNysPSvnLVbqCW9mdSAxbAHQ/WvVvg9dyTaFdwucrDN8vtkc1xYimnHntqcGZYWPJ7aOj6ne4FMkmSIqHYAscDPrVLxBqQ0nR7m9IU+UuQGOBmvGP+Fkale3gW8ihMIf5dq4II6H3FYUqMqibR52FwU8QuZbHrWoeIre0vZLZVLvGMuR0B9K4jxD421SRkh0/y4Q3GQMtn0rHtJ3vLhXJyztl1DZyDXMeLta0rTNTNtNKUkRsbV5A5610UqCbsldnr0sHRov3lc0n1rWL6Y28t5cFm4KhiPrUS3N0qosdzNhyQ6liBxXO/EPU9lpavpU+zfEC0yHBYeg9Kr+D765n8PedeybgszRqx6nABrpUHyc34HbCUOblSOpEk0hZYpGLD/aqw2q6hZeSttfXEcqjJIbgD0riLzxbPbSNFZoiMjfecZFdPo5bVtAkvp8CdX8s4HBwMn+lNxcVeSHKUG7M0PEXiC81iK2W7mKlI/mxwpwepqp4Ujg17VjbxXC7o/vEcgLWJ4it7yezS3sonLuAHzwQM9fpXS/CjRbjRfMupYAzE7SoOc596lxjGk3fXoZzl7NctNWO0n8KRi8ji3Fh5ecgcEjtVm9tbKytTbC2WWZ4+WwSEPv74q4t9Le3W0YVo/leIHqP8a6SyhtJInMaMgdQrBq4pTkkuY82riJ07c+p4xNYPHdLbiIu8zZj8vv7U/Sta1Hw/f5hMgVDhon4DexFdNq8EGn+I0e0kDKqswyeEI71y1nPHrHiK8uJ5PLtUiJDerDvXTF8yu9rHoe1VSNpK6aPSj480028cnzfMoJA5IJ7VLZeOtJnlCFpI88EsOAa8q0q0a+vJobUMGCmRF+nan3tqQzxz/urg8YxxnPtWXsKexg8uoX5T2lPEWkPIEGoW4Y9AzgVpRSRyKGjdHUjgqcivn2z0q4vpEbLqoBBbGcYp8ep3mm7DFcvGATGCjHBx+lTLDR+yznllUW7QkfQWOKCK8K03xXqq3qCO8ueT1kfKge4PavTNK8Zadc28fnyhZuj4HGRWM6Eo7anJXy6rS1WvodRRUdrcQ3UKy27rJGwyGU5qUday2OBpp2YhopaSkIKSlooGZfiO9ksdJuJ4RmRFyPb3rza08QXLXkbRzSNIW5HUGvW2RWBVgCp4IIzms+20PTLWfzreyhSXOQwXkUXPRweMpUISjOF2y5AWaBGcYYqCR71JR2ooPOeolFB6UlIBDRSmkNACGkp1JigY3vSd6djmkPWgaGmqsrv52B0q0etIQCckUykNPSig+9FMo80+FNwF1G8hznfHnj2P/169MHXivIvhg3k+IYFY8yRMP0z/SvXVAAPvXTiF7x05lG1dvuLt46V5x8RcpdgE4UrXpOeK89+JsPmFMf3eail8QZc/wB8jz2OaJgzfex8oPvW5pmni6sbiOSP904KE+h7VyelWtwt8kcqkRb8Bh613FrcPbTzwpwjHIWu6orL3T3ajbVkcRHYsiTyM2DExRlHc+tZ2jaKsN5JeNJiNjlF77q65LWRxfTgAR7mxnvmsxjHEsUQJC7snPU01LdLqbP3rXNfw/HF9vtjesfKRxgk9AK6nxFP9qlj+yKXhbAZegznrXFQoFTeXIDtwp7e9ahnuImRlnfy0wRxUyjrc56lNSkp9jS1LT0tNPR1kDS8qwXpWfpwWaZPtM29MkqD3H+TW4++/wBEF/IMPKSrBRxjtXn0GrCbVTbxtvMQ25HAAHUCiEXJMmlLmVmyt8S44bXVLF4QSjAqGPrgGuk8ITRz+F3WX/WQOAxPcdR+Wakv7a01260uzuYSYGcqJOMjg812+i+ELWLRru2tXIkY/fK857U51YxppS/rU5qtVUpe8Q+FtaWzaWxnG+zbBDqc7c+tcv47hUXTOkYEZPyGvM/FOqanp3iW6tfPkt5LdzHhWIB9/wAa7vTtek17w9BJfFVubceW7dmIPB9sg05UOS1TuaUko1ueHUs6FbxzWVzGy/vsBgemBVaWOGKMSKdhU844IP8AWtLRlWG4idmUI67Xz71TvLKR9Rn8obmHKKOahLVo6+dc7uUbl/NlHyh0HIyMZ+tUtQMOnQvNcZUqCQi859qtzyx20pklaQpyrqyYwfT86p3EI8Q6M3lrtuCxCf7QHb61oopWb2Kc+xxGtakJriOeMPgr07qa9s+AeotcC9jcgs8auSPUHH9a8XTS3TVGtrqNiPut7EV6p8NJl0TxHax422s2Yix9x3/HFViEnTcUcuJhKpSl6Hd/F+4MfhkRKR+9kGR6gV4I0ywyB3IXHNe0/GUt9ntUJwnJz2r5y8YStHdKUYiM/dA6Vz4WHNFIWXtUcLzHp/hW+QTpKMOmDnafavNvHGn3d94nmNvBLK8gDAKpNanw9FwsE8suTGxAXJr0LSWglv3lu2WOIRklm4BIHAzXRzexm7am9SKqw53oecaxoV42iaPbkE3DKUZRzt57/nXX6dpdrpui/Z2kx5PB5A56lqI5I/7UWSFg0WcsevQ9fpXM+Nb/AM7TrqGObLlgxVePlzTvKo+XzHyKmnPyLUPhqHXL+MWEylLh8MVwVzXZaFYmweLR4nJSOQiRm4LHv/Ksn4J6XNMbZG3pJK5mXjgKB3/Kt/x1GuiavI8LtI7Hd+PU1M23P2SZlGpByts2rlDXtYitdaMbyJEkDKh3Nw4//VXomkwqNN8+2Cuk/wA8e3gEYyDXinjCwm1p/wC1BHlZYwCw7EY/xr1n4VyXN74Hs7S4j2fZZGjEpPJUHP8AXFZ1qaVNSXzMcRUaS7E2nxS3WoG5jK25Ay+Dyxqzf3ckd1C04fyznfJGSo+hHvT7+2/s2S5v7QNMp+/GWwSPapWvLS90kmE72kXoRzWDb3WxF+ZqVrosadpcM8aylQdyjd/tH/Jry3VLiHRrDUZVRQsUoCp3PJ4zXaJ4jj0+ymW8lEUdufLQ5ALk5rhdd0+4u/CuooI2kleP7Rwck7TnH5VrRi73ltdGtJSg5ORreAdZhnjutZe2KxR8SbecY/xzWe+sQ67qc1xYyYXO5l24KDOM+4rS+DME0nw6vVHl7Jrpw24cgBRVDwR4dFn4kvGaPEK7wVPIKn/69aNQU5+RMK2rn8hNR1mPRMW91KwZyYyVOAD/AFrhPiHqckMdrFZTMFJZgytxiuh+LtkIJVltsvGpKn0BPf8ApUfha2tzolr/AGpZC6cAOFcZwCf5YrSCjGKqG7k5pqJJ8P8Ac1hDe6nIogSMsxmbAOO//wCutWDWrHUJHjsJUkePlyoyD71g/EuN08MWz2uY7V5AGjQdBz1/Gsn4aaXevqSXsEEptFQqSBzJ7e/NPkU4uo9Be0alZntfw/14Wmpmznk/0ebgE9Fbt/hXqXQV8+RQS2l3unj8oFtxx0Feqal4gXTtDt/KmNzLcLuR+uBivPr07yTicOYYTnnGUN2dJc6ja2xxNOiH3IqOLVrKXOy5j46/MK8jnE107yzTcnkhuapG4tnUwNeQiUYypXB49xQsMmtyVlsLayPdY3VxlGDA9xS/WvDrPVLmzuf9Au2j6j9252n8D1robXxtqlvKvnNHdJ3VlCk/Qiolh2tmZ1MqqL4Hc9Qo/Ks3QtYt9Yt98XySqPniY/MtaZrBpp2Z5k4Sg+WS1EPNJS4oNIkTHFJS0dqQxp5opSKQ9KAEpDSmkNAxDTeRTjQelMaGmm04000FIQ9KKQ5oplHh/hWY2fiGxmbIVZR19Dx/WvcxXzno2uWmrRr5DFCpzh/vJXunhXUhqekQzE5mQeXKP9oDr+PWu3ExejZ6eaU+ZRqrY2a4b4hIfMt3OSvQgd67kc1zvjSya505mQZKDPvXPTdpI4MHNQrJs8+lVWmMsEJVIuSp6DkUvnRw6rBNK5ZMkkdaYZoUtmZQXcjkFuD7H1rD1G/TzEhLjzCCVjHbP9a7lG+h9ElfQv6jrCq8kEIJQ5HHAzWHlTNkptOMAdifWuR8Q3dzNrMkNs7xqv3QDg/jXTeF47q/s50mjDyxMuXz2PAzWvsuWPMNVIxfKarT+faFVkhdoxkqrcgZrU1t7LT9MWa91BYmkjHlgn72R0xXCwRTQ62y42MpIy54Iql4utpZr1JZ5CyRxBY+cqMZziq9mnJK5M7paHq+kazZXvhGGxjvY1u1GVTeAXGev1ry+GGWx12SKQGORZSJF68c8Vy+lXM0GuWUqfwsnGccE/8A169E+JN7Lo13Z3trFH9ruQH3sMjAUdvWrUPZysvtHNTai2dHp0aXssM4heJYGChcHK4711uleKr61mezurYyFchJQMbh2Ncv8KtabWdE1S6uY0S5tyofZ0IPevTLK1g1O2V5CgcRAfL95Sea4q7UW4zWxz4irB/Gro8H+JegX994gm1C1gS6E6qzrH1UgdxWl4e0o6doEcV0yq8zmSRQclTxgVc8d6vc6NdbQwLNlA39arXGpR3HhuS44jnijAHc5Peui8pU0uh10oqNmbly0ccySAZiCr90eue34Vg+PPEt94S1K3msIYGacbcyLlSAB29ec1ieGNamubXUoruVppYwrox5O0HBq7f2dl448PNDBer/AGhZuCjZyADxg/X1pqHJP3tUFTWF0dJJrWmeMvA8N+EaLUY2EF0qDgNjO76HtWF4IV4L2VnJeKIlgo5APrjue9anw58M3vhV77S9W8lv7RA2FGyMrnj9aZqenxaTa6vLDcCKRYyRGOMEnGaV4JuENnsY0W0uX+rGR4su7Rbm5uo2R5UYIUBAO78OlTeHbqS8FlKgC75gpY/wsDXlNxIwQGMsDnnOcnINev8AhG2ij+Fvng4u/tDPnHPy4/pWlSmqcToWIs1Dvodb8SNXTUbBY0KloDh88c+o9a8ju7K2uwpmG7Yc10uqXi3elMQ43lhurmr94LIwmWTargZrnhDlSUTqoUo0ocnQhbXbawfyFjdlHG1MCo/EOotqKWtukhS0Khz2Jb3rK1m2aDU/PUb7aXlWXkGte9sfs/hyzVwFuHDEE+hOa64RjGzRjOcpXi9jR8L2N4mn3MkSPJGQVjxySB1NYulWJ1fU3trhSqurbm6H0r1D4feY1pAh2rCIwwOOcDkn3rmobRtH1TVtTuUItzKzRDsVJJ/pURqaz7kSbbUOh1fh7UV0HW4nXAWELCyA8FMAYFXviNo8aXWn3UcjyQ3JZsEdOM4ryuDULjVGgmbIdLsAuD/ewQK9i1y+i1rTrJ7Vt6wz+UcjhcDB/WsZwdOUZfeZza9rFx+ZzujQD/hF723CFmeUFD1Crx/hXo/giyuI9HhtpERI2yS4+9g81x9tmCIxGMEOMccAYNeq+Hsf2NaNgZaME1zYiehz46p7OnZdWcp8S7xNJ0RhHkMykA981x3gq5M+gW7EbM5Y85r1jxPpEOtaPcWsyjJU7WPVTXkLwf2P4avLaFiZI28rI9zSoyjKly9biwE1OHL1OA8YSSXV/CULGEyswHJzzXXeCNQN14hh0/eXjkhYKjHowp1vo8TXGlPcn5ccAds81paf4bs7Hx9a6hYMy5b5ox3yP/r12SqRcOXyZ1193Yv+HbU6FLf6bb4jheVmaNe79j7DFdTd2629ojLGIvtOAPXpWfrqGy8Qeawwu4SKR3GehraurpNa8Q6XawIwtY1eaU9OgwB+ZrjnJyal95x1JW5Zpabsy7zwv/atjCrmPkkEsmcY6Cuc1vSE04XCXEQWVIyOOg6YIr2OONI1CooAFeY/Ha6i0/Qo7r/ls37oAcbgSDioo1JTmodzLC4yUqnK9mcbpVotzKkcyedCPmdWG7jHp36105mi04CEQpB+7wFRcBcngfXis34Y38dxYPdNExZ08oj0IroL2yXWdG1aWCRVnjffyMkbR0/SuippPllsd9Woue72OTvozLGgVyS7ZYjPBz1qvp8jxX8fmgsoG7aTwe1d/wDD7T4JfDgkugH83JfPrXFeK7D7DqAWE5DkhOeQM0KV5OBrSxEZzdLsbMu3ULK5SO3LSxqQU74PQ151/Y99ZW95dXUT70OF46g8HFdppV3PZWlzcxSOlxEMMQu4Edv8K5+5+KNnPO1rfRGYOdrSeXsCnpWtP2ivyK6MmnCVk9DntEtdQZ5mhWV4srjKng12xsjEAjbjIq7iAOmR+lM8QajZ6RbW8li5dpYhIwzwO9cbH4ye+eYxXLeZ/GemR/hSk5VNUjqhd21PT/B8lzZazb3Z3C1kbyiSc5r1lJY5AdjA180eCfG0EOtQWzu7wb8tHJ0Pute4Ze2ukMUhZHw4x3BrlxNJqSueTj6SqTTTOpFFNh5Qd8is7Xrq5s7Uz2yq4XGVwSTzXGld2PJhBzlyo0qK52x8SRzgKyfvP4lzgitWHUYpVBHBzgg9qbi0aTw9SHxIuGkNCsGAKnIpakxENNFOpGoGJSGmNNGvBdQfrSGaPdjeufrTsUkxx6dKQ9Kd1pp6E0DQ1hRUSzbnKkUUykfF2iPPZX9xJAwGEyPQ89K+hvgnqJu4blGOA0YYr2DA/wD168Q0i4tr5plSBYZD8zDOdw9q9p+CVva28dy0TM8p5BJ4APUV7OKadN3Wp7WJjbDys7o9ZqpqRiW1dpmwqgmoJNUt4L0W88iozfdyetZ/jG8+x6JcXS4IRMj6ngV5STujxadJuaT6nkGrXU6W8yWaqC7HnjIGea5TwnqFlHr0bXjs7E7IywyC2ax9N8TXL3d1a3L8OHWNsdGwcCs7RQ8mo2x4G11LKe2D1r2Y02k4s+jlUTtynXeK9GurHxbeNEC9vMwkjYcEA84/DNd18PLa2hSeK6lEazjLupz06CuK8Xa4zJcSqN5ZQiOD909BWN8NdYubTVzZtI0kEwYgMc7WAzmk4TnS1MZKKtDqb3xb22OpKluzGBxuDdNw/wD11R8CmLVILvTb/wCeKNRPFnrnpiux8T6YPEWlkEr50Iwue2f6Vxnhyzm0HUpprtAjDMQTPBNTCSdK3VF2baQtr4dfWPEdpJpTQ+T5qJKu7mPB9K6L4iWF7renwLa2rS3Fu54THTpx+VcX4Cv5LTxrDG7lFncq3OMZPX9a9n1PZbTKI3/0fAXcDnB+tOq3TnHrbYzupN+ZyHwVsb2Bb+CaKaFbiVUZWXB+UE1LaeM5vD3xRvLYTbLOS6MEqPkqF4Gfw61n+K/HkuganEulvGbguJJMjPyg8DPqa5bxIv8Aanjy4uApie5xOyH+HcATVQhzylKotJL/ACMJwvLkO3+NtqX1S0uUOfMHmFR0XI/xFUNOsnvPB+pi42CVIMRju3uPWoNW157rXGXbviVFRgeflAqnL4hSPXBbKjGNmWPeDwvoAKmEZKCguh1wgoxV2Z/hgixlmS7Vo5LuAwKuMHnv7c1meBr6TSPFdvHKG8qYm3nX1U8fnnmrXimWS28SOX3FyQQxPPSpbyxjl8W2EkTBDMBKR6PjP862TTTb6ozmruy6HotprMk0kwkk+0vZNuVQwJQD1rCF/Za3qN1ZNeb7qSM5I+7u9PwrhfC96bbVZf3xRmJjdR0fPXP86seC4RceMLCJAylrnaSODioVFRu+xXtUlorF+08M3NzqE1pNCYSRwxGBwfWvQ/iLaR+FvhRZWtmSJ58RvIOpzy38sVas9OT/AISme1j3SQhDsYt6dq0/iHp0WueDZbaMktHjy8clSDXPOrzThfbcxqq8o8p4N4TvnW4a2kkZo5F34POCO9afxGhktNRsVziJ7dZEx3z/AFrCltZNJk3rKDKwOCBjGDXUeLTLq+laNcxoDL5WOewzXW1eakb80lHkLHhkRSeHX87h45MIx5zkA4rpfE+mC9tLAwxOSuwscYBBFcNeXk2lwWtrtQll84jHHPb8q9d0q5fULKzihfEgCqFPQr/jWNW8XzotyvG3YqaXLDo+myXTfKI90JU8cHgY/Gua+JUhXwyPIYkPIobA6DGRz9c1l/FHWHjkOnWzFYxKxfaeSQa6X7OmpfCm53jM6wxTIT3YGpUeTlqPqzOc97bnnfg28S10+OS6UmL7Yoz7hT/jXs+nLb2NikVgGlMzpPg85yMtXk+o6d9n8KaVIykM10zSKRjAYYH8q9I0aYx6HYpMMN5Iyw68Z4/Wqr6rmXf8gjG6s+hF4rv2s4Y5Yn2iMGQD1yehr1D4Y64mueFbaTI8+HMUqjsQeP0r55+IWryxX/2PbmMQ569iSRXT/Bu+u43ZbcshYZbkjK/5NY1aHNRuzPFUVWhyp6rU958Qagum6XLcPwAMc186+O/GX2O/GnQx7gSsspPqen8819A+KbQ3XhqaKMDcqgjPtjNfKWoafNrHxJuopVYRfaNz55wgx+mBWeXxg7uXQ5MC+WDcd7nsEEUSx2W7PCAqWHU4FdPLaWunR2d3GoExGHYck59fxrxTVfG+3Vmjhi8y1jOxZA2Mr04FeuW2oJJ4cF28m9o9piye45x+VOpTlFJvqdtS7tqRfE2/htBHGZCbhgHcr/DgdP1rM8JeKk01FvZEM6shRQrck5rjfihqoyrzv886KxDHscmuc8E6l519HYyyKIp8hDjhWPT+VaQoJ0tTRQgqapS1PXrf4vG31WOPU9PxZyNjzIWy0Y9x3rF/aA1GG/g0v7PMZIXfI444Gf61y93Z3sevR2X2VXsxtY3DkHyzjkj/AAq74utUudO09LqZkCv5g46oTgfTjmnClThUhKKsY/Vaalz0zrfh1arY+ENPDApNPmVmb+6T1/KpfBHiWyHiG7to5lkhlZhIMcDnGfcVfv5Wh8Mwi0gxEtsIEUckkggYry/w/pd9ovie1ivbWWENujYnggEfeqIxjVU5S6kKPMnF9T2e3WezuBZWq4hndgrHgKB3rmfHEMsN8pJ3yIoAA6L3/Ws/WfGF5eXcCxMEMC7FKcF29T9cVpeLL+LQ7aO51u5WWW5KFmPX7uSB7dqzhBxkm92VCnOlNOXUPClpNcWt5HdK5YneM/e7da8j8Z+GHs/FV7JOjRWW7zHYjAwedq+5r6G8GanFqGjwT2dm8URUrudgdwz1968A+OeuNeeLbi3tZSIVIXaOBkDH+NaYec3WkloQqjlUlzLYra1df2p4Y1G6tSVSB0Tb1wG7fpXK6Vply7s8IZgsZZsA9MVp+BkZ5bmAtuhKZlU9CewNejaILaIutvEkRAwVPIPHIrolP2aaR2Rg6lps8t8L6fc3GvQlVYeW2W44wPevrPwdeWl9pFkHfNzDGEIbrj/IrzCO/wBN0i4YTqj3AjJjzjA46n1rU+G2oCfzTGP9JCkJn7pXriuXFN1Y3tZI569DmpPyPZBwKo6hfWUatFcXMKMR0ZwDXlfjzxvf2fh+eC1byr0kgsvULjtXznLqeoXtwZJbud5M5JLE1lRwLqK8pWPPjgJRs5M+qdWtt1z5sYV42Iw6N0pLK8aCfyJCzK4wG7g4rxjwn4n1Ww0wn7RvUDozZNdb4e8VTaoys7qs69BVyw8o31ukesqUnCzPSba/u7dwqOxTPGea7C1kMsCOwwSBmuB0G6Mt2n2sjywMnt+Ndnp+q2V7I8NpPHI0fUKwOK46q8jycZDXRbdTQrnPFWsrpsYQOA5Ga1b/AFSy08j7bdwQbunmOATXFfEG1g1mzjvdPuY5njXaREwbj14qaUU2ubYywlNSqLnWhxmo+KZri78uORwCep4rR0++1K5OIvMkkVQ/HPy+tcpFpDecsskmxk+8Oea6HSJo9PjvZZJ8MyiKNevB9K9CUI2tFH0E4pR91HqXhnUhqGnBmdGljOx9p7itYmvGfB2uron9qXdyxFtHHuCngsc8Vx8vxu1y51kC3jtorMybVTZk4z1JrBYSc5Pk2R5FfBtVWo7H0iqgMTiiuY8H+LYNbi8qcJDfL1TPD+6/4UVzSi4uzOadGVOXLJanypZM9vdwzQ8qqszFecjHSu9+GXidbGNpkkYOjFm3dgeufauZ0GzVtI1GSOPdIqnjr0wazkt2srS5kikwk8YUKPryPaveklNOLPYtprqj0L4pa7Jqk1hqenSkIDtbY2QD2rp9R8RPqHwlud8m69iVcjuea87+H1rFrAudOc7d6gjJ6MKmknNnfahpNyrRxLGyZPcjp+orKcE4Kn1jr8jONKLatpbY80sy66lhzlmYnceMH1rqdRgS1EMkRwGUyOQfvZPSs+0sfPllmYoGTJOO+e9aTWst/asbcB2h5wD1ra+prCDjFo6v4caXa65PPbTqdoXzI/TPYHPuP1rX8TaPpvh+yu9b0+3McjEqC7Zwx9u3Nc/4Ymm0W1kCSxrdysGMe7nA7frWhrF9/ayXOhS3CreXIDxRP2fqBnsTWM03PR6f1cfI0uZlL4d+Iri61g297MGWVSqOfUc4qX4hTfZ7uFLVFUNKAC3Tpz+tc/4ZsZ7bxLBZyRvDKjZYMMYIB5963fiGm+wsZBg7WZCT7f8A66qaXtVbYUG0mctY2t3Zawl6ISYY5CVkHIJx0/WvRNGvrrUtCcj5UMux1/ukDP8AKuT0OT7RpQHmb4YXLED+Vdz4EtPM0fU1RW23EvmjauSoA6/rRVfu3fQr4LdmcVrnhf8At2+ins5VSQfu3jI64PUe9emWPhG3vI47+W58y48sKVCDCkDGM/hXDa3qkegu3k7nuZM7gDjbWLp3j7UodbiCvi1kIVlHU571LhUqR917CqqMXeLs2aE9p5fiidBwrPg9xXO3Vo9trTib5U8wybh/Dg5z+Vat9cXUWuw3G5tksuGTtgmtr4hWCR6dNdw/6xjGrfTn/CtFJxaT6lyaOe1RYtcPn2jK86HkHIPPerd/by2/j21RSGjhSMoV7jHP61h6Qxt70nAUCFix7HArsvBMljr2qxXF85intkAj29Hwe9KXup22sRO0lzdTiYNLnm8dxW9ugHmzjr0GTzW+dPbw9rDzzjzHcsqrGcFVzhj9e1eoWuh6Y/jYX6FVw2UU9C3civLviFNLbaqj/MnmBinrjJpRq+0lyrsZ07Jts9Q8BypcwxzWjbhG2QjddpFbF6Psul3V07YjG4nd7DNeZfDi9ayvLNJpGHnxYAPQ4Peu0+M801h4Ci2uqmV1Rdp+8CK5qlP96odya0rTXmeFeJ75by6M0XCMG/MmvRdL0g3vhfw4i8zOHY8cgE5FcRFpco0iCaSMNFnccivXPC09zFo2lReWI242My8Yauqq+WKUejNWm5c5w/jvQJbfWI4APMm8pQSBgdBn8q3/AAfrcV5a3MMCNE9r+9jY4JZB2ro/HVnJFeapLKEaQWTiMrzghf0PNeXeCJn0+e4miIIMflnPRgeoqIP2lJt9Ag3Jq3UxfE0U99rzkhv3hynuWP8AjXq0sP8AZOmQ6arFohbiN8jI4wc/nmuamtooJVuWVS67fLbrjNTfEDW7i00zTvLba8gO5scngVUm6nLFF8qpzuzt/wCx4rnw/akFZUADBscEq3cdq5bU9Yia7lt0Yx+WD8vQCqXh3xfPH4Tu0D71VCuR2JwQfzFcFaXNzcX1/DIzvI6O2W65x/8AXqIUneXN0HGXJLXW5Z8TXUepXVvJaOJBs8hjz1B/+vXb/CvWA3iJLaNcOkRxn+LaOfxrjPh3ZNqOqtaBd7yxseR0YfdP50nhS4n0nxRazocSpK4JPbggit5QUouHZGPtG7vufYV4XvNNYxADcNw3c5FeQW2kwtbeJSpQXk0REbng89s12MHiYQ+Aba/Xr5e0579uK4Xwubi+mvLlkBjJGM9sGvLpU3FSucuGp8sZJ7XPFL20nsZVt5IHWcMcqVIOa9FTX0s/CFmszhSHKjnluAMVa+K1s0l/FPbRFmjj2uyjIHFeV67JK2mWscoIUO7DsO1ekmq0U2dilyLmNXxzex6rNBJG7OqRKq5/h9qrafZzWZgdmaIJEsyuRjr0qbTdJbUrCyk8xEP3SrHBIDdffrXoPxR0uOXTYTaukSwQxwxBej44p86g1ATTcuaxy3gNtT1nxPFbvPPLaK2+bOSFFWPHWsnUvEb6fZMpSIiIYH3mH+Famm6ta+DvBLpE4a7uSCQvXjqT7V5xZ3BS/F029nSXeMfxZOaUVzScrWS2/wAw5nezPeU1eTT/AAadQmm8yKxCqQV53YwAPzNefab4/vtX1wW9yN0EvGWYllx3rUuL+DUvhVqCWzMLia7RVjz12815ja3T6NctJPa5uJCAobjaueT+JrOlTi1K61Bvllfpc2jr17H42S3WQLbpc+Rt7EZwTUvxA10avaW6QXb3AhmaIAnIAxwBU/ivw8tpqFxrUcwMUsIuBFj5gzDGfpk5rD0F7S3NuL+AuJJw6DHIA4BraHK7SitiXKTvGXU+ptFUaD8MYpNwDx2Yx7HaOPzr5g8U6fcTz/bHZ5HZjlu/WvqyHSzr3ga1tJmMbOitnp0P+FeS+PfCrQxtFbyZdBv2txwOP6V5+FqKMpXerZhhOR88W9bnj2lXR0yUMEwRknP8Vdj4c1wXAuZLhNrRReaNp4YAdPzrg9bieGcxg7jn5iK6fw9ZSHQLueJecLCM9yTk/kK75xXLdnVCcovlI9U1h9avmk8oxyIoUqpzXXeD7y6s2gMLFZEAJ98Vy89tBo+ny3kynzmZQF6dal0XxLAus20OG2yrtLEdCRU1I8ytFaG1OUYpqT1Ot12C5166kezj80LGWYA9hzXL6p4fisoJ5tqKdvIHX61teCPG1vYa9PA0ZMc+U+Y/fGcGnfGQxo0P2FTFbOAoOfvHAP8AWskpRmqeyJdVbW0POpHEca+USGY8bTzXd+H7F4rC2kCt5zr5jEdRXGaRZRLF9ovJcQIc8jJJ9K9S8NXMM+iXN1C6FzhOeNoH/wBerqtpWRVNte8y1rWpXUVotqjbHCje3QlaT4ba7BpPitLa4Dg3P7tXJ71seKLW3MGmuxwnlDzGHHzGuRkNvd6vpl9Y8ywzCNgOe4GRXPFKcWraMmo1Oi0upb+Os89j4pDtveGdFZPRQOuKzdB1VrPyJ7eXY23I7Bh6Gup+Mti+rQwljh7YHGOrA9q880qwl+0wx5yIohkdverpWlSV+iFhZvkUZbHeza6t4uXsIYQ2MtESDVKe5jjieSEhgTgbuGB9RXEXHifytTeCGHdCj4Bzg4rQ8SarDYGAxxu5kAZcntxSVGSaR0KdNLTY09RsLjUtLnKOSkfBBbGTXJaD4Va3u/tl+P3EXz7R1PPFew/DiG11TSJ7zyy9uWLMW6qQOa5uS2hZ7mIbipO7c3XBqY1HFuKMvdrTfkUrbVPtF4qwjyJUIZCvXiirtjptrY6qk0km+PAx7Z9aKio1dcqNb90ebWGpXOiqLcbSWyz5HUH/AOsK0bPSpb3TnCYSLbujJ6ZP+cVkeJQkrW15ahlSRNuDyVYdv1rZsfEUmnPa2ckKtbLEscmeuT3r0Gm1dbnKpJSs9ifwZv0jUF3kbzKASv8ACBXTfFWwI1S31O2Km3uYstj+8OK4XzC/iGEhyFMuGXsRXXvJc6ro19CU3rsaRDnO3B6fiKicXzKQrJSuuh57YCa5luURiEMRJ9RyK1fBmLXUygJKyAg56HFXPB0EMN5dyzKHWSMoV9MiszwrMIvFkUU4JtxLtOB0ycA/nVPW6Q/htKRDeXMzXu5d24yc+uP/ANVWvFMc1rqFtqccjEyqrhx1DLj/AAzVvxPpF7pWtSwRo7BpMhl5BGeldh4i0KK68HW4VQs6HzBu7fLgij2ijyslpyujL1fVxfJYa2ybZHgy4XoXHBPtmsSfU21bRbq1uIwGhBkTZnHPU/Wjwtci90250+fblI28sj1wTVHRdsd3cxTSoheNxycDJHFJRSTVtti4u6SWweH71bKGc/MYkiztH8RJwK9a+CmprfW9/AG8q5ZcBW7jmvMtB0SWfR9anZWAggDfXDA8VtfCnUxpevSTzKj28iBdr9ee/wCFTXhGpCVt0c84yqR5EZHxBhk/4SOXzMrxs57GsjRfD95f3lmYFBG4FiTgjDf/AFq9R+Imi201zFNIMOf3ilT1Ga8m/tO4ivHmtpni8uTKhW+6M4qqM+aC5TSaj8T6m9rEzw+IPn8wxpJjI5xzzV2TxBNrD3NjcKrWNwdsR2/Mpz8re/NYMV1cXpuZpn3MCGDHqT3pljHJFNBG8bxuJg67gRuU1aino90W5Xd0WdV05rWzTznBnkBGOwUf/Xq38MFLa/GoOU8wcfnXQ+LtMN5/Z3krudEPmKOvJyDT/B1mNLv2IQHeGffjB4B4rN1L033G6bbuil4m8YQRaw8Mdo7zW8u0Sh8KOewrV8Xxtql5DLLbgMiKQSvQbR29yTXK6V4Wv9S8SH7XE0UJlMrsVzlc54+te96B4eS8xdXkO8kALHt4A/rWdacKNrESnypupseSNot5NplnNbqUkibcpU+9dR4+t9Q8ReFtGtZIHilgclyTkNgY4rvNTsNPimFvC0Kyr8wiDAHH0p0tlDJYpCJAJFPG7tXP9YbalbYzdSE7SscFqPh8Wnhvw9FjzFlVvOPvn/69X/Hl9B4c0K0DIA4UIu3nGBxj86z/AIm6lc6BoyhdpbIjjPbGT+teeeJdYuNb8MaZcTghYZWjYA9OMitqcJVOWT2uzRaJa7XZ13g7XZdb1CBb4lvMYo4c7gymsTxjDDo96bKyAhRnZnwPf9BVL4f+cupQTAEKJAFI9O9XvHF3aaprrR2/mF2cqxH3R7A9625eWrZbFxk73fYs2DSX2m2zY34HPHcHiqXxQt3k0rSzgqU3DB7DArp/CkKaQtql0CYweeM4yKxviTk38RX5oCMr6Gs4y/eWRc48z17HAabdpa6bfxNuBkCkL2yK3PDtiBK2pXMmBPGSqfTj+lY17mWR1VQoCZAUd+la+os1no+lxKxLvbBiewBY/wCFbyV1buRFpPXodR8FdP2a2JvlZnkMan0A5z/n0qD4g6BDYeMrye2cLbSN5wQdnY8j6Zya6z4GaW07xS5+WN2Zm/AD+lUPiNNH/wAJbfxSbS7OcL16Djiud1GsQ7djKmozq8vZHSaJNFqdpbackStDaWwbHVTIx9O+P51y3j3xBH4UurbRbX5lijEszI2D5hPf14qp8Mda+wBftC7Ua4ILt/FgdK888QST6l4o1G4nkdjJO7bm9MnFVCl+9alshWcZJx2O58TeLDFtktmRfPiUvuPGMdPfNYHik/29o2n3NvCiE5iCxcjdkVj+N7SWCawbGU+zKMdQDXUeGRHD8Pj5uDKk7MMDkeg/rVKMYRUkbuXNLktocvoE01j4g09ACzx3ax49t2MV6Z40mF1qEcGQfKl+6OM4GK4/SbGCfWLXVxLuC3G54scswweKW61oy+IZ7x1LRRbjtHf2/WnJc8rrogjDlfvbFbxpaTrepbrGxWZEQNjIX15+tVr3RZLDS3eZh5jEhcdMf/rq/wCGNWuL/WVsroRv5jEqBnk9RVvx14kFnqaaakEbxQgeaT3brgfTP507zuoJD9xXk2cheXl5p9vHp8UrxLFiQgcbmPJP9KRIbnXvEGnWzjdNKEXIXjGTk/lzW3r1hY3lhHqgkmjnZ1R1/hIxkH24Fb3gO4tbq4muIlQywRNHGF6hcYH86bnaPMlqZum2+VvQu+Ln+1vJaiVFg3JHv2/8s0wAPb1rJtNEm17x2yadGrWse1o2PCqiiszxTdPc3IhQNhTgIv8AETXV2eoSeD/CkUMX7vVLpCGcjJiXr/OoSdOK5d3p/wAEdZLZdD6J0DUbK5tVt7aeN5LcCN1B5BArlvGF9o97b6hbxKr38YMYbsT9a8b+H02rSIjS3bRQSSECXJMmCfmP0rU+JGsQ+HNK8jRl3iUALO/XJzk1xLCqFSyd2clPCKnL2l33Jv8AhFrRbaO8eGOR12rtx375/OuWfxFaQ69bW0ES/YVkwVXAABPJ9zVj4aaxfahp2tRXUu/ZCdhIHLEcVxXh3Srm+1e1twcL5n7xj/CoPJ/KuyFP3pe0ex2Oq2vdW52vxl091jnW2TiB1c7RwVI615jYx+TcaZOCSfMBYemG6fka9v8AiRqQtGiihiSSG4jJJAyWUYHX8K8h1Lyv7e8mP5IyyujDtkCig3KCRjOF0pFTU7V7TxHPB8yiOdgCePlz/hXq4s08W+EtMhLslxByZHPDDOKzfixp9vb6SdVWNBcX1wsYwOdqoCT+JNS+F7xYPBdjc3EqQo7tCuTjJFEpucIzW46STbi2Y/jDSH02yht2A2BwDj3BrM8KXcyXZt4JNsMrrleuecV6R4gsINWtkhVmwYwxI5IYL1FVfBfhm00eK51bU2DQWsbN83QvztApKqlDXcurde8a3xLvYo2SwtSoCwq3B6nb398msrwBpd417ayOmI2dR7E9a5bTNRl1/wARbZgWEknpzzXpGteIbfSH0+1gCxR2MW93HHNZzTpxVNbgoNJRidFr91p13bXs9xtH2MBmyeFbGP615Umu6dc6p5FgSHYY+7gEdzTlvjrDXNrYy+al8JHkIOc45Ga5PSrcp4viZEZBnYR9Bg06dFRTux0o+zfLHU1brwbcHxHC8U0Bt72U+Wd2GXJHUduuPwp3xJ0+Syn05/LxbIhh3DoSDWjq2tJ/bKxQoFVCu1s8hq7IRprVl9mS2F3FgPh+QXxzin7SUXGUtipQstCL4aPdaR8N9QuuQLuf90W6AYwT9K82v/FDnXJ7eJd0DSeXuJ5z0r2NULeGjp2PLjhUomANuew9q8M0jw9eS6vcpLGVeDfIxPcjJ4/GppcspSlIzpuUG7btnRw+I7X+0Y7GRpDGrBBMBkFv8O1FcpolnJfavbxxnjcGftjByTRRWhBNJs6YTqSu0bPhOIXkbJcjfAJFAU9cY5rM8V6e1jrQTJYSKjDvz0x+ladxYT2eh+XZxFsyZYg5OPwrSSS1u7KeS4g8y5gUbZG5KHvXQpWfMtjOVO6UXujJtNNeHxDCTGfKQ+YW7HPavUvBenpHBq5ZQP3Q2g9MHrXkviPWnmtbQ2kjI5yXI4ORXpfhXXbNdI09prqB7q5jMbR7sFW7Ege/rWdWMpQM6qi/dj6nnWrwXWh6dLNH+6eWXajcEgA0+yt0uZLS/jGx7ghzjswOD+tdb8bdIS0srV7UE2smyZOuQMc/rWf4Fjgh0eE3RUqd7Rg8kH2q41Lw9p3CMvaOy2sdVf6laapY+dclftMI2yqB2Hce9YWo+JrW00Ew7VuPOYruJ+ZK5W01mS9XVLZE2F42KEHltvX9KxLnfPbxOoyF6gc4xShQS0Y5VElaJL4dj8vxBCqsSrzDH+6eD/On69ZeTJNJGVbMpUAdgprd0S1gsJbTULoEc4Vc8E84pbnTLfUNTCJKE3sZCvpnmtHK0rjVO8Tq/hsGvtB1COWL78flcd88/wD1q828Sx/2frkkFsCqwAbSOoP/AOuusfXf+EXNvb2YEkwYSOAcADPU1X8baU+pT2WrWKgwXwG7/ZPvUU/dqc3RkTWrV9SebXDq08Nv55kmjRQUxx0GcVy8Wlwx6jNBdcRMcEqcnnpWh4ZiEHiOSX5hFFE+cjqen9aoX0F1/bUphikdXUbSATkirUbOyHJ3jqi1/ZbWMstvJJnIBBVemDkV1MmoPJpTXk8aMI03A4ycjtS3tg91JaTRL85hVZAe5Axmp7rRZv7IltUJExUHA6E56VlOSdmzemuVHH6Dql5P4ltneaQrM2113dseleo3Ni948X2dGGz7nGPrXG+AdCmTVftl/GEKMdobk59fpXr2gqdS8S+R5RGnxxDJAxlj3zUYia5vd6IwdV0Y80y94U8P5mS+u13uVyFx19PwrsdQuorC13vhSBgELxT44RaeUqf6tBjB9K8W+L2v+Lb65WDw3FcJpasULWygyOw6k9wK8+EHXna9keTKUsTPmeyNDUfB8mp+LjrOn6k+84kljc4I+nt2rvZNH3WvlxMRKRnJP868n+DfiLV7zWX0/XBM7wpnzZVKtt/un1Ne4RZEYYqNxHPPatcU6kJKEne2xpVnKnazPNPiL4VOvaPBDcuImUZ3jnleleTeMI7fwzpFjp0YS6cnzTkfKTjn/Cvp27skubSRCc5zXz78RfCFzcJC9sS0nIUP9elaYSrdqMnodWHq88XbdEHhuW2n0Fb2yj8gRxyN5ec7Wz+tcqhlW/gkUbkkOVJ6j3rtPDmhz6bpC2keySUqS7McLnuP6Vg2fh+eLW08wgWysGyfTPSuyEopy1OuSbSXUu/ES7nh+ywqrohJL7Tgk9vwrO0yaTVNLWK8kJmtmDAnklCen51peL9+r2FxqMDb1tG/eY6HI4/DiuR8KXbwaoodiYrgbGB6EnkfrTpr935oOa01c0tW0mdHZ4kxBPIFDdCuTW7rOnWlxEYI5f3iBLeFTwWAHX862NZsGkltkdgIlOSg6r0xXn3jOaSLxNOiMQIjldp9O9Km/aNK5c2o+8fRvwg08WWjPGoChML79K8D+Itw978UNTMMhylyqKR14wOK9r+F2qSrY3H2ggGW3WcD/axXlFrpBvvGeo30mCDMzRgckknr+Vc1D3atScuxxQpydeT6aHJa288OqwWVqzrHaKTkc5c/MxP8qk8EyWl1qD2uoTbTKu4SOPuvg11Wj6WbLUdRu9QCv5++OMDk/Nnk++OMVw2mWDwTzmddh3GMZHSu1SUk4m/JKLTO+1XT4ptF8m7RluAMRyhhwO/Fcpr11PZRQaNprZihQTSMwGWZuf5VF4xvbuHVLSNZmYxxqFGeDwKo6+0n9rYjB5WMtkewyKmnDZsqc1rbdF3UGmtY7cqrQyArKo6YPFbkmnRvompPGVN3NIGGOwAz+ppupo2uWdnNCqtLGhVsc8DmsPTdVS2v3e5chC+zbg4YD1HpQryWm5baTtLqavw80l31w3kyOqoh27hj5iKXx54enuvGMpt/LaCQoTIjZVflG7+Vbf8AbLabbahLaNHlYcIo5wx4zXJeGNRum1VC0hkSYlWB5BPUH2pRc23UXREyhBNRZc8U3mnxac9mrMTEABGByzDjrT/hbZyzR3tyikIQIgB37n+lV9S8K319fi4QCNJXIxJkEDjJ+ma9j+GPhsxKtpDGUt4x8zkdff8AE1lVqRp0rJ6kybUnUlokZUHhWFZluLa38+6bnJ7n0HpW+vw3n1VlutYASR+CpP3Rn0r1O30y1tlBjiXeB97FN1qfytEupY2w3ktsP+0Rx+tebLEzb0PPnmMpO1NHFaRpnhq0LaNaXFq90PkCbgXz6f8A1q5zx98PPtOkywwB5Qxzkfwkc5FYPwp+HesWPildZ8SKgjXLRqX3NI57+3417w8fmNmQ4GMECtK0lRqL2c+b/Mn6zOnLe66niPgbwb/ZmieQu8zSMd5xyW/wxXY+HPBNvYh7lo1Mm75QVB3V3NrYxpICFAwT0GKvhQudoxnrWM68pN+YquPlblhojw74s+E3XThqFovlmNi5gB7HrXiPimza3urK4CsC8K/gRxX2V4j09L/TpUZNxAyB614V4y0S3vnSBozHJDg8ccV24PEbKR14Wo8RCz3RjfFa5tv+EW8ORO5SVoFlOB1JUA1g6lY7fCWjR5LwMpeMg8bj1rf+MugySaFpGoW7Exxw42joFJGfyNUfC1uNT8DWFvJJhre5faMclc9q6KckqSku5cE72sJo/ib7DJp1mx3Som3J7ZyMH8Kl8W+J1uNLj0yMFdjAvj+LA4/WuZ1CxY+MJIIlK+XJx9AKd/Y099ezF2dBGNysRwfarcIXUn2udGso7Gt8PpLW31X7Zdlg6xNgLggEDrXK61rlzqEt7K0zESt909hu4rrtM03YHWL5mEXlt7ZB/qawNL8PSahNfLteJYoQV3L/ABZFUuW7k/IylGV7I6z4UR2tnpd3qN4peWUtGiZx/D/jTJ2jh16ERKEkkYs3A4qDxkR4c0fTtMtvkZYA0jqOTIeT/MVV8G+df3MElyN0gOAW/iB7msWua9TozWjZadShqMTW+pz3U6sV3nHv7ivXPhhc4j+0RoXhJHzf3MjpXmnjZwt3Db7gAIyce5Jrt/h3dNYfD6W7kPDzBcfTgVNZc1O4qrSi49zoPG+rf2BPMEgEkV0wkBJxyMZI/OvHptfuJPFTyggQyyA7FGDg4re+MOuyXN1p8VuxEXlb8j1P/wCquR8OWck2sW8k6lUyCW/HtRSpqMFKXVCo3skt+p3UOkxWmpSyRxiNnG44HXPair2rXStcjazDaO/HFFc0+aTuejBJI43SNd+3yeW0Sxq6Ffl6hsVZ0KKHz7+2chp5k+UbuePasjTtOlsddhtHjzOJMtjpjHX8qy/Mkj1iO6Tctx5/PqDu/lXo8ibdjzXUaSctyC9gbfGQpVQWj+lWtMnENum3BlXBXPqD1rto/D0M2pXJbBG3dtI4z3rjdZ0qS31mOOEYVsEY4AqoVFJ2FODhqez/ABCuVvPB9nNJGG8qMoM8jcRXh+sardRJp4t5jHGgJCpxgg98V6jb6hFrfhy7sI5C8luFcKfpj8s1yPhXwvD4mvLm1vnaI2v7zK8HrgisKVqafN0IacY8qf8AVzI8FWsl/wCKbeNVZgCzOB12gc11WmaHZ2GoT2zSKWnG0IxGQM9K6fwh4bi0C8uL5U3tJ+7BPTb7flXmviWO4t/GM8rbxI8okhPpz0H8qtT9rNpPSw1+71audT8VIU09tM+yIEjWMJx2+U1x2h3Mi6hBuzvIYg9+9en63p39t6NGt2GLzzLtxwRtH/1652+8Niz1iS4jKiFE2qncHGM1NOaUeV7lqEr6HG38zXmpXU2C0jNsC/TpXr+k2S2nh7SrK+hYbSJGbGdpJ6frXP8Awp8IQaprckt8pxG2U75OeDXv6adZ2+nSJIqoqscu3Oee9ZYrEKLUF0OWpWVKXvbs8ivvD9vbahdpEuXucAEdhnNTT6Mco3lKskSDKL1+p9a6jUTayNvjBaWOUlSvKkEdOK3bLw9pr2hkzJ9pxuaYNgk9/wAO2K55VWldm0sUqSTaOJ03RjfXSuEIUBvL2cYbrVnVtNt9sjWdxHKy4EojkDFCPXHQ119xpL/2ReRWJ8q5eN/KfphiuM14Z8MPCWu6f4tuGv4ZrW3jRlnZukh7Y/vc85qqVqilJytYy+tuU7rY7/QdMaZhaquZJGySR2/wr1Ww06G0tliUA45JAxk1l6XpttpoDxqzzMOW6/h7VrtOTGCqkk9uhrlqTctjixtZ1pLl2F1JS1qwXhsEfpXnBjlhkPko5LjZ8q5/GtH4s6xrejeE573RIw86YDYXcUU9Wx3xXn3wg8X6/rsd+NWO6K0AlW6MW0E5+4cDB9a1o0JOm6iasPCzdJW3uei6XpkWmyS3UpPnMBgsOB/9aug07XNPvRFBHcwi8PBhLjcKsxyC+tUkZAUcDoOtfNHxb0jUPD3j6W8s2ljjnZZ4JEzwR2+oIp0KccRPkk7MJS9u/f3Ppu+xbIZGcqh4auH8RAzSLb24iYQkuMn5mz1H0rnPi34i1e1+HugXCM8dxdhGnkXja23OPxNc7p+vS32n2eozOy3JjAYr/eGaIUHGHtW+rR0ZdSc35nVLPo9tH5us3sdjEzmMeZ1ZsfNVXVvDpuZVbTJRNbtGCkinKsp6MDXBfEK1vfEdna3VjBJK8MhWRIxk/MPvY/CvX/hT4cudF8KW9vqzlp9pfyz/AMsg3O361tK1Omqilq+hvWqzoVGmctZ6I9pb3EP2Ykuu2VHGVYmvL9c0CXRdTKSoVDHMZ7D0r6MRb2XXriGNglsu1i5TO7I6ZPbiuW8V6fAZZEmjLyA5JPIz7e1FKu4y16mlOoqr5ep5j4u1iewubREx9odBIS/AwOP1qjc6XL4hvbK6hAU3GEmHXae5HtWr8QdJuL7VrJ7KF5ka3VGI6IR/Tmtvw7pcunW0UdwGTZyxHYHvXVzqMFJbmkU5tqWxj6N4uaHxlNZxoFsSTAjDO5QBhf5Vs6K7abPLeSRbsMTj1J4xXI6fpbxePoYPLHMu/JHGOTn9a9XudHSRliiYEvyo7jnHSs6rjGyXVDg1G6kcze2kl2IpYVZULMdvcEnrWB4x06ZbFP7Pj8xkkLSKB8/Trj0r3XRPCqw2aCfmY/MSBgCqeqeF4nknmY+aSu4BVww9q5o4lRkZ/XKU7wueDT6JJc6jp1xIA+Cu/PHHt9Kp+LdInOq3U1okjqQSmBxjFe4af4YJnKXFu8UAAPzYyO9auqeD1EZudPGJAMmNhlXrT63yyFOtRvy33PnH4Zzt/bM9uvR4SSh9uv44qh4t0s2epi3jy4dco3cktXo+i+FItC8RX80qvE8zMIkb+AE9M1o6zoavqFvcTwoGhjymRnrzn9a6PrEVU5ltY0jScoKLOE8H6RJq/wBtgmJB8kx7j2IxzWp4Z8InS9Sd7iRppUJ8raMD613lnoUEdjE9uQjNnODjPSuk8EaGLq9Se4y4jOcnvWE8S7NrYc3ClHnlrYseEdCF3bz3Wp24f92I4wy9Of8A69dzpdrHaW3lxKqgY6LipJ5YLG23P8kS+gyBVSfVbWG1aeWdFQAsNpyStebKUp6nhVq08Q3bYn1C9itUIl3ElScL6V4Na/EdPFGp6hpt1cvaQWxJtkVsedg4wT696xtW+L9/feJcCPZppfyfJ6EoTjOfWuz8NfBfS31RdZuZ5/KeQTxwD5e+RnvXdGjDDRbr7vY2pWw/vM7z4e6idT0dUupN91ARu3feI/hatx9UsDerbG4QzE7QoPf0+tNW00/SpPMgW3tS42sRhdw/rXF2Hh+eTXiI2G1JRKJCeNuc5HrmuNck25bCUKdaUqjdkeiRqEk46EVJ2qjq2oW2lWkt5eyCK2giaR3PQAYrwPUPjlqFzq8qaVYAWjMEj3MSxGeuB0Jp0cNUr35EckKUqj0Pok1wfjPSkad5EXJkQozEZwK7LS7n7Zp1vcldpkjDEemao3kZuZHYRiSHaUOTx161nBuMrmuGm6VS54nruoIugR295HvMW+IqehBxXnF3q8uli3h08iOKIeaVIzkk9/yr2LxjpMMlle28eC6qGHt9fSvGPFmmy2+rWsSod80KhccgnJr18M4y0Pecvc5omvqEom1tNStwfMvUjcH+7kDOPxr0vRtIC2lxPMiyKI+hHOPasay0MW6aMBAJZBbAhfQ54NXbpdVs9QaQy+UjDaVDcY+lZ1JqdoplKLcbJkegaNFPbXkjOEZSTzwXPrVe9QW8ht4ChmVQ0i9x6L+Faclytvp8scIDM7rhh6dTVG50Wa11iS+ly8d1tdfXnH9aSercmT9rXqch8TI3vrlZIInZgSpC5JXAAzj8K0fCKR6XptpJcqvm7wxxyQB2Nc7qN8bjxtO7ysoNwU2bsfKDyK1fEuq2em30MQSSRgdzqmOAehPv7Vs4vlVMceX4mYXjJrXU9dXy5vKYAKhI4rsp4zpvw0t0DMpjvQrj+9kcGuLt49+sG42CVCdyh+hBHWtaLxEt49npFwD9mc7B/vA8H9MVUotpJdBTin5akfijT5rjT9Jn2sxkBQcdeaoeKtQl0K2hsbWILeMqnzupUe3vXt+oaTbm00S2O0rDA0rY9h/jXnOqWtrdTXc11bjzYJGWIkZBH/1qyp1VK11ojOLcovl0OKvNXu9Ps7SN2MlxLGJJSxzjPRfyorM8XxkarGWJKmNSpx1GMUVpJLewvbTi7XPY5NPjfXUaMhmVSxb19qwbnwkx14XEhVYN+8wnqzdsVqeKPE1n4ZvltruxllnJz5q4B2+v1rjfE3iJb/WFmsriRoxEjREHBzjn6HP8qmlCo2mtFYudSL0Z6JBZO+pkoMb0AIHc45qtr+jmW8maKGLckYAwOOldD4OglvrKCW6zFOYxuI5LH+lWb+zvY5pkWHzUQ4DZwTx/OsOdqVivbLmseY+CbCSDxNMr/LEFyT2Iz0rurLS0gvrq8tU2NI393gg02KxSB3lKNFJjdgjnJrRWLULjUUgB2QBfkK8BvfNVOfO7idooryFI/LS7l22qtuPv04qHX9B0+S/srsQ+YEzIuecf5NdDdeHYpLu3a5u4VPHmQyH73v8AWrevXuj2oNrLLHHKseMgEkDHArD2i05dzBVXOajFXRieG7VJTbLeSBRGGwvBO5j/AIDFUPFGmqtxbsgJQ5B7bgD/AIV0KyJLo9paWO0ANveTjO7PWs+PzLwyRznPlHAb2qlJ35i4yfPzPbsHhi6/st3aCKNUfu3Ucetc14v8TXeriWNJpABkKQQFH0H9a7SGCBI2WXG1hyx4xXAXWiSpcPFYt9qBb5Sikmocne8VqdGGhRnNznuec+G/FGraJrDxJO8qF9siO2Q2D19q+mPD1xNe2EEh+UlQxA7+1eVaV8OLu5v2mOnOSTu3yNsBI9q9t0bSUg0mGIuS+ArEcY9QPStsVWhNJrc8zEThTTV76jJbz99FbwMBK3BA52+59KkOmxJNHLIWJK7DVqHT7W1ZTGm2QEktnk5qC6vClxEqqZBnJHtnFce79041Lm+Au28bNIyPkYXIPrzUyxqbjJ7rnHvWfLqEsV1BvVNhJHHUA9B71oRTRTSgow3MpJXuKhpowmpLVkk8SywlWXcpGMdqhs7aCKzMSW6RpyCoUAH8BVwdKpWDSTQO8vJ8xgCONwB4NRYzWwliPIt1DDCDjA7UX1naXm1rmCOYD7u5c4qdiQ21VyAPSs2RJJLl44xLGhGB82B+Aqt3c1j7z5r2INU0W01DTXsLuAXNqxw0bgYUeteQ+OtGg0C8gt9Oj22ZiyijnnPSpvjF4u8U+G7mC3sGWFJRn7Qq7un8PPANWrW9uvFfw8sdT1CJUv7aVo5Cq4Dg98du1dLpThS573iz1cum6VeN3ozG+FniiwtvFF5pWtMkYlCLGzDC7/TPbrXvksCRtGyYXPy/WvjrxLpNwviSbyVfdK6FMdTkYGPxr6201pLLTtPtL7cZfKVWkbklsDI+taYulGMYTh1Wxhj+Z1m2+5cSOOJ5AxUFuWyeTWDr1vCXBkHL5VV7mvHvjrfa9H4tsrG3e5htlQNCUY/vGJ68emMYqh43tPF+peNNDiiFzJOtvEIjGSArAAsW9OeTTpYTmUZOaV0Z0k4PmTO6srFpL9bMgqNx568ZzW3LBb2djcLPsRnBRWfjI/8A11ctIxBrNkLhMTMyq7r03Z5/Csn41eE7/wASWNnb6OwWaKRpCpO0MMevrWcWpTjGTsn1OypiveS6HKaXbRtr6yPwwZVz7+lUfAdxqOu/F1533rHbySF1z8oRSQF+nSuq8K+F9Q06300a1tMyYLMrZBwejH1xXU6VqXhnSdXm+yAJcTEhpgvyk9cZ7Vs6yhzpK7asmViqrqr90m9Drrm6jjgeSQ7EVckntXz98Uvidrei+KhaaPiGBI1O6SPPm5789B24r3K0hXVP3kynylb5B2b3rP8AFfhvwzrZgi160t3kTiJn4YewPp7Vy4epToz9+NzzI8sHy2uzO+Gvi1vFmhW93eRpBcFCHQdCQSMj24rsJrpLa1aWb7qDJx6VSl0+w0vTITbwQww2iBUCqAAvpXlviL4l6bqd3PokLTQuG2b2GA4HUA+tCp+2k5U46fkVToqvJcuiO78V6TFrmmi908I80a709H9jXi+j6h4ru/ELWetWsxiYtHuaDAQD0IHTis3SPGWo6B8QbVLO6mfS7iRYpLRmyoB46evevpS2TMw3AYIOFPoa6HfDJJpNNaeR0ynPDPkvdLYydE0Gy/shEeEMG5LFeTW5p9pb2SMLSJVz97HGatJEI4giYH8q5fxhq02jaXfyqu54ojIoT7zD0rivKo7I5OeVeTjfcXxP450TRGa1u7qM3JGDHnOPY1zunXWn6/drDA2N5zmPpj096+aNWhv9R1I32oecVmc7CTln56CvfvgnotxaQLPfMFKKWSLqVB45rvqYeFCndPU7oU4UKba3Ox0T4c+GtN1H7aulwy3hO7zJfn2t6gHgV2rrlGUHGRjPpUUbiRmx0U8VPXnTlKbvJ3PJqSbld7nzH8RdE8XweK5rcPcPZOn7qYZKY+vY13n7Pv8AbVvp+oWes+Y0MTAwNISSvqoJ7d8V61PGj4MigqOCDyMGqN+Y9NSOSJY4olByBwK6p4uVWn7JxR1PEe2hyNanA/GTTtS8RCy0awYR27kvO5+77A1Y8A/CvSPDdr51ygu9TdSDM44jz/cHb69a2ND1221XWJFKEB8iNiQVbHb2Peurt0KqQSSM8ZrOdWpCCpJ2RNXmpRUNimTb6PohNzIsVrbREs5OAFFY/hTxr4d8SySWuh3yTSwrlo9pU49eev4Vm/G2zu774eahBYBjLlWIXqVB5rw/4A2Nxb+Ko7jyZEKv80hGAEwcj+lVTownRlUk9UFOj7WLk33Pf/EemwB7i6dBjyiHOK8k1a2VdUSWQKwCFI/9nJx/Wvb/ABBOg0O8kOMGMgZ9SOB+deTSaSZJYXkkBYKCAen0p4eVldnp5dUbg+Y0LmSTQNDv/EM+XFrb4jHBAPRR+Zrk/AXiG98YaNetqK+bfRT53hMLtI6fhivZbLSLW78Liz1KNJrOdP3kbjIbmneGvCuk6FbyQaVZpbQtyUXOST6+9Ht4KEk1719zmli+Wo5djzVbbS0uFs5ryM3LKW8sNkg+nsasXd6Wt7OKR1xEhUsRyD0Aq1q3w5SDU5tSjuHDeY0/4dcflWJr3iDwut/a6fDqKfaABuONyo+eFZugOa2Vp25Ls7KeIjUd5Hl9xo87+LJ1xlzM20fjTPGVjdL4mMawvJJI2xV6gngV63pvh8T6yL2bho2JOOoz9Otbt34UlaP7bCd4TLYK/MOOa2+tqLTLm4R91ux51rHhiDRvsYu7pIlSBAzngM2OfyPFecQWso8S21sp+YXCbD2ILcGuz+L1wZTpaxuxQxspye4NY/gi1+0QTTyJmWxV3jfvjb0/OtqTahzyYnd2i+h6zdeKoJLv7PGgaSCFYt24YIByf5Vwmh69Hq/ig28kapA7ttPbrn/69cpoU2zxWioWZZ2MZBPHIIH6mrPgG2dvFnlkMTH5jkY6YU1Koxgn6FRkoaR0PQ/GfhjTHnWAeVI9uRlxxgdcZorgX1m4S2mBcFmk5XsMe3eis3TlHS5tFwirS1Z7X8Q/BFp410KOSN1ttTg+aKYchh/db2rzrwP8Pg2vxWGvxlWjbcsithWYc4/HFd3oHiB0c2kY+0RovDKeB7ZrRvtZshALmNiLyMhlQqeGHvWUZ1KacL6fkedGhJNpa9je03TEsdRdY+YzygPb2rTjtg80ysOCQaxdK8S6Xco15OfIuSpLqQSAO5HtxXU2csNzbxXFuweKQblYdCK5Z8y3OOu6kH761Obv/Dwa9V/nljY5YE9D/hWxPYq1m0EIEWV2qV421oStge5qss/zMOODgg96nmkzN1qlRK/Q8u1jS7+x1wvKGmLchzkivNvHk2rS+JWYxXBVyrII1IBPT+lfR2oRecVZUAdTjLcjHpVPV7B2sXlt3jt9qk79vet6eI5HeSuenHGuajF6PY5CwtNZ0+ygYWRIkQEhuqn1qnMuuWfk/YdPeQM/zlhgYrGsPGS+H9TlvtcuJrvywY413ElmP17V3PgrxQ3jWK5exDJEjAt5i42H0HrVpTiudx0LxNSVKTjK3qNg0q61GQC73pHniOMZY/4V0+m6bb2zKlkmzK8sVPGPc1sRxqsasF+ZRjOKlEg+XNcsqjloeXVxcp6LYckYGCcFqdsG8tjBPX3pU5ApRWRwXZUuwNyZGATjdjpWPOsenakChaRZDvYuc7AOv4V0TIGBBGcis2bTI3kYy5aMrsxnt3q4yS3OmjUS0ZIrwXKfuwrblyrD0ryv4o61rHhS+sL6xkxErFTxkOOuDXqcQixtiAVI+U28D6VhaxY2euafc2upQGa2YZ2spyp9iO9a0ZqnPmaujai7Nq2g3wF4507xbpyvDIiXij97blhuU+w7j3rqYnCSCLbtzkqB0/8ArV87ah4Ck0LVrXUdCupRaq+WIPK4PqO3bmvbtLmuLrSbScTyB5B0cA8+tVXp0k703o/wKq4TlXP0Z0fSoZGjWdA/VsgZ9az31C5t7fNxBvYd4+hr5x8a694s8TfEc2Gkve26wy7IIlyoXHVz/j6UqGGdaTV7JdTnjRl12PpXUdHsdSj2X1tHOnXDrnB9aqSaRYxaY9kqRwW7HooAFU9LTVbXTYIdSvvtEoUK8iIAScc1natI8haHz5Qy9GJrNQ6X0N6NKTatImtfBOn/ANo2d5JFHJLavvjZhkg11sw8xMlRuT5gfevGdJ+IjaF4vXSvEcwjtMYSYqcDPQn2/lXs8bpNGssLq8brlWU5BB71VenOFubboRiudVPfdyG4srO8MM9zbxSvH8yM6glfp6VQ1WDyXN9DCrzohHpxWjGwXZF25OfxpJYPPR1zjcPvHkflWK0MoS5HrseEeLvHsdnqZneCX7TGQvk5289jn0r0nw14he9ttPOor5a3ahlYnlGIztb6+tcl8VPh5c6zBNc2EaG6XBRhwWx2NQ+FryS60S1tbu1uIL6AojIyHGVPUH0r0JKnUpJx3W56nu1krbWPTfFlqX0W4SDIkI+XB718v2WpXt5r87RSsjRyEEA4wK6/41ePPE1j4sGn6RLLb2kSKQFjz5hIySeOlZVhp8GvXEuq+H2HmSKq3UI6pJj72PQnNFOhKlR53bVaeXqaZZVdNqM9mexfCbWrm/tLyyun8xrUhkb1U9vzrlL23u7jxui6lK7SGYsF7AA8D6V5v4A8bar4f8eJaBGeGWQ20tuRySTgEe+cGvd9GsdT1a8lvNdMcEa5WOOJQHI9z6VFSjKhLnb0aLVeFKvUnFaM6mRxeaX5EkZIZMOByAK+f/F3w8SXV/tGm3LRrLIWVmHQg449817XcX0wnextIw8ZwJJR1Ueg/DvWtFbW06pE9vGY0GVDLytZUqsqGq6nDCfsNWtGeb6D8KdKXUYNdM8t5OjBhCSAgYdT9favS50aERtGBlecHvVXxPqS+HfDeoahBbtMYImlESfxHFebfBP4i6j4uudQ0zXlh3xRiSKZF28E42n1PvRy1a0HVbuonPKpKo3N7HsSOHjV88EZritdkTV/EX2O2KyLHCQ7KQwJz901peJdNvdW8O39lY3JtrmWMrGwJAB+o6V5l8IfA2r+EvEd1d6vKEZ08tIFfd5mTksfpilShDllJy1WyHQXs25Lcp/EHS00DRJdeNvm4tD5NsjcqHY43Ed8VH+z0mvahf3esalNM2nH5AX4Dt7ewr2XUvDmn60rf2jH9otnIPkv904rTgs4LOyS2s4Y4beNdqRooCgemKv60lSdO2r6+RVbEupoJdMIAJcnap5CjNWY2DoGU5UjIqqofBDEMuKoRaoLOTy7xdkTH5W7CuVRb2Of2bmrLdGtcHbCx9q8s+O+pT2PgaRrZ2VmIjLKelehXms2i2jusqkDqScADHWvFLvxhp/xA1S98OwQzSwBHkSZgAJNo5wOo4OQTXThqcudTtpHVnRhqbTvLQm8JyuvgjS73zGWbygxfPIIPX9K9j8MamuraNb3Q4crh/qOtfPfj7XE8MeELXQ7Ast5Kmw+scY7/Umu5+BtxOngSHzpXH+kYU5yQM5/Ktq9Lmpuo++nodWKipwUeqPX5Y1mQo4yp4x7Vm2ug2Fm7vawpEz9doxWpVC9umWeK2hUmWRhn/ZXuTXnJX2PKgpPRGJ4+iZPDchh5KMrEVxNist2bPTI28yd3WRmHOxepzXpOv20l7YtDEOWHGa5xLGPwppU106G4vpvkQJ+gFdFKSUbdT08NXjTo8vW+h1MVuDbxCM/d+XJ5wB/Wp2xFIFDEF+BmodIWVdOia5GJ3Xc6+hPanyuWli2Lnacn24rB72OB6yaIdTh860uIpCMOhHHXBFfN+s/BXU49SVtMvreW3Z8OZAVaPPqOc/hX0rcpuXcW2tjA9qrW8awW7biCScqT1Oa2o4idHWDNaU+VHnXgG6sltZbMXDvJZL5Msg9Rxkj04ruNDv0lkeEHcufyPpXj6W954Q+J+ossJk0/UVZmU8AE85/OuytJrqC3uJ4T+9bLKM9DjAFbVqaeq66nc6XtouT67GP4h8Kfbry4t7yzM8IlaSLAwAM1jaToKaXeyWkUPl2ssRVw2SfmFdF8RZPE0ngKG40p3a+Rs3Atl+fy8dB9O+K5P4V6zqOpaRLDq1tdzyK4VJjGcke59jWkFN03JPTsbU8Q23CSXY5218My2PiiJmZHjjnDIw6+v4Yrq/DmjQaf4umuolLCRsg9sNnNdPeaMscL3UsZV0Ibc3fPbHWmS6VNbtDcq7CUsH29iOwputzKz9Do/dtaHk3jzSI9I1CFBuIkLS8joSen5UV6F4ksItauhJdRB41Zflx0AorRVo2XNuUqcnqeq6ZoFhY2n2eOCPHc4wTXmfxat4fDUNve4dreeQp8oyQfevYSQOpxXE/FGztNd8OSabKQ0rHzIz/AHWHT864acrzXPt1PDwVerCqnFnhOveJporW2lsJgFbPzYyAK9y+DXiSPxB4MidsLNauYZFHQdx+HNfOltpclteXej6nG0c0TcA/09q1vDF9qnhX7XFpskkYkKltnQ46H9cV2ezhJOhfVapnr42jUxUFUW35H1JMwuQUiYhh6daw2ubqG7ljitZp4g4LSKuQOOf6Unw8uDqOhw6tLcvPLdL85b+FgeR9K6zPHUYrif7uTieI6ipNxSujDKl7hYfnBZBJkjkU+ey81fIcySR5+6T1FWpm3XSqmPukn16irsIUnevOaluwSquNmctrXw/0DWLKKG6sI1MfzDZwc/Uda0vC3h/S/Ddi1tpMPlKzbnBbLEjit2qN1E6XKXEeCOhz7/8A1qOeTXK3oZc7qaSZK0m2bg9RkVFuxgyEjHr7067dRD0y24DA6iqsWNQiSWQMkSSAhehOD3pJdSoR0uzYRdqqPQU6mqQR8vSnVBzMWo5mEcZdjwvJp9QX0kMduxuT+7PUetNbjirsoGPN0GinCRSfMR7+o9KcYlheRVBKkZxRbW5hmO2RmgZcqjdqs2Y5+Ycgd6ps6pStscwYrvS/EjSNbCfTLhdpIx8jH29M1uW9/Y3QMdsVLp1ixgr+HatYqpxkA1mapaxLIlxHHi4JChlHJp8yluNVVVaUtynrz3L6ZcLZHbcKu5WIzXl1p4hlhvGncRvN93evBIFexW1kRbeXO7P6E8ECsCz0/Top5rW1sYRcKSAFUDpzkmhdkd+DxNKnGUZR5iW3muLu0hEP7qTAYlx0z/8ArrM1MmJy80yM4yGYDitKTw60cRkubmQCVgHiiJAAPoavT+H9PlgIjUjA2jB4+lXzRRmq1OErp6HgvxS02DXnD2Cn7Zbpwf8AnoOuPr6V2PwJ1PWF8NJb3MqT2CSFIzyZIcHlCOwo8VeHv7LmZ4y7FADz1xmpvA980El0Y1VE4aQngHn+ddHtXKk6T1W6PQxGGp1qKq0z1eBo5WC/3R909cirXauak1IvAJ7JRJKjZKA8/T8RW9Y3cN9bJPbtuRuCO6nuD6EVxSi1qeBVpSjqx0KyeUVuGSRiTyq4GM8Vj2Vqlvd38PlqxeQyqemMgcVtsDkFTjFZ93c21rfEynEjoPpgE0o9UKk3qkZXiCDTNS067tGe3iup4WhVzjcuRjj8689+Dfwv1PwnqOpXGp3UDxzRiNFiJOSGzuPpXT+N9BjvlW/sZAkyNsdA3B9D7V2mhQzQaRaR3JBmWMb8HPP1rbndOm4xekt0dFSMadNTg9WcsvhfT7PXRq9xpNm14rEi4Ay3+99a6KQASmWLb5b4OQep9as6nkQdODxk84P+FcfrHiK10OGI3r7Imk2jHRfepipVGurHTTqrm6m8ZrcX7Mc7pFwvYcVfjVmdTvx0wPWuVgubLxClvNZ3GyVDs+YYDe49q7EW4WBQGwwH3velNcuj3FV92y6kk8MdzbvFKgaORSrKehB7Vy+meDNL8PzGXRYha+a2ZVxkP7V00cpZQHwj9PYn2pkwkkYY2gKQfqc1EZSjomc8HKLGuUtIsNwM8Ec81BeeW7xOxBaM5z7HqK5H4i/EWw8JXEdpNayXd48Zk8qM42p0yTWfpPiQa4sV9pq7DIoZ4+oAI7j1rWNCfKptaM6qGHlUXMekWMSw2yomdvUZ7Zpt3JMoPlR79vOAevtWboOpi+s3EZCPFw6sc4P+FaNlN5ksqv8AfGKyaabuYTpyhJ8y2KlvfxhyHzHgfNuGMGszULpZvNWAFnI+9joPWukkt4pGJdASRisTVPMtJA1nCrS5Aw3QjPIqotNmtGUXLRamTrGkS6tolxBuKrIm35cbl4x/Wua+GngHTvCl/cX9xK0l3KPLTcMKiHH6mvSBmKJ5lRd5U8dAx/wrN1eF7fQ7hYHzdmJirdfm61oqsuVwT0Zal7T3H1ZxnxL8AabrF3DqDyeX5QIKrzkelc1YfEPwp4UjGkK0siqdrmKMsq/j6/SuV1rxZeaDqFvLveQs2XRmJDjPINcd4t8JXizjV9IhlvNFvWMsU0SltmeqPjoR0ruw9JTglVenQ7a9L2D9k3d9z6v0nW31TS4LzS5obi0mTdFKOpH09RWtYtcyKXuVAbAGABx618/fAy6v9ElkjvVmW1cnyo5MgAkckA/QV9CxXaGFX6LjvxiuPEUfZT5VqjgrQcFtuUtR1VLFseU8m1lUIv3vmOM1o3VvHOqbwDsYMD7iuIutSLeMI3t03xDCseo64z+td464Q4HNYTjy2Jr0vZKNt2JKwEZPSqazrDuDj5j0Hc1BdzOJFSQ7UzwvUsfT6VIlqyuZZZN0/QAdBmkkluZqCitSx2zIPmYfd7CqHlNDPbI7gIWIHr0zjNaiRhc9yepqK8jRoy0g4TnikmTGdnYx9U0aPVLt2uI1Kx4Ebd/f61h39mtnIWnkWOFe54AFdnFcWxj+SVNoHrWB4z0yy1vRpra4ldYpVH7yPkqezfSrhJ3s9jpo15p8vQ5xPiD4Vg1GPSzqSG4JClhygPpu6ZrsC0a2hWAgq3Tbj868GsPg1I+rfao757qySTK7Ytpcg+pPSvcLDTUs7aJJCAqL+8DMegH/ANatq8KMbezdy5xS1e5en02C4ixcIJCR/FzVbyEuAsZAbZ0PpjtWjaPHNbxywzebEwDK2cgis+5jkgvo5LbYAxIdW6dKwTexlCTbabOe1HTkh1ORWUCOUbgO3vj8aK1dXhN0VPzGUEAlB90f4UVrfTc9CFVuKu7B4a8QQ69YyyQh0eI4kVhjGaW0sbcWtxPMuZHkLO0hz8oPA9hisjwPotzo9jqbXW3fO/yhGz8ozz+NaUN1NqFzEsNufsDZWV5AQxHYAelFr3tsc1WMITkqT905Dx54XXWTDqNjEDfQLwV5Msfp7kVxEOk3E93HEVCO3qOMHvXv0tqjOHBIKjAxwBXOaro0dxGJIW8t3GcgDIIJ5H40RabTfQ7MHmPJD2b2POviFqeo+FPD9jp+h+YltktPcJ3Y849q7T4beJbmfwDNqusu8nkE4J6sAOnvQtg0tkr3MUd2m7YY5Bw3NW9dg+3aNHpNjp4s4d67imAFUHPAH0roc4yioNddzlq0uea7X1Nrwysl/aHVTOd90PkQD5UUHgfX3q3FPLBOPLUyhztaMEfKe/NSacFttMitoBkRIEUg5HHerdrF/oaIcZI5I7n1rllLVs4pz1bkhsOo2ktw1utwguE6xscN+tW3RXjZXGVIINZU1rbzylJo1eQ/MTxmoJdPmacJBdTxIylWw5Iz2OKmyJ9lB7Oxj+L/ABYNDSzWOHfLLOIQ55GPXNdDp0zT287MuIyBx79zWUvh211aNWviXnt5CCM8Kw9vpWvbJFaTiNH/AHTjaVJ4z61pJw5bRWprJxs4x3NOE5jXvgYpxzjioY3AmaLIB+8o9RU+eaxOOSsyrLd+TKokjcKeAwGRmqt1Z/ab2O481n2crEfuZ9cdzV6YbYyXOVHJ+lYDXF1eTC4tGMUcZKInH7xc8k/0qoq+x0Uot6x0N+3HmQq0i8+h7VCmYr4RnlCuQ3cexqmNYisZY7fUAY2f7kg5Dn+h5qfT5pLm3M8kTITI2FYcheg/xo5WtXsS4SjdvZmgxIGT6/pUF64RYn64ccd+opPtAW3VirNuJGMU5I0cFnQAk8Z7VKViFHl1ZLcsywyFMBgODjNZ2jRJAX3HdcSfM7kck1LfStFEQZNoHAyah0//AEiUuzlgVwD2ql8LNYwapsuX+GjReuXFNuFkFu7QsEYjj0qrq91HaWqmduC+B60lteK0VsI50lWdxtGOi0kna44wlypoiisI9RS4W/jBkkQKwPUD29PWvPNbe707zbGYjbHnEgXG9OzV6tK8VuCeAWNcz4+0T+1NJE8HFzECQR02nqK0pztLXZnVhMRy1Pe2Z5JpHjqOw8QCxeVyTj94MYB7Ka9Us5r60votQ0yP7Rp96A8sQOMN0yPQ18k+I4ZtN1ieOQOsu4g59K+gfgp4hudT8NRW024GFtiFuj49K9DE0FCnzx17nRiZe0ctP+GPZLW9hushGw4+9G3DL+FeV3XiuDXPFOopaSEraMIdo747+4zmu9uTFdWU6cCZflJPDL9DXzd4HkfQ/idrEFw3yxiYMHbAJByDz+dcuFpRkpvqkc2EioS5reR7rJfx3emGeMqJNmyQY5yK7PTpPMsYJP7yA15Not9FfC5jikjd5QWUIwOCOo/XNemeF7gXOi256NGPLP1FZVo8qKx1Lljp3NUgMpDDINeffEXwTB4ijVUkeGQMCCo4rN8feMryPU5tP02Xyo4vld16lqxfD3ijU7K7ja8nea2zlw/JxRS5oSUouzN8PleIVP2yfyPQPDGmro+jW9myBmgXaXxndit+F1ZSY94C/lXlHi74q6foGsxafPBNMJVWRpoWGI1bpx3OK9V0G+tdQ0q3uLF1eB0BUg57fzoq06kUpzW5w100rsjm8xHKwRuzk7sHp+tSsLt1ywSMY+71yfrVuWRImUucA8ZNR3F5bwLulkUD61jdvoYqbdrI+e/jNouo3HiRtQ0uLz7qWEQzKOeBx8vvXZ/Bnwjd6B4aubjUbd4bm6j3CKQ5ZcZ/LNdHeXsEmpC+t4wdh9OH9acfGllNem1uG+ydsuwG4+1dcqtSdL2SWh6M/aciUF6nCay8mjaLdXOqXX2E3My+WrNgsBnivS/DEv2nRNPu7eYTI1uAJAc768l+KXh268W2lo2k3sU7wliEkbacHt+Feh/Cywk8P+DLHTLyTzLiAEvjkAk52/QZp1VF0U7+9fYWMnOe6K2vHxZ9lA0W9jibzTnzxn5friug0a61WHTozrgtppwAHeEEA+/NXoL0yStFNbYCjhzwDS3kzzRrBDHhXI+Y9h3rCU3JcrSOVvmdnFBc6laQSJDIwWRuQCRVWC+sruCdvtEIjQYLlgAPxpRaWoncXMUbyFfl8xQdwHpmvOfid4M1LXNEvk0VUjCkTLEjbRMozlfY/oaKcISajJ28yoxgvI1PGPgrSfFWhSpH9nS5PzwXUYU4cdsjqD3Fcx8G7TVPDUmoaRqRD28ko2KmXVXGcn2zxXN/Byw8R6Xqt3Z3kFzDpwQOVmBCLIDwVz3PPSvY9M0qeGWSdEVpcl3KnnJ/nXTUXsoyouXMnsdCs4vndyeTwvDfaxHduQkKJjaowS3Y/St1rBSMSEkdMButR29yXVCw2MR93GDS3V20iNGgKuQcN6VxtydlfY5ZOpJpXKN3oUMpBhxAAcv5fBq299NIRDbLmQDlm7e9ZunNqcAEs0iXUYJ3rtwyr7etalqsbzSyRODHKOo9ab031KndfE72KxtrmIsxRZ5CQQxOMVLFfmOZVu4igAyZCQQtXI0LShSxAQZI9DSajbxS27iQcYqea+jM+dN2ki0rK6BkIZWGQR3oPvzWXKksUaLGcxcAqOCtXbMOIhvk3noTUtGMoJK6YrW8TKQ0akehHFRy2cbMgG5FXshxn2qyemawJtf265bWK20hjlYo0vQI2DgU4qT2Kpqc78pleL/E0ugSwW9naK5c4GOg9sV43rfxA8a6t49OiaH+5Al8owpGDuGPmZieg/lXv1/o9veXnm3AyQMAVj6RoqWEMstzaql40rb5kxukQH5ckdvaumjVp01flTZ0p05QSW4yxvG0fR2htykogGxnz96XjOPbNcHd+Kb+5umlmlZGLYCp/CK9On0+3m0l7d0WNWy+FOMGvLr/AMKaqt7LbwwFmJ+WRunNZOTesdz18ulh7ydXfzPR/BmpxX2lRB5Va4IJcdzziivG/hr4a8W6X8Q431GGaK1Ut5js42OvYL60VWIhGnL3Xe55GI5XNyjsz3TToWS0LF8uOSD/ACq7CI/IDrhEYZ54xTbqNEikfdsGOTS20UctqoKDaRjHrUdDnlPmXMzkNf8AGmnadqsOmtfJC8pAMhG7Gf5VuWJe7tFksVjYLmP5zweetc5qfw0sL7xPFqbf6tWDGM8jivQIo0iQJGqoo4AAwK1qSpqMfZ79Sp1YpJQM1tNYQxqCpdWDHAwPpVifT7e5KSbSkinO5eCfY1dpM4PT5SKxuzL2sn1MuGzNqrmFiAThlz0PrzWjbl1QKwGMdRUGoMRDuiXzCeCg6sKTTk8i2UO2VbB5PQ46UPValybnG73FmjljvhMi7oiPmA6/hUm8NKQocEc7mXA/OrQI6U48jHUUrmTqd0ZsazWt9vwGhl4du+ex/pXA+LbiT+2riN3ZEVuFHFemzbBExkAKgEmudk0nTdethKFDSKT84ODn0NNPqd+BxMKU/aVFpsZ3hbUJ3iQktKsOPmbqFJwR/Wu4VgwDKcg8isW2+x6Zpc0eyK32JliehwOufSoPCXiXTtctHGm3MUzwACRUbO0nt+YpyTkuZLYyxbVaTqQVkbt3zbuD3GOax3Q2uneZbYLhtxBHUZzj8qu3k7TWyxRqyyyg4x/DjrT5httMDldvQ9c+lJaGVO8Uk+5n3kEOsae3l/MrqdpPUH/9dadhI8mmxZ/1qqFfPHI603S4I4bRFTk9Tx60soeG6jMeBE5w49PQ0N30CclL3F0JzGFi2r+Jptsu2LByQvAJOSferGOCDVfaI8KMAdqkxTurHO+IrebUbpLeM/uzwRuwR3J96s6DD/Z7yWTStIiqDEzEZ56jj0/rVa6nfzbry2U+U+AwPKtx1/OtGDTh5AaZS0rgEsTyP8K1btGzPQm+WmoSehU8QaVHqpiWQtlJFYnPBA6j8aTUbjTtGsPPu5BBBF8i4HA4qLxHqH/COaLc6gVMqRqTjqa4nw1rVh8TopbO6SaIJyyqccelXGEpR538C3M+dqKTfuoe/wAUbDUr9NO0uGaeUttMoGQRnrXqsTw+QsOf4cbT9K5vwn8PtA8Lu8mnWxM7dZJW3MB6D0ro7r9zayeWMEjrjofWprypSaVJO3mYynGdoxPK/iX4HsrvN/DGCxIDrt6+9UvBLx6eotI4wqqPk7FSDXpem6W39nP9rkaV2J5bnisn/hGIWkivo8o6Els9Gpqo7creh69HF0lB0qmvmcJ8TPHOp6Bex/Z7BVDIC0xyRJ9K4TWtKm8aJ/wlWmIYpJF8u8hVcYkA6j1yMGvoHXtFs9d0CezuVQKwwCy8oexFZuieG4PCPgs2iESqJfOkZRnOf/rcV0U8TCEFyq0729UcsKsU1p1seSfCtJdL120a8DpAGIkLA8E8V754ejWzmvYEfcgcuuOeDXN6XDo2uIsIUxuhD4TAJzXTWVuttrcxgJKyxDK9lxxWWJqe0burMrFTUrx2djxnxLbyf23euEJXzmO4+hP+NZ53oo3Nz3+leweLPDouIHubbIfGHRUzuyfQVxC+AdZniEmxUUjO2ST5selYtKclNOx7mEzSj7FKbscNongMeOb2/e7uZbQW0qrFKF3b0I5Xn09a948O2kWh6XHaWaYhhVY1DHk4GMn34qn4Y8NW1pah5mmFwVAK78KpHpityJHEixYBIJALcn/69bV6zqe7fRHgYicZTlbYhvdLm1cf6bdNFBjKxw8H2yTWXqejfZLdpLYNK3CsXOeK6qS2GwBWI21WaQ/ZpkQCQgZHvWCqPoc8K0l8L0PLfGmvz6PoEE6qkNzGzZjxjjoM/nXgupXV/r0gkDSvMzbmYnGDnpXpHxLe51DxT9inB+zTDYAOqsP581kaNbWtvGxuDtxxzxXpxqLDwUkrtnuYXD+3v0NjwR/aU9u6XobfAEEcinBPH61p3/xG1PwlqcYuLUXNkzDzM8E/Q+tZieM7GCC4s9Pk8y9t0ZkymFfA6Z7muD0zXrvxRfz2GrMZWuVOw4A2MORj8qIQc251I6dgrKDXs3rc+uNC1TT/ABLolrqVi3mWs67h2KnuD6EdKfKq27INxyGwABk7a8j/AGbrq5tdIvdMvMqpuGMIc45A+bHryK9nUsH8uXBcjJI44rzq9P2NRwWx4MoulJxZ5p8b9Uv4fDEh8Pyut1HOm8xffVec4/8ArVzPwU8ZavrUt3oWsyvK4TfHLIMNjuD716DrVoza/HAIvMDuG+tdDFpVskokihRJUPDAYP8A9etVWhGj7Nxv5nROMacI+epHFao3lLIuYxjrzwKsRuIJ5ZRjymOAB/OpZcx2zucZAOMetfNvxN+JGtWPjAWOmkRR2g2KAM7yeSajD0JYiTjEzj7977H0vPEs8WCAH7H0NU5YJbYb5JN0Q64XPFUPBOrSeIPCWnajNGYp54h5i9MMOD/KtvdOqENtfjrjmsWnBuL6GKbjoCOjlZI8bSOfpWRrGmytC8lhKYs5JCnGf8KupbMrM0WE3NzUN8xsreWSWcJDt5PuaFo9DSHuy91kujErZW4lcvIUAZm6n61oMM9sn3rzy58c2FlMlmsvmTOAFVRyfoK2tE8X291tt7yOWG56DK53/wD16qVKfxWLq4SrrOxtXkkcCBpJAis20FjwTUkZxFtVtrHkMKy5L+0vJoYmt3mhd8tvXhCO/wCdbaxqM7QAPaoei1MppwSUkNWQhAshBcDnHQ1WuhAkcTvEGAkD5Azg+tYvjKRrO1+2rctEYgVCL/ETVXwXfXF9p032os5GNpPvTUdOY2hhn7L2yeh1EssasvIy3SsTVdftbGNzdukcpwFVz3PT/GmR3dutwy3E6mdAcqTj8K8++IulXmrX1neW0cvlSrt2j+DnrVwgr2ZvhsLGU7T2OzTVftz7QBLCuBIVGAfp610kzki3ZcAO4DeuCDXF+F7C7s47XTmRnRwGkc4+VR6/U12l8pSHdGuSnzY+lE0r2RGIUYzUYivCpnWQjLJzk9qK4Pxrrty1yLS1M1uSFZmHBI9M0VDXLozroZVOvBTckjpdB1KfUoyLiMqHGc10KgKqr6ACqqSWsC7FaNAOMDirETBk4OccZqpa62PEm76pWQ8mlFRSsEXOararqEGm2TXNzNFFGuPmkYAVKV9ESotl8VHdQrc20sLkhXUqSOozUGm30V7apNGwIfkc1U1TU5LTULOCMRssxIcs2NoA6imou9iowk5WW6LltBHaWkMCjCoNo9ao6ldN5sNtEMsDl27AVDe3iiQfvtq5wz5wB7VQvvEejWNuzzXAJdsZHUkd/pVxi272udVOlK/Na5r2j3fmsqOsrIc7WGOMdAa0rW8juGZRlZF+8jDBFcroHiHStVmkuLC8TK/KdzYBxW7qzJKsHkjdckgxsrcgd+fSiUWnaSsZ1Kd5WaLupGZdOujbKGnETGMHoWwcV87eAvilrVr4ki03UoIporicRyL5eyRCTjt6e9e9TagWs1MEpaVgQqLyxI6j2NcT4e8CM3ixdc1FLdihMgVhly5PBJ9q2w8oQjJVFe46cVGEuYt/GWzvLjwVqg00O0+xcrH95kz8wFeOfBe31LRNXudcvxcWOiWsZNxI6lRIf4UAPU19NagpW0dwMkc//XrxT4tarcrd2+jTNCLSTmOOIcYzgs3qaeGrNQdLo9/Q3wlN4i0DWsPiNJNNPPbx7oicxgryAe1bXh74jWuq6jHY36pBM2Quc/MfavLoOm1AAFH0zWP4ijkgMV5bErPA4kUjrxWVOdOrUUWrJ7eR9BicrpKi3Fe8j6ugZWUFcEgAZHQ0spDR5I69KxfC1y82k20kg2mSNDuPfIH9a2SzRgI2MdARWLVnY+RnHllYdvMa5kPasW71SZWun+zkQxRl1kY8MR2rTd9wIPYj9RWTJYzOLhpJWdZWACN91UHp9acUuptRjFO8jF0SOTyb6a8Qq858xlIxlgM4ruLdxNbxSL911BGfTFYlu5klv/MKMI32AEcdM/1/SrenSzmILGMIrchupHqKqp72ppib1NSLxNpqajZ/ZZCRDNlGwM/5FZvgXwRp3hNJXsgxkl5LN1xWjNNeSXZinSEW7P8AKxboKu2k5Cje+VB2Nk9CKXNOMORPRmM1JQUbl1lJkUg4AzketNuVD28ityCppCSxyDkVVurtbeyeRzuI429ST6VCXYwgm3oLe3CW2nM69sIPqTirRjUxCNumMVgXK3N7facYv3cHmb54X7FemD/Ste53+acZA9abVrGlSPKkupn38Qt5B5rbYZB5TNnoOx/pXPaL4u0xrm90u7vra4lhc/Kn9w46iug8QRpeaZKJAfkGcg96+Uta8Jape+ILhNAV7iSSVsRq2GPP6114WlCsmqjsdtKHtKTl2Ppmw8M2trePdWFxKAxyo/uA9vcVr3FtNHcB4WIkMZVm7GqngLTb/SvCGk2Wqy+ZfQwqJWJ3HPpnvjpWnPceTeOszfuymRx0Nc8pPmavexh7adR66l213fZ08w5fHJouplt4HkYEhRkgcmqzXKQ2vnqwMeOfenW8qXFuLjqpBOD0ArK3VmHI/iexVs2i2Oy/KrtkfWpolMh8xDh0O3kdayPC98t/LduhQwrIQir0Fb5BUM6DPqKua5XZm1T3ZND4pVdATwc4IJrP1G3IcfZmMcpO7OePpT7eCV7RmZh5zksf8PypYGLB/tCqsyjGR6UttiYrld0YV74dsdQuY7u7gUXKkNnuDXlXjfwi9rqjqCY7WZtyHHy9eme1ewa+Lu4ijt7Z/IRzuknHVAO2PU1XvbOO+057G5gdtoykrdz6j/CtIyas2/8AgHpYTEyovmb0fQ+dBoOn6NJLeXpZIFJG9+2R0HqaXw7a6BDBe+ILCSRhaIw2OMbWxxxXafEPw7danobabIVEkcgkikYY2t6H2Nef6J4J1R7d9Ohbfc3Ei7wMlTg8D+tejStOLc569fQ76lTmfuxXKd58G9O1LWtES9V8vBfZyxwQrYJI+mK9m8Tav/Zluksab5N2Md8d6i8BeHIfC/hi006Ih5FXMrdNz96k1OFWVpJTuZCcDHGK4atVVarfS547qqtUXNqkLZanaailvc25Uv3B+8vtWg7hZME4z8wNcp5cEX762ieORed23H6elaEt5KkaGZCJVI2rj76nHSs3BX0HOgvsmzJKrROGGVrgPEnw20fxFrcGosHhuVxlk6Nj1967ORlkKtE5KsMFR2NRyCSG1iMLAvnn2x1ohKUHeDsyIpx23NbTLGHTbCG0tl2xRLtGamK/LxWfBeSq2yUbhjcG/oa0I3EiBhyDWTT3ZyzUk7srSSbZFXueRXF/EvWUtLa3tQfmkf5x7f5NdfI0c2pxKrqWiDbl78jivBP2jLm4sdSsSkjhZgW49iOK6MNTVSqos68LyqalLoeYMLqXx75gWZ5hc7hsByOePwFe4/EK/uvD+hx6zZrH9pRlxnkCsbw9dQ3Gmw3eBudFLMo+YnHTNUvGr3N1oE0GyQxTcRq3Qkc12Sq+0qRTW2h7LwrjFtM774ZeJpvGWhLfXUS213BKYpDDwr8Zz+td+txwV5EgGcY+8PWvmu01vVvBOlaHpllbg3N1+/kGM7yzcKMd+K+hIFW1tYT92XqVY5IzgmubFUlGXMtnex49WC0KPiuzk1PR0hYBbg84PrWF4P1h4dbl0t/LEMUXrg7h/Ot/XtTkjUG3tHupUAOY+QmTjn0rk49DY+NJxtdIzBJOGxj5iOg9smsoxfLZ7anbh3F0ZU6m1m0dRFpun39xJdCESO0jZYd8cY+nFbEmnRSW8aEEbef/AK1ZXhG2lsLNLeQbk7N71vvOBuXaQV9eBUTbvocNaUlPli7pFPSYVR7iQEEs+M9SMDpVxl8xSG9cGqFhIZ2fyWVNrEkdepq/CNoKsctnJpPczqJ812cT4nso57h2kjYNuA3A84oro9VtDdTL8oIAyB7iirvC3vI9KhjXCCSlY80vpS+qQ29hI87nAOzJ59z616XoUN5a2jLcpuYnI+bnFV/C2j22lWaBQhuMfOxAyCe1b+fSrqVL6I4cXilP3IrRFO6dxGXaJ/lGSOM1xPjLwvN42isDJdNaWCtuMR5Ln1IHT8a9BdlA+Y4+tVIofIJEagrk4HpU06jpvmjuc9OdlpuUdK09NHtorW0YFQoRfMbrgVV8V6ImoRCV2ZJVH34zjFaeo31nZxJ9qmRGdsL3OalupEe2y2WRlzx6UKUr8xcZSUlI5WbQWi0fZLdPLLI4IctwM+teV/GbRL21vdKtrWN2tpFO4Jk5f3Ne1WAmLlpYX8lwNgPOB/SprrS7O+2fbAhkU8DONtbU67pT5nqdUazi7Sehw3gPwlaWWgAaisYcLudT6n1rnfEXiOx0rxKLWwaUW8YALxykYPfHbFeh694UuDbltOu3AA5iY5DD0rzi88A3+oT/AOjwPFKDyCQVIrWlUjOblUZ005xlFzjP5HovgnxBaT2+1pEZSSUlxg888/rXYQ3kM022J0O4ZHvXhl58NPEv2dF0248kxkll3FQ3uMV23gXw3rNra2r65K5ntmYr82dwPrUVqVK3PGfyOKvGlKTdz0eVQyMrDIIxj1rxT4u6M8eoaVqTJlFdopG7KCcivbE5HPWs7XdPtdSsZra8QPFIpBHp71yQlysxwWI9hUTPFb3TLW30RbyC9iluC4BhXqq9z/8AqrjvEOoJBZO7LnAyAe9dtrXhXUtNhMqqXtQSAw5IHvXLWWp+HItei03XrdnR3VHZhlFz6+1aUKDnUTSvbsfXVMZCFByU73PWvhh4nudV8AWN3dWbySAtG4hXJABwGx3/AArtrO+t5IuJAGU4IPDA/Q81H4btbKzshDpUUcVknyIka4AweatX0MbujlRvzt3Y5waVSUZSdlY+ObTfK1qc/rL6pBq6zWrI1jwZFPX3x+FTR65BdAxRxzBVGGbZwvtVTVbqQCdS4cxAsVz37MfapdBY/wBlJJcFTM4JbaOOf507e7dnc4L2aclsXtJO+GaeVfmeUs6+2OP0qeAj7SXhJCKQPY5qjb3QhtCvCk5HHTNXbG1dbZHKsN3IIPIqX3MZq12y1JECRu6kE4qKWE5iwoQq4f6n0NPt5c3SGTgAEA9jV+eMSKe5qb2MHNxaTMyTVIreSOCTCbuAT0zUE9g897FdrIRKgO1ATtP1HrVW6Dm+aKOPcz4Urtzx61DquuQaRMVvUmwsYlMqg7Vxxz6VcYt/Dub+ztbk3ZtWkckNyouBvO0kN71PqEz+TiLO5ztB6YJrgp/ijoSWE19PcMkEDBPl+Zix7cda6bwx4gsPE1gLqxlEts4yrlSOfT2NOVGpD3pR0M505J80lsbr2yy2jRycFkw23scVxFv4TFr40t7+1VfK+/KBxtY55/Gu8TO3bnOKYgCylgPvjGfcVnCbhe3UypVpU1JLqLcOyxE4BPQHsPrWfHdRXGXilMpBxuCHFXryMvAyjkHqKbp3y2iggDBIwKlWSJi0o3KWyO4heIgFWz9Kprb3dtaNbxSJ5W3Cs2cqe5q7c24nuZDC5ifHUdDVe61SHToDLfSIiBsHJ4FXG70R0RbtZa+RDoGmppVqYbeHBY7i+ACx9faugg4jAPXvWfbahBdWoms33A/dx0q7bsWjDEfMetKbbd3uY1W5asY00drxO6xp/CzHArOutStp5xFbuHz9515AHrVDxRYpqs8dtPISh5EYOOneprbSUs7YR5AX+6BjP19aaUUrvc2hTgkpSerIfMme7QgtJbkglO+QeK1SoUHGQOwNZ0dxi1aWSKRh5hKyIM9OOnpVpybi34cktjGOops0nqQtNp+oXTW7nMiYXds+Un0z0NXrXTrS1k8yC3ijl9VXBq19lt7eL5Ylwv51BFcwnLoSFJ6N1HqKh2fw7GDm5K0L2LMDDDLzwSQDWHbTJcR6idQZVjE2ArcYXFajSgy4UgAgYfrmuZ1/SG1KeQLIVgIAcg4yaqCV7PQulFXaelx+sararPbW9qvnyzYDbBwqj19617qB2tPM/jVVVR1HWs2x0yDTEt4bdd7E4LtySP8A9dWpbiRJniRsbV5B7mm7fZNmrpKBP5CxXSy5wXbDAdCMUl1Nb2rbpZI1RyepAFTWQeWBTMmCx+Ufh3rC8baOmpaabXJRnUqGHGDjg1Kte0iI2lPlkxYfFnh3VtWNhp+t25vfu+Wv8RHUKeh/CtKG6l09i0vz2zdcDlT618oad4T1+x8R2ySW8sbRzr+8HQYYc+1fYzxRywKjqGUgHmunFUYUeXkd0yaq9laMtUzI07UrW9eWWGMJcLnIPUiuJ+Mng+XxZoNvNZbftloxIDHAZT1H1rV8X3Emg4urWLdKzYyBwfrWn8P9a/t7SZpXj2sr7WU8jOOnvWaUqdq0OhTSglUjseA28+veH7e0sdGiVrogiR3XKqPTnj867bQ4dY8SR28WuSwyvBnPlJgAV6drOgW7utxFApwcOmPvD/Gpba3htbaOMqiLxu7ZJPX860niVJXSV/xO1YyLXNFa/kZDaIdQiRLApb/Z1Eaz7csmPSrej6LPpNzG13fy3rsSWeXnPHQelbenyLGHjIwAxI9waZq0TXEQVGwQQRiufnl8PQ4XWk5cr2C0aGNpSigF2yT6mkfdvjkeJCckbhxgVWhDIwaT5Ywud3vUmqSSfZojAoIZ1z9M1NtSXH3rIsRJ5eyMDHcEdqj1NY2wJpjEvscE1TsdWin1SazVwXiXDH0PpSzwr5sryM2UwUcHgDHINFtdSlTcZe9oPsM6ekwnH7gtuWb29D6YqWC7FxI7W7K8eBhxyM+lY0GtRW9syzPyc5B+vWrltqFvPbqLZkUqQSuMFT7iq5XvY0nSlq2jULhXy4wQp5oqhe3K/ZiScev50UlG5EKLkrnExa1ewyLIJU2MOdw4PuPWtKLxU6LiTZwcEg4qtq/hWaGcy2fzWzMSU7rXO6ppd00agREbMknpXV7sloelCGHrWeh3Nn4ysrkFQSrggYbkEe3/ANetgmS6liNq5W3Iy7A89OB7VwPhTw5f3FuT5SQxSEBpGXOQD2r1C3gSCFIox8qjH1rKpyx+Hc8/FxpUZWpFO10u0SAK0IdmHzM/zE/iamjCLG8QIGw7Rg5p11cR2kDvI20KM+5rFu5ZoLQzvhXlYSFD+GB9cVmk5HPCMqm7N23wPlJyCMgn+VVtQ05Lr95ubzF5Uii7cTW262fDY3KyHkGqMWqz2YVL+PczDO5Dyfw/woSe6CEZ/FF6mhp10ZYdkvEycEVAIGgeW7kcqC2cD+EcdaSGcSbbpofKjY5DcZA96dqTrf2zWdtMnmy/KSDnaO5otqFmpaaJ7mnFJkDJBBGQRUp6e1c6rXVncxWUg821CjFx0I9mH9aNQ+32mnz/ANmTAybT5SzcqDjjn60uTzIlR6pm7JmJS6HAHUdRVC8898BGCO3TdyMV4t8I/Eni5vGVzpevNcS2bl2m85c+S3sewz+Fe06xNs0mR1OJfux+7Z4rarQdGai3ccYShPlZM0KSaYsEwQnYFYdq878R/B3QNfvHvY5rmzuWPzGIgqx+h/pXpCRrOiM4GSFziriqAOlZRqzpu8HZkObjomY+iw3WniKyuCskKRKscvRjgY+b3961SNz460sq7hnuKwdV1CfRYptQ2NcWKKTLGPvIe7L7e1JXm/MaXtNVuZ/ivRXcTXtmH80Jtk28ll+lUf7UgsIrBHY+bIoGxlxnjrjtXY6BqdvrOk29/aHMMw3DPUfWsfV9DS41BZSAuDncOoAOcVpGVnyz6HZRxHN+7qdDmLG9d9euIpZcw7Q21u3POPwr1CPHlrtPy4GD7V5ItrcN4zMZhIiClFk6LznmvUNKRodPiR3LFRjnt7VNXZGmZxjaLj2G30Sh42HG5tpH1qoLu5tLx4ptr27Y8tuh6c5rFuPF+j6nqcmlWd4pvbdiZFB+6V9PWrV5fCbQJJZto2Bt3qCKOSUbKSOanTbSUluacBga4+0FwCw28n16Gq16sEwltr+LfDcfu3JGQV5/xp/h6eK+0e1leJTuiGSF/n+VNntYzGUaRm2txu5/Cls7MEkpOLOD1f4VaXdaZNpsLyFZJvO8xeq4HH481reEvCltoM9ja2V5Nttfm8pzguvc4rq0E6zQCPDOeHJ4GPWvK/jr4n1Hw5c6PJDCgnLO0cin5cDGQa6KcqlaSp825rCbvy33R7U5O0lecjvUShvMjHbPIrL8J62mv+GbHU4l2faIlcp6HHI/OtaGdJCVBAcDOK5ZRcW0+hwWaWxJKcIazbYToZNrBhI2dp5C8f8A1q1Coxg1Ub9zngt8wAP1pLsVTelivDEWmCoc4HznpWb4o8OQ6rp0kLlhu6t3rl/iP8SrbwHeQQS2kl1PcDeQpwFFdz4Z1iDxDoNpqVspENwm4K3UeorVwqU4xq20ezNHUlBpowvB3h2fw7aR2klybm2LFgW6p7e4rppbiO3R3YcAZPvSyKY9sa8rngntUGpwLeWUsOdjkEAjsamU3OXNLqF+drm2KFzeJ9nF1G0ZU5KSE8Y715L8TPiVq3h66tbe1hifzQSzSKSMjsPU16OmihNGaDz5WmiQ4AbGaq/2VbSRK1xaQXeGD7ZkDbTjqM9+K3oypwlzSXMux2xjCzS1NHSNQM2h2E0sXlvNEjMnZcjJ+lXraRZgY4xsJHysehFZpvoVQx2xRnUgFR0Qe9XrSFbre0bRq47A5FYvuQ4cqvI0Hnyuxgo4xwec1S2tb8vHuyD071JDbv56qUx7jpVrUpIxbOGKBsdzipWjsjG6i+VdTEGtW+miWW+KwWi8mRz8oAqXSdd0zXNOubvR7uG5hSTD7DnHsRXLfFjwVqHiLwvHFp0nzwsJTbjjfx0+tcx8HPCuseGlvptSjeCG5ZUET87tuTnH44rpVOlKk583vdi7Rk7xPXvLBIlzkxkfh7Ul9Z/8TKC4A+QfeHtV21iiMBwSfM5O7rmlnmVEEchw/QHsTXLfXQy9o1LQdbn5WU9VOKy9Vu4Hm+zXI28goT0NOFxNHCzZ3YYp05I7UkumhUR3PmuR8xb19RTSSepUIqEryMzWtAi1KJ2T91cryjipvDGszSEafqCkXkPyk4xkDvWtbkKV5HTGPWs7xBYtuivbU7JoeuP4h6GmpXXJI0U1UXs5/LyNHVrdJ7c7kWQgZ2kZzUXh60trPT1W1iWIOd7KPU1JbAtYo+7LOA2aw31qOxnmgJUyhyyqTxSSbTijOFOU4uCOplICEmsNoN179olOIowQu48H8PXmpby+85IYowWZlDMR0Apba3j8hbrUXDNuLJu4VM9BSSsKEXTV31I2kAkeEHLFd6sOoHcVatm3RKHGJCOmcmorpYY0R4gGeQja3Gf/ANWKnUhVWUDhRj3oY5NNGXOr+dJ58u23DhTnjGa0bsBIFIOQCOPasjxVCLzw5qaQn5zHv45OQc/0qp4d1uTVPDkbSR5ulTa5HKsR9Ohq+VyjzI05XJKXYj1DwwJ7mS9spJLeUnIKHGSO5roLWF/sY+0MZXwM7e9Ed2kGlgzNhkX5snoaktmeW3jkX5fUGpdwqVakopS2WxzM2lRedcboJfs6txx19hWrBp0MUAa0BBwAT0Y+xra8tiOTUMluCCckd+OBRztg8S5aNnl3xIvNStbcTWMLSsPkliBzjJ647iius8RWwkVJVG25Tox5B/xFFdMaiUbNI9GjJuCs7HWDoPSoZ7WCdSssasD2NcFrXxA03wxfLYaxPKu7LRtEm8oucYb8a6rw34l0nxHZfaNJvYp0U4Zc4ZT7jtWTozjHna07nhShKmzWRRDGFQYVRwB0qGe8WCJnkYBRUF5ehHKxgyOB0XnrWCl295diNkeRg2Qq/dCilGNzelQc/ekaMMLXkb3N6WG8/JGegUdPzq5CYr+TDYKK3CkHkiqeorcSeUiRsmR95D09qliSeKxVWQZDZVewH+NN6mkldXv6Fu98uIrF8qLtJVs4C4rxD4ueGvFniPWra80lWmtYIgqeVNsOQc7sZ6mvXLlPter26XIcqg+7n5XPv64zmtJra1kLSRFfMj4+Q4wfeqpVXRkpR3FdQST3Zi+DodWj8DWdrrXGpLAQ5bk98Z9TWnZ2cNuY5ki2yo29mXjfkYqe/ldNH87IDBAWP86o6s4ksYsKHiGGx2PFQ5NtvuQn7vk2azXEUt2sYPJXPI4rzXxhrl/pOtyWsc7CBQGROuQa72yX/R43+boQCTnFZuqaTaa5eW0slukkkR2ncCCwHWlGyfkdODqQpT5pK6safh0pc6Yk4RBIygFsYLCq0sVuNYSW4m8rZ+7VZGwoPrg960bZYrXyooyVjTC8+1cB8avB+peJrK2OjzbZo3yUL7Q1VTSlOzdkzBSXO7aJnc3t/DpVpLeSNmCIEkg9AOtcZ4i+NPhvRrqO3jWe9kKqzGEAKoIzjJ6ms230DW7H4W3eiatJ5t4YXWF0Ytyfurn9K8Y8KfDzWPF0dy2nmJbi0kWOaOZipGc8/piuuhh6MuaVR3SE6UWuaR9b+HdatPEOjW+p6exa2nXI3DBU9wfenNbiS4lhkXdbyKcr296zvAXh/wD4RfwtZ6WzrJLGMyMowCx64qxrt3LZz2ssC7hvw4HJ29zXC1Hnaht0MKavNxgT2VjFpMYjtF2QZ+72qWe5QuAmGLA4HsOp/WlSdJ1dcMcAE5HUGqgjW2fyoVLSSnKg9OnP4cUt9yoq7vLcz21CG3vooWxslRsMegI4xV+KGVdAuEgkJllVyrk9Cc4NZ0GlBNVkMz+ZC2WVOMqSe/rzWhbqdLLW5ZmtnJ8snnYT2+lVJK1kdFVRkuWJ87fCPw9qa+Nri+mgdYrYuJHfgM+enuak8D+LPEeofE+WxvEaSznmdJ7aVTtjQE8+xGK9sgjm/tBlQxrbrJkxjuc81otYxR30twtrEWmULI6qA31z3rsni+Zycop3VvQ0n7ulyxo0i28EigbYg3yjpxz/AIVmaF4ntfEt7fWltFJE9lKFZyPlbnsfwq3Dm3ZFlYsu09e9RDW9Fs53iiARnYbmSPAJyckn2Ncqje+l2ZyhduSV2XIbSe21SWWN2a1kG4KTnYw6jHoRUHjHwxpfjDSHtNUi3MoJikHDI2OCDXQoUkiV0KshGVI5Bz3qHyFQtjvzjtWam7qS0aOdz5nd7owfCvh+O08Madp7M6RwR7XVGILHvz6VYXSRpNzHPa3Ev2cnDxyHfgnoQe3NaWny4aZGzw5Az3FW5VV4irjKkYpupK7v1G6koyt0HKcjmonjLK/qen4VTa6ktjmWPMAHL55FaETrIiuhBQjIIqGrGTi4ankXxE8BXXj7V7OdZFhih/dTN1wQeceteiaTbWnhjTdP0uBGW3Rdgc9M+/1q1pcVxHdXzzALDJLujHfGMf0pdchSfTpkbjKnn3rWVSUlGm37qNpSU5qL2L7qHUg8g1Q1CylmiItZRExGMkZp2nyPsEUjbyighu5H+PFIdTt01L7E7FZNgfJ6HJ6fWskmnoZxUoy93oc2sGq2N0ReytNCTxJGBxntg1pRRhIzGY1Zo+Vb61r30kQgbzSMCufgmUXRGWKORjjIwK0u5anZGbqxvYr3FtbhlWDMJFwA4j4LD3Pcc1qiGNFkEe1C+RvHDD39+lZU1rN/baSQhWt2yW55PuBWlfRqpXzGIUnHHNNvbUuWtlcI4ryOP5rxiexCjpRbW4lv4WvG3vncoA+U4B5xUsaSw25YlXUDjjGRSxbd1vd5JwdpHXGam5k5b2Nk1U1ONXsnz1Xlfr2qd5o1ALOAD0yaiuCZNoQbkBBb0NZpanJBNSTKM0YFwiypkMoPsCDUOtmdBELcgs7YJPYVNLNKzsxUgAgAfWkj8tty3QyI/mGTkVa7nSnZqTGzq9vZRbSokBAfPO6mjVBLHgBGbJwAetZ3iHU4J4YYrOZHcybWweRxWVotteBXebBKkFeOnPX3q1D3byNoUlKHNPc69FS4hdXUjdg7RwRVK/W+t7d0hxImPlLdR7GrFndIt2IXOZdu4kdKl1HUYbLyw4ZzI20BRk1GqdrHOuaM7JXKGnNcS6KAV8uYZAWuG1Pwzem9m1QSk7ycox6Y9K9CurhI5I0zsLsMEcn/APVVcac888jtIyqshIXdwwPaqhUcLtdTopVnTk57XOPtfE8djYASI7P5gTpywxz+FdNqksN7pLW84k8t1+bZwwzTItItpL4pLbx7QdwPXn/GtK4tY0nRFOSVLYPYUOUbpoqtUpSa5UVoY44rS0jRyyQgBCep7Vcimjnty0ThgflbHNeN2GjeK9M8b3+patdSy6QrMwCyZDjPyhV7YxXpXhi4tb66u1hcghVYr0yD3/Wrq0lHVO5EqX7vn7G5LHEsMsZwAynn2xVbwraLZaJDCoAwzHgYzlj/AEqS9QRKpDEooIx/Sn2DNHbJv4LDoOxrH7NjBr3NOpVv7RWeUfwEjK460s+oxWcG6QMVxjCjJqWeQZLPyehxWLqZE0lvsyNjhnx3X0qlrubU489lLY3NP1CG6UKrYkxna3BI9annmVEc55Uc1kXlmk0aTMghmU/K6cFff2pFmmIVLoJJK3y5XjcMUrIl0ovWJau1SS3UkbhjINFZsV1NGkqeSxhjBKAdcUVXKzaMZR0RwXxO+Hf/AAkEi3UFwkM5IG5uc1Q8CeCZvCd1cjUJZJJJVUxvFkIeen15qz4G1nWtev5bLVYJAkgJVypBjP8AhXqc2meZYrGz/vFwQx6ZFdc6k6K9m3oZKqoNKZmzalb29r5ds6NcSDbgEfKe2ffmtTSbG30+FV3B7hlAdz1auNlWw8O6pEdYvIYbcuXXzG5Zs9PcCu0tdSsri1S8t5kkt3GUkXoRXPNO11swrpJKNPVMJ51S7hh2Ek5IPYYpt9OPNSGPPTcSPSoHnbVIZvJHlRY2pN1Oc9RWeml39tDKYrzzHwOHXPI9DU2XUUKcftOzRavpiSWjISVFyrN0B6Zry/4caH4ssvGN/dak8i2BDln35SZiflIrrY5NfB2rpsJG7G7PDDua6SG1a3tVEjkFVyVB4+laxm6cXFW1N501BJXRoJJE9ikMpUgqMg9OailktrazKylVjUY+grPjt+m6QlmG4Dv0pHhS4uB5wzKrAmNj0OPSskkZKnG++hZS+U2gKoCWAKgN2PQ4rPW7McOoT2AmeaGHcd4OGbB6ZqSW13XcX2faCMk7u3NaltCsWmykt5kknzMx/i/+tTdlsVLljHTqeP8Aw98W+IbvWL698UXYg0a3VvN88bADngD3r17RNZ03W7BbvR7xLqBWwWQ5xjtz0rjfiR4Jl8W6dHZWF8lmRL5zh1JVxjHb0q98OfCtv4E0F7Jrhp55XMksu3AJ9AOwAretKlVjzrSXZGEld+6dk/8ApN1Gv8H3s/Ss7w3o0GmeINcuLeIR/anWQ46H/J/nUNxrdto+ny3jo8yBtoVOpyaTw74g/ta7uJ47O6t4l2geav3we49elYcklFtbDdOai7LQ6se1YWpEy6tHF1Pltj8a0rm+gtrU3M88UcIzlmOP8msbw9I+oXd3fTIVBwsWf7vrURVk5GdGPKnN9DaE6W6xLKAAQFDDoTjpVeWdYdRgLlQGDKM9jjP9KyPFmspptoAImkd3UADsMjP6VY8QRPItrPaKXDNhhnGEI6/UVShazfUqFLVOXW4yKSCG7ur6ViWll8tBkcADn+RNaD3Md9BG1uBKjHnPQAf/AF65Gy0m8mma3ZHFqGIVicnHc/jXW2duLVLaCJBsHDH+v5058vRm1aMI2ad2Zs6T2d0sqgSQgElR1A/rVyy1S3uXMSN+8BAw3Bwfapb6OSCQtC2R12nv9KoT2MF4kbzx7XXoVOCufQikmnuF4zjeQ/xDblVSSBmQg4JHofb8aiiiRo/mVCT8rFhgYPeol0+6urjy9UupJ7WMZiXO3/vrHWmzPPZ2Mi/I6KxUFuuKduiZpFe6oJ3ZtabYpYKwgmkEZOVjLZUcdgelW5pmERY4LYJ2/wD16wLfzLoxy/aHiEQPy9m/yKtzTJcwvCJRGXjZFJbBJPXFRJdWc9SnZ3bMODxha6tfHTtCk824tyWmIHYccevNTS63rcLG1e33tIcRSovOfQj+tch8FfBWpaHr2q6jqjLt+aCEKc7xu+8fSvT/ABLcPZaRcXMAAljQlTjpW9X2cKnJT1X6lqpBS9nypiQ20iWrRXmZ1kXL5HfHIqzaqtqrPC5+zk/cJyF+npXnHhDxpdS6vBa3MhmjuJNmD1BPQiu48ReZZ2rTwHCD5nXrnHp71nUpyjLll1CrRnGfs59TfNZWvS7bMRo2JHYKvuTS2Ws289vvc7Dt3YPXHrVWS4i1O+hWzfcEBJYD7tZxi09TCnSlCd5LYe1w1s0RRd8hBDD0Heqd2vniSRRuJbh+wOMVoeTbWEsjSOd0v8THP4VWsfsy28ts8uAJWxk4yOvFNPqjaMl8SM1NHWeTz72aR3yDgt+Q+lQT217Dq8T2AfyWQGRX5CgdvbPtW5Ouy3laZzx91V4zWJYalBJ4hvLV7jaqosaoT1Ydf51abdzeE5yu97HHfE7xfqXheyiuLK2QkyY3HJ4Pr6V2HgDWj4l8L2ep3MJjldSdvYHpxWzrui2OtWJhu4IpY8YwwzVPSrddOtI7SCPy44hs2L029jVOpCVJR5feXUyclUWmjLTyySwTW0coB6K45Iqnb3cthpVzJqkiLHEeXxgEetVdb1CPSYnEQ3MxVcHqSa5z4uakz6FDp1sMXE65x26UoQ5ml0ZtCk5Wilo/0O50PUrHWrSG5t9koAIVjyBVqRpoLhSBugJzxwAfT6V87fDDxTfabqK6NOfLkLbkVjwx7j6175pl9NeTT4UiMFQBjBAxyaqvQdGVuhnUoOGq2H+M75LDwvqN7kjyYWkGOuQOP1rw/wCFnxKvNd1g6BrCoRdhhFMgwVbHQ/lXvepWiXtnJbTHdG4Kug6YPavKL3SvCPgDVFv47Py7twVSUsW2E+g9arDSjyypuN29jKlquVHVz+GjHb2Itm56vIT83/1+K2ocWYwrZj4UjPepvD1/b6rp0VzaMJISAA2c9qmutPiaTeCQSRn0rBzbfLM09tf3Jk0EMXlSSIBvZfvd8VwWreM4LfV5NF8i5e9VvlcrlQSAR9R713sEg+ZR95Rg1Xj0+1a/M7W8TTFNokKjdj0z6UQko35lczjLld2eQXmoeLP+Fj2UsPnLo7hA3yjy9hHzAmvW7+5kTRLy4sAXlWNmjUc5bH+NZ+swLGwVAoUEnbSeHL9jeT2rgJ/Eq4/OtKs/aRTSWhvUp88OeJ4N8LPEXiKb4kwwahc3Mkc8hEschOB/hX0o8sTyiRsBlzG2eozzWXZ6Dp6eIHvUto/PKlt4XGD/AJzVnUbBiszwKBMRu55DN2qsRWjXmpJW0MJcjktS1GkV5BIu0FAxUg9zWdpukwaVqUlxEgTzxsf254rX0kymzVrhQsjfNgU+8jDxZ/ukGua9m0iPaOLcL6MhuY/kIY8mqsL7GaJuing+1T37bF8zPBH61kSXSDaztuU5B5oSuaU4uUTSukW4jaHJUMD8y8EfSuYuL97XxFbWu0mIjG5uSTjitzzFmJgVgJVG+MjviqjwwRsk8yZwDhiOQauOhtS93RmH8R/FUmg+Hpr22h82dSAI3Hyn3P8AOofBviaXxV4Mh1VYlS7hcrKidAy9x7EVs3KwySst3DHNazAq6MoYYPtWdYWlroERh0qKO2sJyQ0KDkue9aJx5OW2vcpU9VymvaXRnnRw25ZhkAcY9qKrWFmYSzqrc/dorOS10CpFX91nUW8EUZZo40VyeSBgmpyMjH4Vyba7c6ReSf2nE8tpKwKyRr9wY6475rpra5iurdJraRZI3GQw7ilKDWp5lSlKDuzxX42+BfEHiHWba80tftNqsezywcFDnn613Xw88KzaV4QsLDU2JkUl3TPTJ6GuzimRyyoyll6gHkVI33a1liJumqT2RXtZKy2KkklnAq226OMdAnSmiExSh0OY24xngH1rw74px68vihZLZphApyCvQV1fh/xldJLbaffskiSRhQ3Qq3Y571U6HJCMlK9zrpYOpUjzQdzt9W1a00W2hm1C6ii3kgZONxxnio4J3u7OS6vHMKyrmOML8yjsSfU14F4z0PxT4i8cl7iOQ2nmAQNuGxEH8q9h8Y6feX3gyWy0eceekKruDYJIAyK0nRhBQXNq9/IORwsnudPbRebbh4H2S5zv644pHU2lsTvd5CcuxHJ964PwLrcmg+GYLTxVdxJdK5XmQZVc8ZPc13dtf2l3EJo2EyY4w+RisqlNwbW67k2lfVaDrGaO6t/ORdiEkEN1ovLhLa1eGPLuQGB68ZHFOW4g48soVxx2Aqrd27IlyINhuGjJAJ5B9fpUddRxSctS1PJHNArQsCx6FTyasPEJ4FLkk8A+ma47wrcm2V/tm5IRko207VOcMM/Wusy7FTDIuzIb1BFEo8rsVVpOnLlTM68t1k1lYxhoIE3bccFzwD+Wa1rceYVUDaqjB9vSsq0Zf3tzGTudsNu9BV62uMXKxtg7hwR0JolroFRO1uxyvjrwveeItU0+zhuvIsWkMk4B+8VHp6129kkVruhQjZHGoyT6cZNMmj8uWOYEFg24j0H+TWPBesusXsbEOJlUW6Hgse/4U3KU4qPRGfK6sfRGg9jbahqT/aY1kihQYB6ZJp188OlWwjmfNucCMseV9s1aVWt1ErpgtgPjkYrP8W2SarojxqdxQh1A9qhO7SexMHzTSl8Jq6eyGLK9epqUgZbHXr9DWD4ZWaC0LXJJkkbIz1xjitPUr6OxtpLq4O2ONcnHWk462RM6dqjjHUjvi09srREgxuMkdcA8/pUUsX2dvLkY7Gbcj/0NTKRJCggJKyRmQN9cH+tZsN79qglt7iNlmt2xk9x2IppGsIu1lsi7PIVaNiuf5/WnSYa3AkC88EGscXTyTKiKHiIyCG5POP0pZLZb67EF3KxlgbiNThSD0Jp8vc19nbcrw3TJftbRyCPy8Aqy5BB6f4V5V8TvCHjTxB4pSWyiEljjZEYpgqR+ufQ16PD4g0e916fS7SaM6tEu14z1bHoe59q6GDUIxbxqflcvsYJyeOv0reFSdCXNFa26lVPeXuou+GYpNP0LT7W8cy3SQqskg53MBjNVtfvrtmksrex81ZUIWQtnB/3e9aEUxbbt2kEDgdhUrBFfeSB2z0wa5r+9zNHHFcsrtHF+FfB8GmanHf6hF5U5OY1Byit/Q13s0STRlZFDA+tVboMbdidpB7HpisRVmmfFveyQxfxBWDAj0Gehpyk6jvJly5q755Mt2+i20OpyXbvmQrgLnjHuK2YYo41PlKq5/ujFcUulO+sJcxTs2xtrfNncpHO7P9K2p7W5it9+nzPDIF5ydw/WiavbUutDmavM8L+LvjbUG+IUWn2krpbWMyx7F6uxxnP54r2fTYPPt2MqlNyqwboVbHNch4g8LeHf+Ekk8TzB5boESPlsxiQDGceveuy0+9SIJ57IYnAKZ44rprTjKnCMFsvxNI05RgmieSzZ1ZjOSqngD1qmzwiZ1awAl4CzhRliD+hFaN8vlxStEchjuA6iktZWhtUEkfzzHJI5AzXMmJSdrkNtfbLhVdSHb5W3ccetS35zHvj++AT8vWmParK2+Ycj+LtWS6XMGpArI0lsDyp52iiyexUYRk7o8OsNV8SeJvilF5n2lbS3uuY8EIqKf1PFavxI1Sb/AIWfaxSgxwJGAqHpk5r2uG1it7yGbyUC7edoxhu5/KvP/iZ4Lm8S3dlfabKqzwuwkLDDAZBFdsa8ak1zKys0a0anJNM4fxHa24vbXUkbyZ7eQSb17juK+gNCZG0e2nIDMyqxI7g8188eKtD8QX2qJpwthFZhwWnHTb6mvdfDN/ENItbS3bLWyLDLvHfHX36VnWi/ZQTd2vyNse1Ud4LQ6qWESROANrMOorxL4k+D9X1+YNAA0kRz6AnvXselagLlJElXy5omxg9x2NPXDIxOD8xzWFKrKhK8Ty6cpUm00cf8JNIuNC8MizvXH2gMWKg5AGa7CQljg8BeajWEQorY5U5qzKA0YZfY1FSbnNyfUmTXNczHiuFmR4wPmJ3A8AipZ2kMIltv9YnY9/atFAC2cVC8eyXKj5X6n0NTcftL7oyFU36yu8XzYwEPOD61k2ejXdlrjXKsTETuBPQD+7W7eQvas1xbHDfxIejD/GrJ/wBLhQKcBsFvarUmttjdVXFe7sySzm3TOhjK8ZDdm9qtOMrWVdrLbICMNsOUbuKuWd0txGOQJAPmXp/kVm11OacPtIdC+2UxngH5l/wovTItrKYQDLtO0HpnFMuF3xq6YLKQR71JHIsqcHBx07ijzFb7Rn3yO+mAMQJFClvTPeuGv7eS21edfMYRyrkA9Aa9BZVdRE/IPB96yPFNupt0kVASpFaQlZ2O3DVuSXL3KOlK1lbW9zIfM2jOT1UEdKs6hfW0P+udBBKcrzyG9MelVZXFtD5Sh3eJgoT1X/8AVVOO3truRHlIcjlUJzkf4VVru7NuVSfNI0bqwjZ0MMQGxcKV6YrK1G5S0kZLpXAVQ2RGWXntxXSWONy27cFRkfSqd4Fhv2R2/cSDG4dj6GknrqTCpaXKyjfazDbQW4ucoXA2NyAPTn6UVX1e8063/s+C4lgj+1sRGszgFhntnrRTasloaRlStqdG0PmPKpAZF4UMOP8A9VY8+kIsjDe8BPGUcgY/pWzCSS+TntSRqGtjuAP1oi2tjgp1JRehQttDgtCrw+aJWOd4kJb86t+ZqMEamMyTc/dlQHj6ijQyW81SSVD4APatkfdolJ311Iq1mpWlqc5qWqeRYvc6hpnm7Dhto6D8a8203VPDWseLETSxc/aSSVhkXauRyea9d1gA2coIBBU5z9K8K8OxRxfE0+VGife+6oH8JrfDwjOMm1sjsws2oOUND1+PSo7oIGXBX8+atyaEFk82GaSNyPmCnhh6EVRsJHFqGDtu29c10RJNupJOdo5rnk2mYVas4ysmfO/xf8J6sbpbi3TzbVWwyqeRnvjvVjwTpN5oul4uZZVeU5CrIRtU9uOlel+LuVweRtPX6VzcfMSZ54xXbGvN01E9LDU1JKbOgXUU1SKJrfZBf2wBER+7LjsD2PHeun1HRWvXivreU2t4IwG4yCPQ15VbkjVYyDg8dPrXt8HMS59K56t4pNHLjY/V5RdM4GxS7kFyk0Cgk7JMEruY9WHrxV7+z7qxS023n7kdVIzgY5q3qBwsxHUMpHscnmnb2ezh3sW+Unk57Ursp1W7Fa2mP2FYZBM5eTeGEeAFJ6Grz3du1wkEXymNv3Z7ZHWorz/j2t1/hAXAqW8RVsUZVAYDggc0t9SdJGxHKs8sgUbsKOPrUFhaxNrE94Vy6xhEz2ByT/IVkeC5ZJJb3zHZsMPvHPYVp6E7NqmrBmJAkQAE9PlqGrXOSrH2blFGpeTLbwPJL9xRk15rf6jeR6i7rK4ty2AueAD2ruNfJ+yyDJxiuE1UAaehAA+Zv5VdFHVl8VZtomk8K6pqWu6LrGnav5cNqdphlJKnBJxx1BHHNdJ4+1GLSvDF1PfQtMmAHSPv9M07wiSNLXBI+cfyFHj5VewVXUMp7EZFVzuVSMZbIxld1+UPB2sWuvaNb3lirxQ7NqA9RjjFWp4g8jsV2yMu0sP4v/r1neBoo4dCRIY0jUM2AgwBzVuR2GssoY7doOM1NRKM5JAtJMxYDJpetYVN1tMy5ducHuB6HvWuLXfrM1ylwRHsADcHJ9P1/Wk8SqBa35AAIVTketMsfuoOxK5/Oh6q50OTlHn67HBD4em28dw69azSLJ53nOin5Qf54rrNRiXT7i7vxIWmmwFjJ+UH19q27kkaxEATj7OTj8a5DxPI/wBscb2x5B4z7ir9pKpbmfQvDrmklsW9CutW1Odp43WG2ztGBjeR3A7CusfS3kXa1w2SODgZB9aq+GgBptlgAfu1P6Vt/wDLQfQ1jOWuhz4ms+e0Vaxyc39qaOxSS4N5bHghgNwHt60mlQWtvqEVxasTHcEowViFQ+u09Dmuh1ZFZE3KDyeornbVVF6QFGME4x9apNtGtOXtIN7G9Iiw3OVPBXB9zSRTSM0iZIj2kAn19aqSsxvEBJI2DjP0q/af8er/AFNZvY52rLUwYfDSPYfZ5JGbMhc+nrV+/wBNtbixW0YbdjYLHrnHBBrR0ok2luScnB/nUs6hnG4A8Z5pucr7g603KzexFp6/6KI2LOqDaGJ5I9abeI3lqsYI3YHHGPWorTjgeuP1qRGJk5JPBpPRkvSVy4LVVtxGnTGKzjp8vn7onwU/hPRhWxASYVJPO0VXuSVuItpIzxxUpsyhUkmyhPJJb7ItqLKPu7vusPSow8huEumiTygdsirzgf8A1qk8Sf8AHpGe4fg/hVexY7Lnk9qtaq50xV4cxeSztLyaXdDvRDgMemfasdPDBjE9xayvHO77gpPAwePxrY0Ak2z5J+9/StOlzODsjF1Z05NJnnXildQ1DSAumsI9ShfccZU5Hb8a2/DOo3P2eK31qI293jIZsASH/GpNTAW/YqMErzjvzT9YVWWLcAf3Y6itObmioNHTJKaUbbm+CC+DQ5wpHpzWXoDM1nAWYk46k1dmJ85Bk9DWLVnY4nG0rE5zgFT2ppnRY98jAL6npTLX7h+lZknzWZDcjzTwaFHWw4wUnZmncQpcwAg/KeRimJB9nXKde49ags2ba4ycAdM1cBPlCjyB3joRTnzoueB1PrWS8KzDyizpKBlHQkEitKT+L/Pesu9+XUI9vHzHp+FVE2pdkT6JbXFozQtzCQTlmyQaS5n+x3Ewm4V1yp7AitZfvn6VkeKQDpUrEDcOh9KSd5a9RQl7Spr1JrC8t7i48pJ4zcRr88e75h+FS6ruMKgIHQt8+fSvNrNmX4i2+0kZdc4PX5K9PuSfIoas0bYmiqE4tO91czLi3je9jkIYhF+XPbiuL8aagnhp49RNvJKjMFynBQ+v0rv7j/Ww/SsS4hjuIrpLiNJVOch1DDr71pSlaSvqhUptFDw5ri61BFqUEToqfK+RgEHuK43wt4f8RQeOtavr25aXTJ94XdJnd83y/L2Ir0+GKOHw9GkMaRqIxwoAFYmjsxurgFjjjjNXz8vMo7PQpWneSVrHN/EDwDN4m1PSJYLxbZrdSGDDIxuzx70V3l11X2XiipVeokopmabP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal urothelium is composed of three to seven cell layers; the thickness varies depending on the extent of bladder distension. Normal urothelial cells are approximately two to three times the size of stromal lymphocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cristina Magi-Galluzzi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2247=[""].join("\n");
var outline_f2_12_2247=null;
var title_f2_12_2248="Testing and challenge procedures to evaluate allergic and asthmatic reactions to food additives";
var content_f2_12_2248=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Testing and challenge procedures to evaluate allergic and asthmatic reactions to food additives",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2248/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2248/contributors\">",
"     Jinny E Chang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2248/contributors\">",
"     Ronald A Simon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2248/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2248/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2248/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2248/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/12/2248/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1749867\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food additives are synthetic or natural substances added to foods for multiple purposes. Despite the great number of additives used in the food and pharmaceutical industry, only a few have been implicated in true allergic (IgE-mediated) or other (immunologic or nonimmunologic) adverse reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss testing and challenge procedures used in the evaluation of allergic and asthmatic reactions to food additives. Specific food additives that have been implicated in causing allergic and asthmatic reactions are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40681?source=see_link\">",
"     \"Allergic and asthmatic reactions to food additives\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other topics that discuss adverse reactions to food additives include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Occupational asthma and rhinitis in food workers, caused by allergens and irritants used in food production and processing (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34824?source=see_link\">",
"       \"Occupational asthma: Definitions, epidemiology, causes, and risk factors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/48/7945?source=see_link\">",
"       \"Occupational rhinitis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Food additives and hyperactivity or behavioral changes in children (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4954?source=see_link&amp;anchor=H12#H12\">",
"       \"Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis\", section on 'Dietary influences'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The oncogenic potential of food additives (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/38/618?source=see_link&amp;anchor=H7#H7\">",
"       \"Risk factors for gastric cancer\", section on 'Environmental risk factors'",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1215823\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR ALLERGY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An allergy evaluation is most likely to be helpful in patients who experience the following types of reactions in temporal association with ingestion of food:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anaphylaxis",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Urticaria/angioedema",
"      </span>",
"      (isolated episodes after eating without intervening chronic symptoms)",
"     </li>",
"     <li>",
"      Asthma",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All patients with anaphylaxis should be referred to an allergy expert with experience and knowledge about testing and challenge procedures, if possible. Patients with",
"    <span class=\"nowrap\">",
"     urticaria/angioedema",
"    </span>",
"    or asthmatic reactions in association with eating, who find it impractical or impossible to identify or avoid problematic food(s) reliably should also be referred. Of note, patients with chronic urticaria, which is defined as the recurrence of urticaria on most days of the week for six weeks or longer, rarely have allergies to foods or food additives, although many patients are concerned about this. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/7/117?source=see_link&amp;anchor=H4#H4\">",
"     \"Chronic urticaria: Standard management and patient education\", section on 'Patient education'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Common goals of allergy evaluation are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Proving or disproving that a food additive is causing a specific acute reaction, particularly in patients with anaphylaxis.",
"     </li>",
"     <li>",
"      Excluding reactions to food additives and liberalizing the diet in people who are avoiding multiple foods because of concerns about possible reactions to food additives.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H555940\">",
"    <span class=\"h2\">",
"     Reactions to multiple food additives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with verified adverse or allergic reactions to food additives generally react to a single additive. The medical literature does not support the concept of generalized &ldquo;chemical sensitivity.&rdquo; The term &ldquo;multiple chemical sensitivity&rdquo; is usually used to describe patients with subjective illness marked by recurrent, nonspecific symptoms attributed to low level exposures to a variety of things, including both ingested and inhaled substances. Evaluation of such patients is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/38/27242?source=see_link\">",
"     \"Overview of idiopathic environmental intolerance (multiple chemical sensitivity)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22880732\">",
"    <span class=\"h1\">",
"     OBJECTIVE TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Objective testing for food additive reactions includes immunoassays for IgE specific to a food additive (when available), and skin testing with either a food that contains the additive and caused symptoms in the past, or with a purified preparation of the additive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1215848\">",
"    <span class=\"h2\">",
"     In vitro testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgE immunoassays are commercially available for some food additives, such as annatto, carmine red, and guar gum [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The sensitivity and specificity of these tests are not well defined. Thus, a negative result does not conclusively exclude allergy, and further evaluation is usually required. A positive result is consistent with allergy, but may require confirmation with a challenge procedure, depending on the clinical need for unequivocal diagnosis and the safety of performing a challenge in a given patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4143376\">",
"    <span class=\"h2\">",
"     Skin prick testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin prick testing (or epicutaneous testing) may be performed with an additive-containing food or a purified preparation of the additive. Positive and negative controls must always be included. Allergen skin testing techniques are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32633?source=see_link\">",
"     \"Overview of skin testing for allergic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because skin testing to food additives is not well validated, positive tests should be repeated on volunteers to see if the positive result is an irritant reaction. For example, sulfite solutions can cause irritant skin reactions if too concentrated a solution is used for skin testing. If other people also demonstrate positive results, then it is likely an irritant response and the patient can be challenged with the food to confirm that no allergy is present. If volunteers have negative results, a challenge can be designed to confirm reactivity, but at a much lower starting dose than the patient likely ingested prior to the reaction. In cases of anaphylaxis, a suggestive clinical history, a positive skin test, and negative results in volunteers is usually sufficient to make the diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Testing with food containing the additive",
"      </strong>",
"      &mdash; In most cases, skin prick testing with the additive-containing food to which the patient is suspected to have reacted is the most logical initial test. If the result is positive and there are several potential allergens in the food, testing with individual components and additives is then indicated.",
"     </li>",
"     <li>",
"      <strong>",
"       Testing with purified additives",
"      </strong>",
"      &mdash; Some additives can be obtained in purified form and a solution can be prepared for skin prick testing. Skin testing with purified additives has been described for several natural substances, such as gelatin, carmine [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/4-6\">",
"       4-6",
"      </a>",
"      ], annatto",
"      <strong>",
"      </strong>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/7,8\">",
"       7,8",
"      </a>",
"      ], saffron [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/9,10\">",
"       9,10",
"      </a>",
"      ], and carrageenan [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/11\">",
"       11",
"      </a>",
"      ]. Variable concentrations have been used for skin testing in the literature, as summarized in the table (",
"      <a class=\"graphic graphic_table graphicRef86541 \" href=\"UTD.htm?23/8/23692\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556292\">",
"    <span class=\"h3\">",
"     Obtaining food additives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food additives can be obtained from several sources. Aspartame, monosodium glutamate (MSG), carrageenan, annatto, and some others are available at grocery stores. Dietary-grade sulfites are available for home brewing and wine making through specialty suppliers. Other food additives can be obtained through hospital pharmacies (eg, butylated hydroxytoluene or BHT), life sciences companies (eg, Fisher Scientific or Sigma-Aldrich), or commercial food service supply companies (through hospital",
"    <span class=\"nowrap\">",
"     cafeteria/food",
"    </span>",
"    preparation division). We recommend pharmacies or commercial food services rather than the internet sources for safety purposes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12933103\">",
"    <span class=\"h1\">",
"     CHALLENGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Double-blind placebo-controlled oral challenge is the most rigorous challenge design for diagnosing adverse food reactions, although it is usually reserved for research protocols [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Single-blind placebo-controlled challenge is more practical in an office setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4143585\">",
"    <span class=\"h2\">",
"     Blinding and masking additives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opaque capsules are very effective for blinding the patient to what is being ingested. Since the majority of patients undergoing food additive challenges are adults, it is rare that patients have difficulty swallowing large or multiple capsules. A drawback of using capsules is that early oral symptoms are bypassed because the additive does not contact the oral mucosa. In addition, some capsules may be more resistant to digestion, resulting in delayed absorption, although this issue can be circumvented by prolonging the dosing intervals to 30 or 60 minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/13\">",
"     13",
"    </a>",
"    ]. However, our experience is that delayed absorption is not clinically apparent and we use a 30-minute interval between challenge steps in most cases.",
"   </p>",
"   <p>",
"    Food additives can be masked in other ways when capsules cannot be used. For example, when challenging patients with asthmatic reactions to a liquid containing potassium metabisulfite, we mask the solution with fresh squeezed lemon juice and sugar because the flavor of lemonade is strong enough to cover any faint taste associated with the metabisulfite solution. Other foods that are useful for masking flavors or odors are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/59/20409?source=see_link&amp;anchor=H17#H17\">",
"     \"Oral food challenges for diagnosis and management of food allergies\", section on 'Food preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4143592\">",
"    <span class=\"h2\">",
"     Placebos",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inclusion of a placebo is strongly recommended to exclude false-positive reactions in patients with anxiety or other subjective reactions. Some patients experience unintentional anticipatory reactions (classic conditioning). Typical symptoms of such reactions, and counseling of patients who react to the initial or final placebo doses, are reviewed elsewhere. (See",
"    <a class=\"local\" href=\"#H556427\">",
"     'Reactions to placebo'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    We include placebos containing sucrose as the first and last steps of a challenge. We tell patients that placebos will be interspersed with doses of the additive as a matter of routine, in order to detect reactions that are caused by anticipation or anxiety. We explain that this is the only reliable way to diagnose these reactions, because they can seem as real to the patient as a true allergic reaction. It is recommended that the patient not be told specifically how or when the placebos will be used or other details about the actual challenge protocol, as this could readily bias or prime the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4143272\">",
"    <span class=\"h2\">",
"     Appropriate challenge doses",
"    </span>",
"    &nbsp;&mdash;&nbsp;The challenge doses used in published studies vary [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"    <sup>",
"    </sup>",
"    As a general rule, the final dose itself of the challenge should exceed the probable exposure from any one meal.",
"   </p>",
"   <p>",
"    The Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) jointly sponsor an international scientific expert committee on food additives, the Joint Expert Committee on Food Additives (JECFA) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/16\">",
"     16",
"    </a>",
"    ]. This body has estimated acceptable daily intakes (ADIs) for food additives in mg per kg of body weight [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/17\">",
"     17",
"    </a>",
"    ], although for a challenge, a one-time larger dose is acceptable. ADIs for commonly-used food additives are included in the table of the mixed food additive challenge (",
"    <a class=\"graphic graphic_table graphicRef86672 \" href=\"UTD.htm?26/26/27052\">",
"     table 2",
"    </a>",
"    ). The doses shown can be used as the maximal doses for graded challenges with individual additives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1750682\">",
"    <span class=\"h2\">",
"     Safety issues",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Challenges in patients with past anaphylaxis should only be performed by clinicians with the expertise to manage any resultant symptoms, and in settings equipped with the necessary medications (particularly epinephrine), equipment, and support staff. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"       \"Anaphylaxis: Rapid recognition and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In some patients with past anaphylaxis, intravenous access should be obtained prior to challenge in case emergency medications or fluids are required. This is indicated in patients believed to be at risk for moderate to severe symptoms during the challenge procedure, and in those with significant underlying cardiopulmonary disease. However, challenge would rarely be performed in such patients. Instead, a convincing clinical history and a positive skin test result would likely be sufficient for diagnosis.",
"     </li>",
"     <li>",
"      Challenges in patients with asthma should only be performed when the patient&rsquo;s symptoms are controlled.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1750689\">",
"    <span class=\"h2\">",
"     Patient preparation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Informed consent must be obtained for any challenge procedure. The risks, benefits, and potential limitations of the procedure should be discussed. A general explanation of the basic structure of a challenge should be provided, although the exact number and content of each step in the protocol is best not discussed, as mentioned previously. (See",
"      <a class=\"local\" href=\"#H4143592\">",
"       'Placebos'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients should be in their usual state of health and not ill with a cold or other illness.",
"     </li>",
"     <li>",
"      Patients with asthma should have their symptoms controlled prior to performing a challenge. Cromolyn preparations and inhaled bronchodilators are held on the morning of the challenge, while other asthma medications are continued. It is our practice to perform oral challenge only if the pre-bronchodilator FEV1 is &ge;70 percent of the patient's best and &ge;1.5 liters.",
"     </li>",
"     <li>",
"      Antihistamines should be discontinued according to the elimination half-life of the specific drug.",
"     </li>",
"     <li>",
"      Patients with past anaphylaxis should not be on any medications that may increase the likelihood of anaphylaxis or interfere with treatment of anaphylaxis, such as ACE-inhibitors or beta-blockers, although there may be individual exceptions to this. We discontinue beta-blockers 24 hours before the challenge.",
"     </li>",
"     <li>",
"      All other usual medications should be maintained.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22881485\">",
"    <span class=\"h2\">",
"     Specific types of challenges",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the more common types of reactions in clinical practice is asthma exacerbated by foods containing high amounts of sulfite compounds. A challenge protocol for such patients is described below. At Scripps Clinic, we have also designed a mixed additive challenge that is useful in excluding food additives as a cause of various reactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22881492\">",
"    <span class=\"h3\">",
"     Sulfite challenges in asthmatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asthmatic reactions to sulfites were relatively common in the past. However, in the Unites States, the US Food and Drug Administration (FDA)",
"    <strong>",
"    </strong>",
"    banned the use of sulfites in foods served fresh (eg, salad bars) in 1985, and few foods contain problematic amounts of sulfite now (",
"    <a class=\"graphic graphic_table graphicRef66943 \" href=\"UTD.htm?11/18/11565\">",
"     table 3",
"    </a>",
"    ). In recent years, we have only occasionally performed sulfite challenges in asthmatic subjects (apart from research purposes). The pathophysiology of sulfite sensitivity in patients with asthma is not fully understood, and several distinct mechanisms may be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The overwhelming majority of sensitive asthmatics react via inhalation of sulfur dioxide generated from sulfite solutions in an acidic environment, such as that of the stomach. These patients only react to ingestion challenges with sulfite-containing solutions (generating sulfur dioxide).",
"     </li>",
"     <li>",
"      Two reports described three sulfite-sensitive asthmatics with positive skin tests to sulfite, suggesting IgE-mediated pathogenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/19,20\">",
"       19,20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Some asthmatics with severe reactions to sulfites may have low levels of the enzyme sulfite oxidase, which is necessary to oxidize sulfite into inactive sulfate [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The latter two types of sulfite-sensitive patients may respond to low amounts of sulfite ingested in capsule form [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/22\">",
"     22",
"    </a>",
"    ]. An example of a published sulfite challenge protocol is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef83722 \" href=\"UTD.htm?32/56/33675\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/23\">",
"     23",
"    </a>",
"    ]. This protocol involved skin testing, followed by capsule challenge and solution challenge, thus addressing all possible types of reactions. However, we do not use this protocol.",
"   </p>",
"   <p>",
"    In the author&rsquo;s practice, we would not perform skin testing unless a patient gave a convincing history of anaphylaxis. Uncommonly, we perform challenges, using either capsules for patients with urticaria or anaphylaxis (up to a maximal single dose of 200 mg) OR solutions (using a maximal single dose of 100 mg) for patients with asthmatic reactions (",
"    <a class=\"graphic graphic_table graphicRef86313 \" href=\"UTD.htm?33/36/34379\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/1,24\">",
"     1,24",
"    </a>",
"    ]. Patients who do not react to the solution challenge can be assumed to tolerate the capsule challenge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22881499\">",
"    <span class=\"h3\">",
"     Mixed additive challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mixed additive challenge is designed for patients who report",
"    <strong>",
"     nonanaphylactic",
"    </strong>",
"    reactions to multiple food items. We usually perform this challenge as a tool to reassure patients that they are not reacting to food additives. The table shows the mixed additive challenge doses used at the authors&rsquo; center (",
"    <a class=\"graphic graphic_table graphicRef86672 \" href=\"UTD.htm?26/26/27052\">",
"     table 2",
"    </a>",
"    ). Positive reactions to this challenge are not expected, since the chemicals in the mixed additive challenge, thus far, have rarely or never been associated with IgE-mediated reactions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40681?source=see_link\">",
"     \"Allergic and asthmatic reactions to food additives\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rarely, we encounter patients who have a reliable and convincing history of allergic reactions (eg, isolated urticarial reaction) following ingestion of highly processed foods, but a single ingredient cannot be identified as a possible culprit. In this situation, a mixed additive challenge may be considered, although the doses may be adjusted depending on severity of reaction. In the unlikely circumstance that the patient&rsquo;s reaction is reproduced, the individual culprit can be determined by follow-up single additive challenges.",
"   </p>",
"   <p>",
"    The mixed additive challenge used in the authors&rsquo; clinic is not graded; all the components (ie, 15 capsules) are given at the same time with water. The period of observation following ingestion of the capsules should be based upon the patient&rsquo;s clinical history. We usually allow twice the amount of time that the patient reported elapsed between ingestion and symptoms in the past. In our practice, we no longer administer placebo steps for mixed additive challenge, since we have not encountered patients who develop symptoms. Of note, we do not advise administering this challenge to patients who believe themselves to be &ldquo;chemically sensitive.&rdquo; The management of idiopathic environmental intolerance (aka, multiple chemical sensitivity) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/38/27242?source=see_link\">",
"     \"Overview of idiopathic environmental intolerance (multiple chemical sensitivity)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11677337\">",
"    <span class=\"h2\">",
"     Administering challenges",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before the first dose, baseline vital signs (heart rate, respiratory rate, and blood pressure) should be measured and recorded. Spirometry is monitored if the patient had an asthmatic or anaphylactic reaction in the past. A physical exam should be performed and documented.",
"   </p>",
"   <p>",
"    Sufficient time should be allowed between steps in the challenge that both the clinician and patient are comfortable that symptoms occurring outside of that time period are unrelated. We usually double the time from ingestion to symptoms (as reported by the patient) and allow this amount of time between doses. As an example, if a patient&rsquo;s reaction historically occurred 15 to 30 minutes after food ingestion, we would allow one hour between challenge steps.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12933135\">",
"    <span class=\"h3\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient is observed throughout the procedure. Vital signs, a focused physical exam (with particular attention to the skin and respiratory tract), and spirometry (if appropriate) are usually repeated before each subsequent dose and again if any symptoms occur.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abdominal cramps or pain",
"     </li>",
"     <li>",
"      Angioedema, (eyelids, face, lips, and tongue with dysphagia or odynophagia)",
"     </li>",
"     <li>",
"      Cough",
"     </li>",
"     <li>",
"      Diarrhea",
"     </li>",
"     <li>",
"      Flushing",
"     </li>",
"     <li>",
"      Itching of the mouth, throat, eyes, or skin",
"     </li>",
"     <li>",
"      Lightheadedness or fainting",
"     </li>",
"     <li>",
"      Nasal congestion",
"     </li>",
"     <li>",
"      Nausea",
"     </li>",
"     <li>",
"      Runny nose",
"     </li>",
"     <li>",
"      Sneezing",
"     </li>",
"     <li>",
"      Shortness of breath",
"     </li>",
"     <li>",
"      Tachycardia",
"     </li>",
"     <li>",
"      Urticaria",
"     </li>",
"     <li>",
"      Vomiting",
"     </li>",
"     <li>",
"      Wheezing",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1530069\">",
"    <span class=\"h3\">",
"     Subjective symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;If patients develop purely subjective symptoms during a challenge that cannot be verified by physical exam, then we reassure the patient and wait for the symptoms to subside. Provided no objective symptoms develop, we proceed with the protocol. It is relatively common for patients to report skin tingling, slight itching (without flushing or urticaria), or a sense of dizziness or lightheadedness (without changes in blood pressure). These unintentional anticipatory reactions may represent a conditioned response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556427\">",
"    <span class=\"h3\">",
"     Reactions to placebo",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our clinical experience, it is not unusual for patients to develop subjective symptoms to placebo, particularly to those placebo doses given at the start of challenge. (See",
"    <a class=\"local\" href=\"#H1530069\">",
"     'Subjective symptoms'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If a patient reacts to the initial placebo dose, we explain that they reacted to the placebo dose and their symptoms were caused by the body&rsquo;s ability to recreate sensations in a suggestive setting. We find that most patients are reassured to learn that they do not have a potentially dangerous allergy. We then complete the remainder of the challenge and we have not seen people react again to the active doses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4143640\">",
"    <span class=\"h3\">",
"     Treating symptoms during challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases of a reaction, prompt treatment is administered with antihistamine (oral, intramuscular, or intravenous), bronchodilator (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    for bronchospasm),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    epinephrine (intramuscular) for symptoms of anaphylaxis. It is important to remember that antihistamines and bronchodilators are inadequate substitutes for epinephrine if reactions are severe. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H110122457\">",
"    <span class=\"h3\">",
"     Reasons to abort challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;The challenge should be aborted if a patient exhibits symptoms consistent with an allergic or asthmatic reaction, regardless of the need for treatment. Asthmatic reactions are usually defined as a 25 percent drop in forced expiratory volume in the first second (FEV1).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1210974\">",
"    <span class=\"h3\">",
"     Observation after challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient reacts to the food additive and the challenge is aborted, the patient should be observed until symptoms have completely resolved, and then for at least two more hours.",
"   </p>",
"   <p>",
"    If the patient does not react to challenge, a period of at least two hours of observation after the final dose is suggested.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1750856\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF PATIENTS WITH CONFIRMED REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management consists of avoidance of commercially prepared foods that are likely to contain the additive in question. With the clinician&rsquo;s assistance, the patient should learn about the additive, foodstuffs that commonly contain it, and become versed in relevant chemical nomenclature and alternative names for that additive. For patients with asthma, good ongoing asthma care is an important aspect of management, because patients with asthma are at increased risk for severe food allergic reactions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38920?source=see_link&amp;anchor=H8#H8\">",
"     \"Food-induced anaphylaxis\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1751182\">",
"    <span class=\"h2\">",
"     Patients with anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any patient who has suffered anaphylaxis should be supplied with an epinephrine autoinjector, accompanied by verbal and written instruction on how and when to self-administer the drug. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=see_link\">",
"     \"Prescribing epinephrine for anaphylaxis self-treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Epinephrine autoinjectors contain metabisulfite. However, the injection of the amount of metabisulfite contained in an epinephrine autoinjector did not trigger any symptoms or change in lung function in a small group of sulfite-sensitive asthmatics [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2248/abstract/25\">",
"     25",
"    </a>",
"    ], and there are no case reports to suggest that autoinjectors are unsafe for sulfite-sensitive patients.",
"   </p>",
"   <p>",
"    A personalized anaphylaxis action plan is helpful for providing specific instructions to patients about when and how to treat recurrent episodes (",
"    <a class=\"graphic graphic_form graphicRef60439 \" href=\"UTD.htm?2/42/2722\">",
"     form 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12933151\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Of the thousands of food additives currently in use, only a small number have been implicated in allergic or allergic-like reactions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms for which an allergy evaluation may be helpful include urticaria and or angioedema, asthmatic reactions, and anaphylaxis. Allergy evaluation is helpful in both proving that a certain additive is causing a reaction, and excluding food additives as a cause of reactions. (See",
"      <a class=\"local\" href=\"#H1215823\">",
"       'Indications for allergy evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      IgE immunoassays are commercially available for some food additives, although the sensitivity and specificity are not well defined and skin testing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      challenge are often necessary. Skin prick testing (or epicutaneous testing) may be performed with an additive-containing food or a purified preparation of the additive. Suggested concentrations for skin prick testing are provided (",
"      <a class=\"graphic graphic_table graphicRef86541 \" href=\"UTD.htm?23/8/23692\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22880732\">",
"       'Objective testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Challenges are often needed for definitively proving or disproving a food additive as the cause of a patient&rsquo;s reaction. Single-blind placebo-controlled challenges are feasible in an office setting, whereas double-blind challenges are usually reserved for research settings. Additives can be concealed in opaque capsules, or masked within strongly flavored foods. We always include placebo steps to elicit reactions caused by anticipation or anxiety. (See",
"      <a class=\"local\" href=\"#H12933103\">",
"       'Challenges'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The dose of a specific additive administered during a challenge is derived empirically. In some cases, there are published reports to guide dosing. For other additives, a dose is selected that is estimated to exceed what would be ingested in a single meal, without greatly exceeding the acceptable daily intake (ADI) (",
"      <a class=\"graphic graphic_table graphicRef86672 \" href=\"UTD.htm?26/26/27052\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4143272\">",
"       'Appropriate challenge doses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Challenges in patients with past anaphylaxis should only be performed by clinicians with the expertise to manage any resultant symptoms, and in settings equipped with the necessary medications (particularly epinephrine), equipment, and support staff. Challenges in patients with asthma should only be performed when the patient&rsquo;s symptoms are optimized. (See",
"      <a class=\"local\" href=\"#H1750682\">",
"       'Safety issues'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1750689\">",
"       'Patient preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients are monitored throughout the challenge and any symptoms that develop are promptly and appropriately treated. Patients are observed until all symptoms have fully resolved or, if the challenge is negative, for a period of at least two hours after the last dose. (See",
"      <a class=\"local\" href=\"#H11677337\">",
"       'Administering challenges'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some patients may react to placebo, usually with subjective symptoms. These individuals can greatly benefit from appropriate counseling. Most are reassured to learn that they do not have a potentially dangerous allergy. (See",
"      <a class=\"local\" href=\"#H556427\">",
"       'Reactions to placebo'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Any patient who has experienced anaphylaxis should be supplied with an epinephrine autoinjector as well as written instructions on how and when to self-administer (a personalized anaphylaxis plan) (",
"      <a class=\"graphic graphic_form graphicRef60439 \" href=\"UTD.htm?2/42/2722\">",
"       form 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1750856\">",
"       'Management of patients with confirmed reactions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/1\">",
"      Simon RA. Adverse reactions to food and drug additives. Immunol Allergy Clin North Am 1996; 16:137.",
"     </a>",
"    </li>",
"    <li>",
"     Lists of allergens for which ImmunoCAP testing is available can be found under the categories \"Foods of animal origin\" and \"Foods of plant origin.\" file://www.phadia.com/en/Allergen-information/ImmunoCAP-Allergens/ (Accessed on May 18, 2012).",
"    </li>",
"    <li>",
"     Lists of allergens for which IgE immunoassays are available through Mayo Medical Laboratories. Example search \"Guar gum IgE\": file://www.mayomedicallaboratories.com/test-catalog/ (Accessed on May 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/4\">",
"      W&uuml;thrich B, K&auml;gi MK, St&uuml;cker W. Anaphylactic reactions to ingested carmine (E120). Allergy 1997; 52:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/5\">",
"      Beaudouin E, Kanny G, Lambert H, et al. Food anaphylaxis following ingestion of carmine. Ann Allergy Asthma Immunol 1995; 74:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/6\">",
"      A&ntilde;&iacute;barro B, Seoane J, Vila C, et al. Occupational asthma induced by inhaled carmine among butchers. Int J Occup Med Environ Health 2003; 16:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/7\">",
"      Ebo DG, Ingelbrecht S, Bridts CH, Stevens WJ. Allergy for cheese: evidence for an IgE-mediated reaction from the natural dye annatto. Allergy 2009; 64:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/8\">",
"      Nish WA, Whisman BA, Goetz DW, Ramirez DA. Anaphylaxis to annatto dye: a case report. Ann Allergy 1991; 66:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/9\">",
"      Mikkelsen H, Larsen JC, Tarding F. Hypersensitivity reactions to food colours with special reference to the natural colour annatto extract (butter colour). Arch Toxicol Suppl 1978; :141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/10\">",
"      Moneret-Vautrin DA, Morisset M, Lemerdy P, et al. Food allergy and IgE sensitization caused by spices: CICBAA data (based on 589 cases of food allergy). Allerg Immunol (Paris) 2002; 34:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/11\">",
"      Tarlo SM, Dolovich J, Listgarten C. Anaphylaxis to carrageenan: a pseudo-latex allergy. J Allergy Clin Immunol 1995; 95:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/12\">",
"      Bock SA, Sampson HA, Atkins FM, et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol 1988; 82:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/13\">",
"      Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, et al. Work Group report: oral food challenge testing. J Allergy Clin Immunol 2009; 123:S365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/14\">",
"      Asero R. Food additives intolerance: a possible cause of perennial rhinitis. J Allergy Clin Immunol 2002; 110:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/15\">",
"      Fuglsang G, Madsen G, Halken S, et al. Adverse reactions to food additives in children with atopic symptoms. Allergy 1994; 49:31.",
"     </a>",
"    </li>",
"    <li>",
"     The Joint FAO/WHO Expert Committee on Food Additives (JECFA) is described. file://www.who.int/foodsafety/chem/jecfa/en/index.html (Accessed on May 18, 2012).",
"    </li>",
"    <li>",
"     The website of the International Programme of Chemical Safety contains links to monographs and evaluations of the Joint Expert Committee on Food Additives (JECFA) file://www.inchem.org/ (Accessed on July 20, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/18\">",
"      Vally H, Thompson PJ, Misso NL. Changes in bronchial hyperresponsiveness following high- and low-sulphite wine challenges in wine-sensitive asthmatic patients. Clin Exp Allergy 2007; 37:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/19\">",
"      Simon RA, Wasserman SI. IgE-mediated sulfite-sensitive asthma. J Allergy Clin Immunol 1986; 77:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/20\">",
"      Yang WH, Purchase EC, Rivington RN. Positive skin tests and Prausnitz-K&uuml;stner reactions in metabisulfite-sensitive subjects. J Allergy Clin Immunol 1986; 78:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/21\">",
"      Jacobsen DW, Simon RA, Singh M. Sulfite oxidase deficiency and cobalamin protection in sulfite-sensitive asthmatics. J Allergy Clin Immunol 1984; 73:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/22\">",
"      Di Lorenzo G, Pacor ML, Vignola AM, et al. Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients. Allergy 2002; 57:1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/23\">",
"      Bush RK, Zoratti E, Taylor SL. Diagnosis of sulfite and aspirin sensitivity. Clin Rev Allergy 1990; 8:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2248/abstract/24\">",
"      Simon RA, Bosso JV, Daffern PD, Ward B. Prevalence of sensitivity to food/drug additives in patients with chronic idiopathic urticaria (CIUA). J Allergy Clin Immunol 1998; 101:S154 (Abstract).",
"     </a>",
"    </li>",
"    <li>",
"     Simon R, unpublished data. (These challenges were performed subcutaneously because that was the recommended route of epinephrine injection at the time).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16707 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2248=[""].join("\n");
var outline_f2_12_2248=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12933151\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1749867\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1215823\">",
"      INDICATIONS FOR ALLERGY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H555940\">",
"      Reactions to multiple food additives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22880732\">",
"      OBJECTIVE TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1215848\">",
"      In vitro testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4143376\">",
"      Skin prick testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H556292\">",
"      - Obtaining food additives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12933103\">",
"      CHALLENGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4143585\">",
"      Blinding and masking additives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4143592\">",
"      Placebos",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4143272\">",
"      Appropriate challenge doses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1750682\">",
"      Safety issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1750689\">",
"      Patient preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22881485\">",
"      Specific types of challenges",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22881492\">",
"      - Sulfite challenges in asthmatic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22881499\">",
"      - Mixed additive challenge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11677337\">",
"      Administering challenges",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12933135\">",
"      - Monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1530069\">",
"      - Subjective symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H556427\">",
"      - Reactions to placebo",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4143640\">",
"      - Treating symptoms during challenge",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H110122457\">",
"      - Reasons to abort challenge",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1210974\">",
"      - Observation after challenge",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1750856\">",
"      MANAGEMENT OF PATIENTS WITH CONFIRMED REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1751182\">",
"      Patients with anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12933151\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/16707\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/16707|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?2/42/2722\" title=\"form 1\">",
"      Anaphylaxis action plan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/16707|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/8/23692\" title=\"table 1\">",
"      Concentrations of food additives for skin testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/26/27052\" title=\"table 2\">",
"      Mixed additive challenge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/18/11565\" title=\"table 3\">",
"      Sulfite-containing foods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/56/33675\" title=\"table 4\">",
"      Metabisulfite challenge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/36/34379\" title=\"table 5\">",
"      Sulfite challenge - solution",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40681?source=related_link\">",
"      Allergic and asthmatic reactions to food additives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4954?source=related_link\">",
"      Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/7/117?source=related_link\">",
"      Chronic urticaria: Standard management and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38920?source=related_link\">",
"      Food-induced anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34824?source=related_link\">",
"      Occupational asthma: Definitions, epidemiology, causes, and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/48/7945?source=related_link\">",
"      Occupational rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/59/20409?source=related_link\">",
"      Oral food challenges for diagnosis and management of food allergies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/38/27242?source=related_link\">",
"      Overview of idiopathic environmental intolerance (multiple chemical sensitivity)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32633?source=related_link\">",
"      Overview of skin testing for allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=related_link\">",
"      Prescribing epinephrine for anaphylaxis self-treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/38/618?source=related_link\">",
"      Risk factors for gastric cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_12_2249="Presentation, diagnosis, and staging of Wilms tumor";
var content_f2_12_2249=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Presentation, diagnosis, and staging of Wilms tumor",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2249/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2249/contributors\">",
"     Murali Chintagumpala, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2249/contributors\">",
"     Jodi A Muscal, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2249/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2249/contributors\">",
"     Alberto S Pappo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2249/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2249/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/12/2249/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wilms tumor is the most common renal malignancy in children and the fourth most common childhood cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/1\">",
"     1",
"    </a>",
"    ]. The epidemiology, presentation, diagnosis, and staging of Wilms tumor will be reviewed here. The treatment and outcome of Wilms tumor are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/50/9002?source=see_link\">",
"     \"Treatment and prognosis of Wilms tumor\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, the annual incidence of renal tumors is about eight cases per million children younger than 15 years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/2\">",
"     2",
"    </a>",
"    ], accounting for 7 percent of all childhood malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/1\">",
"     1",
"    </a>",
"    ] and for 500 new cases per year in North America [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/1,3-6\">",
"     1,3-6",
"    </a>",
"    ]. Wilms tumor is the most common renal malignancy in children under the age of 15 years, accounting for about 95 percent of all cases. In contrast, renal cell carcinoma is more common in the 15 to 19-year-old age group.",
"   </p>",
"   <p>",
"    In the United States, two-thirds of cases of Wilms tumor are diagnosed before five years of age, and 95 percent before 10 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/1\">",
"     1",
"    </a>",
"    ]. In patients with unilateral involvement, the median age at diagnosis is 43 months in girls and 37 months in boys [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/7\">",
"     7",
"    </a>",
"    ]. Children with bilateral disease are diagnosed at an earlier age (median age, girls at 31 months and boys at 24 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/7\">",
"     7",
"    </a>",
"    ]. Patients with associated congenital anomalies, such as aniridia or genitourinary abnormalities, are also diagnosed at an earlier age [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of developing Wilms tumor varies among ethnic groups, with a greater risk in African-Americans and a lower risk in the Asian population [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/1,8,9\">",
"     1,8,9",
"    </a>",
"    ]. Epigenetic differences may contribute to the lower rate of disease in Asian children, as demonstrated by a study that reported infrequent loss of IGF2 imprinting in tumors from Asian patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Genetics'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Associated congenital syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some children, Wilms tumor occurs as a part of a multiple malformation syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/11\">",
"     11",
"    </a>",
"    ]. These syndromes include WAGR, Denys-Drash, and Beckwith-Wiedemann syndromes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     WAGR syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;WAGR syndrome (MIM #194702) refers to the syndrome of Wilms tumor, aniridia, genitourinary (GU) anomalies, and intellectual disability (mental retardation) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/12\">",
"     12",
"    </a>",
"    ]. Children with this syndrome have a constitutional chromosomal deletion of the WT1 gene located at 11p13. The WT1 gene product is a transcription factor involved in both gonadal and renal development. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Genetics'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In a retrospective study of 54 children with WAGR syndrome, the following clinical findings were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Aniridia &ndash; 53 patients",
"     </li>",
"     <li>",
"      GU abnormalities (eg, cryptorchidism, ambiguous genitalia) &ndash; 41 patients",
"     </li>",
"     <li>",
"      Intellectual disability &ndash; 39 patients",
"     </li>",
"     <li>",
"      Wilms tumor &ndash; 31 patients",
"     </li>",
"     <li>",
"      Renal impairment (defined as glomerular filtration rate &lt;80",
"      <span class=\"nowrap\">",
"       mL/min)",
"      </span>",
"      and proteinuria developed in 14 patients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In another case series of 64 patients with WAGR syndrome, all patients had tumors with favorable histology [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/14\">",
"     14",
"    </a>",
"    ]. Eleven (7 percent) had bilateral disease. Chronic renal disease developed in about half of the cohort at a 20 year follow-up, including end-stage renal disease in four patients who subsequently underwent renal transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Denys-Drash syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Denys-Drash or just Drash syndrome (MIM #194080) is a triad of progressive renal disease, male pseudohermaphroditism, and Wilms tumor. Affected individuals have a germline point mutation in the eighth or ninth exon of the WT1 gene, which results in an amino acid substitution, and almost all patients (90 percent) will develop Wilms tumor. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Genetics'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The underlying renal pathology is diffuse mesangial sclerosis, which presents in infancy with proteinuria and progresses to nephrotic syndrome and renal failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7753?source=see_link&amp;anchor=H15#H15\">",
"     \"Congenital and infantile nephrotic syndrome\", section on 'Diffuse mesangial sclerosis with Drash syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Beckwith-Wiedemann syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the Beckwith-Wiedemann syndrome (MIM #130650) have a 5 to 10 percent chance of developing Wilms tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/15\">",
"     15",
"    </a>",
"    ]. This disorder is caused by microduplication mutations in the 11p15.5 region, site of a cluster of imprinting genes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Genetics'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The major clinical features of Beckwith-Wiedemann syndrome include macrosomia, macroglossia, omphalocele, prominent eyes, ear creases, large kidneys, pancreatic hyperplasia, and hemihypertrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24473?source=see_link\">",
"     \"Beckwith-Wiedemann syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Other congenital anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with other congenital syndromes and isolated congenital anomalies are also at risk for developing Wilms tumors. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perlman syndrome &ndash; Perlman syndrome is an autosomal recessive overgrowth syndrome due to a germline mutation of DIS3L2 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/17\">",
"       17",
"      </a>",
"      ]. It is characterized by fetal gigantism, visceromegaly, unusual face, bilateral renal hamartomas with nephroblastomatosis, and Wilms tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sotos syndrome &ndash; There is a 2 to 3 percent risk of Wilms tumor in children with Sotos syndrome (also referred to as cerebral gigantism). Sotos syndrome is an overgrowth syndrome associated with facial, extremity, and cognitive abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/18\">",
"       18",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10073?source=see_link&amp;anchor=H8#H8\">",
"       \"The child with tall stature or abnormally rapid growth\", section on 'Cerebral gigantism'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Simpson-Golabi-Behmel syndrome &ndash; Simpson-Golabi-Behmel syndrome is an X-linked genetic disorder caused by mutations in the gene encoding glypican-3, which maps to chromosome Xq26 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/19\">",
"       19",
"      </a>",
"      ]. It is characterized with pre- and postnatal overgrowth with organomegaly, a distinctive course facial appearance described as a bulldog appearance, congenital heart disease, polydactyly, and a 7.5 percent change of developing Wilms tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Isolated hemihypertrophy.",
"     </li>",
"     <li>",
"      Isolated genitourinary abnormalities &ndash; Boys with Wilms tumor may have cryptorchidism or hypospadias, while 10 percent of girls with Wilms tumor have congenital uterine anomalies [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/21\">",
"       21",
"      </a>",
"      ]. Other kidney abnormalities, such as renal ectopia or duplicated collecting systems, can also be seen.",
"     </li>",
"     <li>",
"      Familial Wilms tumor is rare and is associated with mutations in BRCA2 or TP53 (Li-Fraumeni syndrome). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12391?source=see_link\">",
"       \"Li-Fraumeni syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wilms tumor appears to be caused by abnormal renal development, resulting in proliferation of the metanephric blastema without normal tubular and glomerular differentiation. Wilms tumor is thought to arise from foci of persistent metanephric cells referred to as nephrogenic rests or nephroblastomatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/22\">",
"     22",
"    </a>",
"    ]. Nephrogenic rests normally occur in 1 percent of newborn kidneys and regress early in childhood. In contrast, they are present in 35 percent of kidneys with unilateral Wilms tumor and almost 100 percent of kidneys with bilateral disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wilms tumor has been associated with loss of function mutations of a number of tumor suppressor genes. These include mutations of the WT1, p53, FWT1, and FWT2 genes, and at the 11p15.5 locus [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/24\">",
"     24",
"    </a>",
"    ]. The role of these gene mutations in the pathogenesis of Wilms tumor remains unknown.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      WT1 gene &ndash; The WT1 gene is located on chromosome 11p13. The WT1 gene product is expressed in the developing kidney, testis, and ovary. It appears to play a role in the development and differentiation of genitourinary tissues [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/25-27\">",
"       25-27",
"      </a>",
"      ]. High levels of WT1 result in suppression of growth-related genes, suggesting that WT1 may function as a tumor suppressor gene [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/24,28\">",
"       24,28",
"      </a>",
"      ].The WT1 gene was the first identified genetic abnormality in children with Wilms tumor and was discovered in karyotypic analysis of children with WAGR syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/29\">",
"       29",
"      </a>",
"      ]. The 11p13 deletion in WAGR syndrome encompasses several contiguous genes, including the WT1 and PAX 6 (associated with aniridia) genes. In contrast, patients with Denys-Drash syndrome have a point mutation in the eighth or ninth exon of the WT1 gene resulting in their clinical findings. Less than 10 percent of patients with sporadic Wilms tumor have a WT1 gene mutation, suggesting that other mechanisms are involved [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/30\">",
"       30",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'WAGR syndrome'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Denys-Drash syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      11p15.5 &ndash; The 11p15.5 locus (also referred to as the WT2 gene locus) contains a cluster of imprinted genes. Mutations at this locus have been identified in a number of syndromes characterized by either growth retardation or overgrowth including Beckwith-Wiedemann syndrome (BWS) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/11,16,31\">",
"       11,16,31",
"      </a>",
"      ]. Imprinted genes are those that demonstrate selective gene expression based upon parental origin, such that either the paternal or maternal-inherited gene copy is expressed, but not both. As an example, in patients with BWS, the maternal copy of the Beckwith-Wiedemann (BW) gene is silenced during gametogenesis and only the paternal copy is expressed. As a result, offspring with BWS receive a mutation passed from their father and those who inherit a BW gene mutation from their mother are asymptomatic carriers, who can pass the mutation to their offspring. Patients with BWS and 11p15 gene mutations are at increased risk for Wilms tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/11,31\">",
"       11,31",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=see_link&amp;anchor=H1497302#H1497302\">",
"       \"Basic principles of genetic disease\", section on 'Imprinting'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=see_link\">",
"       \"Basic principles of genetic disease\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H6\">",
"       'Beckwith-Wiedemann syndrome'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Somatic 11p15 defects have been found in Wilms tumor cells, perilobar nephrogenic rests associated with Wilms tumors, and some normal renal cells surrounding Wilms tumors suggesting 11p15 mutations may play an early role in non-syndromic Wilms tumorigenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/32\">",
"       32",
"      </a>",
"      ]. In addition, one study demonstrated germ-line (constitutional) mutations in genes from this locus in the lymphocytes of 3 percent of non-syndromic Wilms tumor patients (13 of 437 patients) and in one family with Wilms tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/33\">",
"       33",
"      </a>",
"      ]. No 11p15 defect was detected in the 220 controls. Patients with constitutional 11p15 defects compared to those without 11p15 mutations were more likely to have bilateral tumor involvement.",
"     </li>",
"     <li>",
"      p53 gene &ndash; The p53 tumor suppressor gene is located on chromosome 17p13.1. It encodes a nuclear protein, which acts as a transcription factor and blocks the progression of the cell cycle late in the G1 phase. P53 is the most commonly mutated gene in human cancer and is associated with a variety of malignancies including colorectal cancer, non-small cell lung cancer, osteosarcoma, and Ewing sarcoma. The p53 gene mutation is seen infrequently in patients with Wilms tumor and is associated with both favorable histologic features [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/34\">",
"       34",
"      </a>",
"      ] and with unfavorable anaplastic histology [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/35\">",
"       35",
"      </a>",
"      ]. As a result, p53 mutations, which are used for prognosis in other malignancies, are not used as a biologic marker for prognosis in patients with Wilms tumor. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30234?source=see_link&amp;anchor=H14#H14\">",
"       \"Molecular genetics of colorectal cancer\", section on 'p53 gene'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Familial WT genes &ndash; Familial Wilms tumor accounts for 1 to 2 percent of cases. The mode of inheritance appears to be autosomal dominant with variable penetrance. In these families, there is no association with the WT1 gene mutations. Linkages have been demonstrated to the FWT1 gene locus at 17q12-21 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/36,37\">",
"       36,37",
"      </a>",
"      ], the FWT2 gene locus at 19q13.3-q13.4, and at the 11p15.5 locus [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other potential susceptibility loci &ndash; A genome-wide association study of 757 patients with Wilms tumor and 1879 controls identified 2p24 and 11q14 as genetic loci related with Wilms tumorigenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/39\">",
"       39",
"      </a>",
"      ]. Additional candidate predisposition loci included 5q14, 22q12, and Xp22.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It remains unknown whether the presence of any of the above genes associated with Wilms tumor affects response to therapy or is predictive of outcome.",
"   </p>",
"   <p>",
"    Limited data suggest that patients with WT1 germline mutations have a poorer outcome. This was illustrated in one study from the International Society of Pediatric Oncology (SIOP) that demonstrated patients with WT1 germline mutations had an increased risk for bilateral involvement, second tumor events, and a poor response to initial chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/40\">",
"     40",
"    </a>",
"    ]. The poor response correlated with stromal predominant tumors with rhabdomyomatous changes. However, further studies are needed before treatment stratification should be consider based upon the presence or absence of a WT1 germline mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, patients with 11p15.5 constitutional defects appear to be more likely to have bilateral involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most Wilms tumors are solitary lesions. However, 5 to 7 percent of patients have bilateral renal involvement and 10 percent have multifocal loci within a single kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The gross appearance of Wilms tumor is typically gray or tan. There may be cysts, hemorrhage, or necrosis present. The tumor is typically surrounded by a pseudocapsule, which may help distinguish it from other renal tumors, which have an infiltrative border [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Histologically, the classic favorable histology Wilms tumor is comprised of three cell types:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Blastemal cells &ndash; Undifferentiated cells",
"     </li>",
"     <li>",
"      Stromal cells &ndash; Immature spindle cells and heterologous skeletal muscle, cartilage, osteoid, or fat",
"     </li>",
"     <li>",
"      Epithelial cells &ndash; Glomeruli and tubules",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some Wilms tumors contain only one or two cell types. In tumors with only one cell type, it is often difficult to make the diagnosis of Wilms tumor.",
"   </p>",
"   <p>",
"    Tumor histology has been linked to patient outcome. Anaplasia, defined as the presence of multipolar polypoid mitotic figures and marked nuclear enlargement with hyperchromasia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/43\">",
"     43",
"    </a>",
"    ], is associated with poor outcome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/50/9002?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment and prognosis of Wilms tumor\", section on 'Tumor histology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with Wilms tumor present with an abdominal mass or swelling, without other signs or symptoms. Other symptoms can include abdominal pain (30 to 40 percent of patients), hematuria (12 to 25 percent), fever, and hypertension (25 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/42,44\">",
"     42,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subset of patients with subcapsular hemorrhage can present with rapid abdominal enlargement, anemia, hypertension, and sometimes fever. Although the lung is the most common metastatic site, children rarely present with respiratory symptoms.",
"   </p>",
"   <p>",
"    Physical examination reveals a firm, nontender, smooth mass that is eccentrically located, and rarely crosses the midline [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once a Wilms tumor is suspected, subsequent abdominal examinations should be performed carefully. Vigorous palpation may rupture the renal capsule, resulting in tumor spillage, which increases the tumor stage and the need for more intensive therapy. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Staging'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/50/9002?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment and prognosis of Wilms tumor\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, Wilms tumor may be associated with congenital anomalies and syndromes. Thus, the examination should include assessment for associated anomalies, such as aniridia, hemihypertrophy, and genitourinary anomalies. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Associated congenital syndromes'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although Wilms tumor is rarely diagnosed in the neonate [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/45\">",
"     45",
"    </a>",
"    ], there are a few reported cases of prenatal detection of a renal mass with postnatal confirmation of Wilms tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/45-49\">",
"     45-49",
"    </a>",
"    ]. All of these prenatal cases were unilateral, and none was associated with multiple malformation syndrome or nephrogenic rests. One neonate presented with nonimmune hydrops with rapid growth of the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with Wilms tumor may also be identified through screening of high-risk patients, such as those with Beckwith-Wiedemann syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/50\">",
"     50",
"    </a>",
"    ]. However, the value of screening remains uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definitive diagnosis of Wilms tumor is made by histologic confirmation at the time of either surgical excision or biopsy. Children who are suspected of having Wilms tumor should be referred to a pediatric cancer center for evaluation and diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging is useful to differentiate Wilms tumor from other causes of abdominal masses. The first goal of imaging is to establish the presence of a renal tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/42\">",
"     42",
"    </a>",
"    ]. Imaging studies also guide management decisions prior to confirmation of a histologic diagnosis, such as surgical approach and the need for preoperative chemotherapy. Important information includes confirming the presence and function of the contralateral kidney, determining whether there is also tumor in the contralateral kidney, the size and extent of the tumor, and the presence of lung metastases.",
"   </p>",
"   <p>",
"    Abdominal ultrasonography is the initial imaging study. It will detect hydronephrosis and multicystic kidney disease, which may present as abdominal masses or swelling. In patients with a suspected renal tumor, Doppler ultrasonography should be performed to detect tumor infiltration of the renal vein and inferior vena cava, and to assess patency of blood flow.",
"   </p>",
"   <p>",
"    Contrast-enhanced computed tomography (CT) is recommended to further evaluate the nature and extent of the mass. CT also may detect small lesions of tumor or nephrogenic rests in the opposite kidney, which were not detected by ultrasonography.",
"   </p>",
"   <p>",
"    Imaging of the chest is needed to determine whether there are lung metastases. Although both CT and chest radiography are used to detect metastases, CT appears to be more sensitive than chest radiography [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there is controversy regarding the best screening modality to use for metastatic lung disease. In our institution, we routinely perform CT scanning of the chest [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/54\">",
"     54",
"    </a>",
"    ]. A biopsy is performed on any suspicious nodule to determine whether they represent metastatic disease. An alternate approach is to use chest radiography. A patient with a normal chest radiograph is interpreted as being free of metastatic lung disease. The impact on management of a child with Wilms tumor by these two screening approaches is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/50/9002?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment and prognosis of Wilms tumor\", section on 'Lung metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies include tests for renal function including urinalysis, liver function, serum calcium, a complete blood count, and coagulation studies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serum creatinine is obtained to detect any reduction in glomerular filtration rate prior to surgical intervention. A urinalysis is sent to detect proteinuria, a finding that can occur in patients with Denys-Drash syndrome and mesangial sclerosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Denys-Drash syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Liver function tests may be abnormal with liver metastases.",
"     </li>",
"     <li>",
"      Elevated serum calcium can be seen in children with rhabdoid tumor of the kidney or congenital mesoblastic nephroma [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/55\">",
"       55",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Coagulation studies should be considered because acquired von Willebrand's disease occur in approximately 8 percent of patients with Wilms tumors at diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/56\">",
"       56",
"      </a>",
"      ]. Although this abnormality usually has minimal clinical significance [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/57\">",
"       57",
"      </a>",
"      ], there are case reports of significant bleeding requiring intensive intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/58,59\">",
"       58,59",
"      </a>",
"      ]. As a result, patients should be screened for coagulopathy, and any abnormality should be corrected perioperatively [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/57,58\">",
"       57,58",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of Wilms tumor includes neuroblastoma and other renal tumors. Imaging studies and tissue histology differentiate Wilms tumor from these other disorders.",
"   </p>",
"   <p>",
"    Neuroblastoma can be differentiated from Wilms tumor by contrast-enhanced CT or ultrasonography, which distinguishes renal and nonrenal tissue. Final diagnostic confirmation is based upon tissue histology at the time of either biopsy or surgical excision. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\", section on 'Diagnostic criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In children, other renal cell tumors are rare [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/60\">",
"     60",
"    </a>",
"    ]. They are differentiated from Wilms tumor by tissue histology:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clear cell sarcoma of the kidney &ndash; Clear cell sarcoma is the second most common pediatric renal tumor. It has a less favorable prognosis than Wilms tumor with increased rate of relapse and mortality. Bone is a common metastatic site, giving this tumor the alternate name of bone-metastasizing renal tumor of childhood [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/61\">",
"       61",
"      </a>",
"      ]. The histologic appearance is generally distinctive with cords and nests of pale-stained tumor cells with abundant extracellular matrix separated by a network of fine capillary arcades. However, in some cases, histologic variation can make it difficult to distinguish this tumor from Wilms tumor. As a result, clear cell sarcoma is the most frequently misdiagnosed pediatric renal tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Rhabdoid tumor of the kidney &ndash; Rhabdoid tumor of the kidney is a highly malignant renal tumor, which occurs most frequently in children less than two years of age and almost never in those older than five years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/62\">",
"       62",
"      </a>",
"      ]. At presentation, the tumor is often metastatic involving the lungs, abdomen, lymph nodes, liver, bone, and brain [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/63\">",
"       63",
"      </a>",
"      ]. The prognosis is poor, with a reported mortality rate of greater than 80 percent within the first year of diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/62,63\">",
"       62,63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Congenital mesoblastic nephroma &ndash; Congenital mesoblastic nephroma is usually detected within the first year of life or by prenatal ultrasonography and can be divided into the classic and cellular subtypes [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/64\">",
"       64",
"      </a>",
"      ]. It has been associated with hypertension and elevated concentrations of calcium and renin [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/65\">",
"       65",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12500?source=see_link\">",
"       \"Prenatal diagnosis of congenital mesoblastic nephroma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Renal cell carcinoma &ndash; In contrast to adults, renal cell carcinoma is rare in childhood. However, there appears to be a subset of affected adolescent males with a unique chromosomal translocation at Xp11.2 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/66\">",
"       66",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18250?source=see_link\">",
"       \"Epidemiology, pathology, and pathogenesis of renal cell carcinoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Renal medullary carcinoma &ndash; Renal medullary carcinoma is a highly lethal tumor that is virtually restricted to patients with sickle cell hemoglobinopathy, most commonly sickle cell trait. It is a highly invasive tumor with early metastases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/3/6202?source=see_link&amp;anchor=H14#H14\">",
"       \"Renal manifestations of sickle cell disease\", section on 'Renal medullary carcinoma'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staging criteria for Wilms tumor are based upon the anatomic extent of the tumor without consideration for genetic, histologic, or biological markers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/67\">",
"     67",
"    </a>",
"    ]. Higher stages represent more extensive disease with a worse prognosis. As a result, more aggressive therapeutic regimens are generally administered to patients with higher tumor stages. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/50/9002?source=see_link\">",
"     \"Treatment and prognosis of Wilms tumor\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are two major systems currently in use (",
"    <a class=\"graphic graphic_table graphicRef78599 \" href=\"UTD.htm?14/4/14413\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/67\">",
"     67",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      National Wilms Tumor Study (NWTS) &ndash; The NWTS system is based upon surgical evaluation",
"      <strong>",
"       prior",
"      </strong>",
"      to the administration of chemotherapy. It is used throughout the United States and Canada.",
"     </li>",
"     <li>",
"      International Society of Pediatric Oncology (SIOP) &ndash; The SIOP system is based upon",
"      <strong>",
"       post",
"      </strong>",
"      -chemotherapy surgical evaluation and is used extensively in Europe.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Direct comparisons of trials using the two systems are difficult due to the difference in the timing of chemotherapy relative to surgical evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/3,68\">",
"     3,68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     NWTS system",
"    </span>",
"    &nbsp;&mdash;&nbsp;NWTS staging is based upon surgical evaluation",
"    <strong>",
"     prior",
"    </strong>",
"    to the administration of chemotherapy. The first four stages are confined to unilateral involvement:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage I &ndash; Tumor is limited to the kidney. The tumor is completely resected with an intact capsule without evidence of renal sinus vessel involvement or tumor at or beyond the margins of resection. There is no previous rupture or biopsy. For a tumor to qualify for certain therapeutic protocols as Stage I, regional lymph nodes must be examined microscopically.",
"     </li>",
"     <li>",
"      Stage II &ndash; Tumor extends beyond the kidney but is completely resected without evidence of tumor at or beyond the margins of resection. Extension includes penetration beyond the renal capsule, invasion of the soft tissue of the renal sinus, or blood vessel involvement beyond the renal parenchyma but within the resected specimen. Rupture of spillage confined to the flank, including biopsy of the tumor, is no longer included in Stage II and is now included in Stage III.",
"     </li>",
"     <li>",
"      Stage III &ndash; After surgery, residual tumor remains but is confined to the abdomen. This includes regional lymph node involvement, peritoneal surface involvement, incomplete resection of the tumor, tumor at or beyond the margin of the resection, tumor spillage, previous biopsy, or preoperative chemotherapy before removal of the tumor.",
"     </li>",
"     <li>",
"      Stage IV &ndash; Hematogenous metastasis (eg, lung, liver, bone, brain) or lymph node involvement beyond the abdominopelvic region.",
"     </li>",
"     <li>",
"      Stage V &ndash; Bilateral renal involvement is present at the time of diagnosis. Each side is than staged separately to guide further management decisions [",
"      <a class=\"abstract\" href=\"UTD.htm?2/12/2249/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     SIOP staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;SIOP staging is based upon surgical evaluation",
"    <strong>",
"     after",
"    </strong>",
"    administration of chemotherapy to reduce the size of the tumor (",
"    <a class=\"graphic graphic_table graphicRef78599 \" href=\"UTD.htm?14/4/14413\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage 1 &ndash; Tumor is fully resected and is limited to the kidney, or if outside the kidney, it is surrounded with a fibrous pseudocapsule. Tumor may be found in the renal capsule, pelvic system (but not involving the ureter walls), and intrarenal vessels. There is no evidence of renal sinus vessel involvement or tumor at or beyond the margins of resection.",
"     </li>",
"     <li>",
"      Stage 2 &ndash; Tumor extends beyond the kidney or fibrous pseudocapsule but is completely resected without evidence of tumor at or beyond the margins of resection. Tumor infiltrates, which are completely resected, can extend into the renal sinus, blood vessels and lymph nodes beyond the renal parenchyma, adjacent organs, or vena cava.",
"     </li>",
"     <li>",
"      Stage 3 &ndash; After surgery, residual tumor remains but is confined to the abdomen. This includes regional lymph node involvement, incomplete resection of the tumor, tumor penetration of the peritoneal surface, tumor thrombi of vessels at resection margins, tumor spillage, or previous biopsy. There is no evidence of hematogenous metastasis.",
"     </li>",
"     <li>",
"      Stage 4 &ndash; Hematogenous metastasis (eg, lung, liver, bone, brain) or lymph node involvement beyond the abdominopelvic region.",
"     </li>",
"     <li>",
"      Stage 5 &ndash; Bilateral renal involvement is present at the time of diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Wilms tumor is the most common renal malignancy in children and the fourth most common childhood cancer. Almost all cases are diagnosed before 10 years of age, and two-thirds before 5 years of age. Wilms tumor may occur as a part of a multiple malformation syndrome including WAGR, Denys-Drash, and Beckwith-Wiedemann syndromes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Wilms tumor is associated with mutations of a number of tumor suppressor genes. These include WT1, p53, FWT1, and FWT2 genes, and mutations at the 11p15.5 loci. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients have solitary Wilms tumor, 7 percent have bilateral kidney involvement, and 12 percent have multifocal loci within a single kidney. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common presentation is detection of an abdominal mass or swelling without other signs or symptoms. Symptoms or signs that may be present include abdominal pain (30 percent of patients), hematuria (12 to 25 percent), and hypertension (25 percent). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of Wilms tumor is made by histologic confirmation, either at the time of surgical excision or by biopsy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children who are suspected of having Wilms tumor should be referred to a pediatric cancer center for evaluation and treatment. Radiologic imaging including abdominal ultrasonography and contrast-enhanced computed tomography is useful to differentiate Wilms tumor from other causes of abdominal masses. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Staging of Wilms tumor is based upon the anatomic extent of the tumor without consideration for genetic, histologic, or molecular markers. Treatment decisions and evaluation of long-term outcome are based upon the Wilms tumor stage. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Staging'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/50/9002?source=see_link\">",
"       \"Treatment and prognosis of Wilms tumor\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/1\">",
"      Grovas A, Fremgen A, Rauck A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997; 80:2321.",
"     </a>",
"    </li>",
"    <li>",
"     Bernstein L, Linet M, Smith MA, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, SEER Program. Bethesda, MD, National Cancer Institute 1999. p.79.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/3\">",
"      Perlman EJ. Pediatric renal tumors: practical updates for the pathologist. Pediatr Dev Pathol 2005; 8:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/4\">",
"      Kalapurakal JA, Dome JS, Perlman EJ, et al. Management of Wilms' tumour: current practice and future goals. Lancet Oncol 2004; 5:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/5\">",
"      Gurney JG, Davis S, Severson RK, et al. Trends in cancer incidence among children in the U.S. Cancer 1996; 78:532.",
"     </a>",
"    </li>",
"    <li>",
"     Ries LA, Smith MA, Gurney JG, et al. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Maryland 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/7\">",
"      Breslow N, Beckwith JB, Ciol M, Sharples K. Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study. Cancer Res 1988; 48:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/8\">",
"      Goodman MT, Yoshizawa CN, Kolonel LN. Ethnic patterns of childhood cancer in Hawaii between 1960 and 1984. Cancer 1989; 64:1758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/9\">",
"      Stiller CA, Parkin DM. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 1996; 52:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/10\">",
"      Fukuzawa R, Breslow NE, Morison IM, et al. Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet 2004; 363:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/11\">",
"      Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 2006; 43:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/12\">",
"      MILLER RW, FRAUMENI JF Jr, MANNING MD. ASSOCIATION OF WILMS'S TUMOR WITH ANIRIDIA, HEMIHYPERTROPHY AND OTHER CONGENITAL MALFORMATIONS. N Engl J Med 1964; 270:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/13\">",
"      Fischbach BV, Trout KL, Lewis J, et al. WAGR syndrome: a clinical review of 54 cases. Pediatrics 2005; 116:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/14\">",
"      Breslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol 2003; 21:4579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/15\">",
"      Bliek J, Gicquel C, Maas S, et al. Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 2004; 145:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/16\">",
"      Koufos A, Grundy P, Morgan K, et al. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 1989; 44:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/17\">",
"      Astuti D, Morris MR, Cooper WN, et al. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat Genet 2012; 44:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/18\">",
"      Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet 2005; 137C:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/19\">",
"      Li M, Shuman C, Fei YL, et al. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Am J Med Genet 2001; 102:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/20\">",
"      Neri G, Gurrieri F, Zanni G, Lin A. Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome. Am J Med Genet 1998; 79:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/21\">",
"      Byrne J, Nicholson HS. Excess risk for Mullerian duct anomalies in girls with Wilms tumor. Med Pediatr Oncol 2002; 38:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/22\">",
"      Beckwith JB, Kiviat NB, Bonadio JF. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990; 10:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/23\">",
"      Beckwith JB. Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol 1993; 21:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/24\">",
"      Coppes MJ, Haber DA, Grundy PE. Genetic events in the development of Wilms' tumor. N Engl J Med 1994; 331:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/25\">",
"      Gao X, Chen X, Taglienti M, et al. Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa. Development 2005; 132:5437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/26\">",
"      Scholz H, Kirschner KM. A role for the Wilms' tumor protein WT1 in organ development. Physiology (Bethesda) 2005; 20:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/27\">",
"      Kreidberg JA, Sariola H, Loring JM, et al. WT-1 is required for early kidney development. Cell 1993; 74:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/28\">",
"      Rauscher FJ 3rd. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 1993; 7:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/29\">",
"      Riccardi VM, Sujansky E, Smith AC, Francke U. Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978; 61:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/30\">",
"      Varanasi R, Bardeesy N, Ghahremani M, et al. Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci U S A 1994; 91:3554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/31\">",
"      Shuman C, Smith AC, Steele L, et al. Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies. Am J Med Genet A 2006; 140:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/32\">",
"      Vuononvirta R, Sebire NJ, Dallosso AR, et al. Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors. Clin Cancer Res 2008; 14:7635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/33\">",
"      Scott RH, Douglas J, Baskcomb L, et al. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet 2008; 40:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/34\">",
"      Malkin D, Sexsmith E, Yeger H, et al. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor. Cancer Res 1994; 54:2077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/35\">",
"      Bardeesy N, Falkoff D, Petruzzi MJ, et al. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 1994; 7:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/36\">",
"      Rahman N, Arbour L, Tonin P, et al. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet 1996; 13:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/37\">",
"      Rahman N, Abidi F, Ford D, et al. Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1. Hum Genet 1998; 103:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/38\">",
"      McDonald JM, Douglass EC, Fisher R, et al. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 1998; 58:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/39\">",
"      Turnbull C, Perdeaux ER, Pernet D, et al. A genome-wide association study identifies susceptibility loci for Wilms tumor. Nat Genet 2012; 44:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/40\">",
"      Royer-Pokora B, Weirich A, Schumacher V, et al. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology. Cancer 2008; 113:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/41\">",
"      Geller JI. Genetic stratification of Wilms tumor: is WT1 gene analysis ready for prime time? Cancer 2008; 113:893.",
"     </a>",
"    </li>",
"    <li>",
"     Fernandez C, Geller JI, Ehrlich PF, et al. Renal tumors. In: Principles and Practice of Pediatric Oncology, 6th ed, Pizzo P, Poplack D (Eds), Lippincott Williams &amp; Wilkins, St. Louis 2011. p.861.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/43\">",
"      Zuppan CW, Beckwith JB, Luckey DW. Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1988; 19:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/44\">",
"      Ganguly A, Gribble J, Tune B, et al. Renin-secreting Wilms' tumor with severe hypertension. Report of a case and brief review of renin-secreting tumors. Ann Intern Med 1973; 79:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/45\">",
"      Ritchey ML, Azizkhan RG, Beckwith JB, et al. Neonatal Wilms tumor. J Pediatr Surg 1995; 30:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/46\">",
"      Suresh I, Suresh S, Arumugam R, et al. Antenatal diagnosis of Wilms tumor. J Ultrasound Med 1997; 16:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/47\">",
"      Tom&aacute; P, Lucigrai G, Dodero P, Lituania M. Prenatal detection of an abdominal mass by MR imaging performed while the fetus is immobilized with pancuronium bromide. AJR Am J Roentgenol 1990; 154:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/48\">",
"      Applegate KE, Ghei M, Perez-Atayde AR. Prenatal detection of a Wilms' tumor. Pediatr Radiol 1999; 29:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/49\">",
"      Vadeyar S, Ramsay M, James D, O'Neill D. Prenatal diagnosis of congenital Wilms' tumor (nephroblastoma) presenting as fetal hydrops. Ultrasound Obstet Gynecol 2000; 16:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/50\">",
"      Green DM, Breslow NE, Beckwith JB, Norkool P. Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study. Med Pediatr Oncol 1993; 21:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/51\">",
"      Scott RH, Walker L, Olsen &Oslash;E, et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child 2006; 91:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/52\">",
"      Wilimas JA, Douglass EC, Magill HL, et al. Significance of pulmonary computed tomography at diagnosis in Wilms' tumor. J Clin Oncol 1988; 6:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/53\">",
"      Green DM, Fernbach DJ, Norkool P, et al. The treatment of Wilms' tumor patients with pulmonary metastases detected only with computed tomography: a report from the National Wilms' Tumor Study. J Clin Oncol 1991; 9:1776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/54\">",
"      Owens CM, Veys PA, Pritchard J, et al. Role of chest computed tomography at diagnosis in the management of Wilms' tumor: a study by the United Kingdom Children's Cancer Study Group. J Clin Oncol 2002; 20:2768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/55\">",
"      Jayabose S, Iqbal K, Newman L, et al. Hypercalcemia in childhood renal tumors. Cancer 1988; 61:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/56\">",
"      Coppes MJ, Zandvoort SW, Sparling CR, et al. Acquired von Willebrand disease in Wilms' tumor patients. J Clin Oncol 1992; 10:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/57\">",
"      Jonge Poerink-Stockschlader AB, Dekker I, Risseeuw-Appel IM, H&auml;hlen K. Acquired Von Willebrand disease in children with a Wilms' tumor. Med Pediatr Oncol 1996; 26:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/58\">",
"      Leung RS, Liesner R, Brock P. Coagulopathy as a presenting feature of Wilms tumour. Eur J Pediatr 2004; 163:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/59\">",
"      Baxter PA, Nuchtern JG, Guillerman RP, et al. Acquired von Willebrand syndrome and Wilms tumor: not always benign. Pediatr Blood Cancer 2009; 52:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/60\">",
"      Isaacs H Jr. Fetal and neonatal renal tumors. J Pediatr Surg 2008; 43:1587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/61\">",
"      Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol 2000; 24:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/62\">",
"      Palmer NF, Sutow W. Clinical aspects of the rhabdoid tumor of the kidney: a report of the National Wilms' Tumor Study Group. Med Pediatr Oncol 1983; 11:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/63\">",
"      Vujani�� GM, Sandstedt B, Harms D, et al. Rhabdoid tumour of the kidney: a clinicopathological study of 22 patients from the International Society of Paediatric Oncology (SIOP) nephroblastoma file. Histopathology 1996; 28:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/64\">",
"      van den Heuvel-Eibrink MM, Grundy P, Graf N, et al. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatr Blood Cancer 2008; 50:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/65\">",
"      Malone PS, Duffy PG, Ransley PG, et al. Congenital mesoblastic nephroma, renin production, and hypertension. J Pediatr Surg 1989; 24:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/66\">",
"      Tonk V, Wilson KS, Timmons CF, et al. Renal cell carcinoma with translocation (X;1). Further evidence for a cytogenetically defined subtype. Cancer Genet Cytogenet 1995; 81:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/67\">",
"      Metzger ML, Dome JS. Current therapy for Wilms' tumor. Oncologist 2005; 10:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2249/abstract/68\">",
"      D'Angio GJ. Pre- or post-operative treatment for Wilms tumor? Who, what, when, where, how, why--and which. Med Pediatr Oncol 2003; 41:545.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6249 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-EC2EE36D8B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2249=[""].join("\n");
var outline_f2_12_2249=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Associated congenital syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - WAGR syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Denys-Drash syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Beckwith-Wiedemann syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Other congenital anomalies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      NWTS system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SIOP staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6249\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6249|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/4/14413\" title=\"table 1\">",
"      Wilms tumor staging",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=related_link\">",
"      Basic principles of genetic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24473?source=related_link\">",
"      Beckwith-Wiedemann syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=related_link\">",
"      Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7753?source=related_link\">",
"      Congenital and infantile nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18250?source=related_link\">",
"      Epidemiology, pathology, and pathogenesis of renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12391?source=related_link\">",
"      Li-Fraumeni syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30234?source=related_link\">",
"      Molecular genetics of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12500?source=related_link\">",
"      Prenatal diagnosis of congenital mesoblastic nephroma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/3/6202?source=related_link\">",
"      Renal manifestations of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10073?source=related_link\">",
"      The child with tall stature or abnormally rapid growth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/50/9002?source=related_link\">",
"      Treatment and prognosis of Wilms tumor",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_12_2250="Food protein-induced enterocolitis syndrome (FPIES)";
var content_f2_12_2250=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Food protein-induced enterocolitis syndrome (FPIES)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2250/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2250/contributors\">",
"     Anna Nowak-W��grzyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2250/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2250/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/12/2250/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/12/2250/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/12/2250/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 23, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H15042616\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food protein-induced enterocolitis syndrome (FPIES) is a non-immunoglobulin E (IgE) mediated gastrointestinal food hypersensitivity that manifests as profuse, repetitive vomiting, often with diarrhea, leading to dehydration and lethargy in the acute setting, or weight loss and failure to thrive in a chronic form [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/1\">",
"     1",
"    </a>",
"    ]. This disease primarily affects infants. It is most commonly caused by cow&rsquo;s milk or soy protein, although other foods can be triggers.",
"   </p>",
"   <p>",
"    A number of gastrointestinal disorders in children have been attributed to immunologic reactions to dietary proteins. Immunologic reactions to dietary proteins may be classified as IgE mediated, non-IgE (T cell) mediated, or mixed (IgE and T cell mediated). The entire gastrointestinal tract can be affected, from the mouth to the rectum. Most of these disorders affect a specific region of the gastrointestinal tract, such as eosinophilic esophagitis, eosinophilic gastritis, food protein-induced enteropathy, enterocolitis, or proctitis. FPIES has some features that overlap with the other non-IgE mediated gastrointestinal allergic disorders, food protein-induced enteropathy, and proctocolitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis is based upon the presence of consistent clinical features with improvement following withdrawal of the suspected causal protein. Affected children are often misdiagnosed as having acute viral gastrointestinal illness or sepsis, delaying diagnosis of FPIES for many months. An oral food challenge is sometimes performed to confirm the diagnosis or to determine resolution of the food allergy. Treatment consists of elimination of the food trigger(s) from the diet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042624\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-IgE mediated and mixed gastrointestinal immune reactions to cow&rsquo;s milk proteins are estimated to account for up to 40 percent of cow&rsquo;s milk protein hypersensitivity in infants and young children [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. FPIES represents the severe end of the spectrum of food protein-induced gastrointestinal diseases in infants and is far less common than proctocolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a large Israeli population-based birth cohort, 0.34 percent of infants",
"    <span class=\"nowrap\">",
"     (44/13,019)",
"    </span>",
"    were diagnosed with FPIES (confirmed by resolution of typical FPIES symptoms with removal of cow&rsquo;s milk from the diet",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a clinician-supervised oral food challenge (OFC) to cow&rsquo;s milk in the first year of life), suggesting that FPIES may be more common than previously appreciated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence of IgE-mediated milk allergy in this same cohort was 0.5 percent. There are no prevalence studies of FPIES from other populations. There is a slight male predilection (52 to 60 percent) in FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Reports of FPIES in siblings of the affected children are rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042632\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;FPIES is triggered by non-IgE mediated food hypersensitivity. However, the exact underlying mechanisms of FPIES are not clearly understood. It is postulated that ingestion of food allergens causes local inflammation mediated by T cells leading to increased intestinal permeability and fluid shift [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. However, baseline intestinal absorption was normal in a group of infants with FPIES confirmed by OFC [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/10\">",
"     10",
"    </a>",
"    ]. Activated peripheral blood mononuclear cells, increased TNF-&alpha;, and decreased expression of TGF-&beta; receptors in the intestinal mucosa may be involved in the intestinal inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Systemic food-specific IgE antibodies (determined by serum food-specific IgE",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    skin prick test) are usually not detected in FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Intestinal mucosal IgE may facilitate the antigen uptake and local intestinal inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/13\">",
"     13",
"    </a>",
"    ], but this requires further study. A decrease in serum food-specific IgG",
"    <sub>",
"     4",
"    </sub>",
"    antibody and an increase in serum food-specific IgA levels have been noted [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042640\">",
"    <span class=\"h2\">",
"     Food triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although cow's milk and soy protein are the most common triggers, food protein-induced enterocolitis can be triggered by other proteins such as rice, particularly in infants who have had a previous reaction to cow's milk or soy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042910\">",
"    <span class=\"h3\">",
"     Cow's milk and soy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common food triggers in FPIES are cow milk&rsquo;s and soy (classic FPIES), with reactions occurring to infant formula during the first months of life. While several studies have shown that over 50 percent of infants with FPIES react to both foods [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/12,15\">",
"     12,15",
"    </a>",
"    ], none of the 44 infants diagnosed with cow&rsquo;s milk FPIES in a birth cohort study showed sensitivity to soy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/5\">",
"     5",
"    </a>",
"    ]. This difference could be attributed to a milder phenotype reported from a non-selected birth cohort compared with a more severe phenotype reported from allergy and gastroenterology referral populations.",
"   </p>",
"   <p>",
"    FPIES to cow&rsquo;s milk in exclusively-breastfed infants is rare, suggesting a protective role of breastfeeding that may be attributed to predigested and partially processed food allergens as well as presence of transforming growth factor (TGF)-beta and immunoglobulin A (IgA) in mother&rsquo;s milk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/7\">",
"     7",
"    </a>",
"    ]. Only four cases of exclusively-breastfed infants with cow&rsquo;s milk FPIES have been reported in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/16,17\">",
"     16,17",
"    </a>",
"    ] and there are no reports in the literature of soy FPIES in exclusively-breastfed infants.",
"   </p>",
"   <p>",
"    FPIES to goat&rsquo;s milk was reported in an Italian series [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042648\">",
"    <span class=\"h3\">",
"     Solid foods",
"    </span>",
"    &nbsp;&mdash;&nbsp;FPIES may be induced by solid food, including grains (rice, oats, barley, corn), meat and poultry (beef, chicken, turkey), eggs (egg white), vegetables and fruit (white potato, sweet potato, squash, string beans, banana, tomato), legumes (peanut, green peas, lentils), seafood (fish, crustaceans, molluscs), and the probiotic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/39/25203?source=see_link\">",
"     Saccharomyces boulardii",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/3,6-8,11,18-26\">",
"     3,6-8,11,18-26",
"    </a>",
"    ]. Among infants with solid food FPIES in one series, 80 percent reacted to more than one food, 65 percent were previously diagnosed with cow&rsquo;s milk",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    soy FPIES, and 35 percent were breastfed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rice is the most common solid food inducing FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/6\">",
"     6",
"    </a>",
"    ]. In one case series, rice was responsible for 46 percent of FPIES episodes requiring hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/27\">",
"     27",
"    </a>",
"    ]. Children with rice-induced FPIES were more likely to have multiple food sensitivities and severe symptoms requiring intravenous fluid resuscitation, compared with children with cow's milk or soy-induced FPIES.",
"   </p>",
"   <p>",
"    Those with a history of FPIES to one grain have a 50 percent chance of developing FPIES to other grains. However, wheat FPIES has not been reported in infants with oat or rice FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]. Egg is a rarely reported trigger of FPIES. However, 3 of 10 young infants with milk or soy FPIES in one series developed acute symptoms to egg oral food challenge (OFC) that was done as a negative control for milk and soy at a median age of 5.5 months [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/15\">",
"     15",
"    </a>",
"    ]. In addition, 4 of 38 children (11 percent) in an Australian study had FPIES to egg [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042663\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of FPIES are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef87555 \" href=\"UTD.htm?25/54/26476\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/5,6,18,29,30\">",
"     5,6,18,29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042671\">",
"    <span class=\"h2\">",
"     Age of onset",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of classic FPIES usually begin in early infancy, within one to four weeks following introduction of cow&rsquo;s milk or soy protein. In extreme cases, symptoms may begin within the first days of life. The first description of the disorder included nine infants who presented with severe vomiting and diarrhea developing an average of 11 days after birth (range 4 to 27 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/30\">",
"     30",
"    </a>",
"    ]. In the Israeli birth cohort previously discussed, all 44 infants with cow&rsquo;s milk FPIES presented with symptoms within the first six months of life [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/5\">",
"     5",
"    </a>",
"    ]. Delayed introduction of cow&rsquo;s milk or soy in breastfed infants may result in later onset.",
"   </p>",
"   <p>",
"    The mean age at onset of solid food FPIES tends to be later than that of cow&rsquo;s milk and soy FPIES, typically presenting when these foods are first introduced between the ages of four to seven months [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/6,31\">",
"     6,31",
"    </a>",
"    ]. The development of FPIES upon introduction of foods after one year of age is rare, although onset of FPIES to fish and shellfish has been observed in older children and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042686\">",
"    <span class=\"h2\">",
"     Chronic versus acute presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The disease typically presents in two phases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/5,6,29,30\">",
"     5,6,29,30",
"    </a>",
"    ]. The initial presentation is that of a chronic disease while the food antigen is ingested on a regular basis. This can be followed by an acute phase if the antigen is removed from the diet and subsequently re-ingested, with symptoms occurring about two hours after ingestion. An acute presentation is also seen when the antigen is ingested intermittently. Young infants with FPIES due to cow&rsquo;s milk",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    soy-based formulas usually have a chronic presentation, whereas solid food FPIES can have an acute or chronic presentation, depending upon the frequency of ingestion of the offending food.",
"   </p>",
"   <p>",
"    The following clinical vignette describes features of chronic and acute FPIES:",
"   </p>",
"   <p>",
"    A full-term female infant who was initially exclusively breastfed was started on cow&rsquo;s milk-based formula supplementation at four weeks of age. The baby developed frequent episodes of vomiting, poor weight gain, and watery stools with occasional mucus over a two-week period of daily formula intake (chronic FPIES).",
"   </p>",
"   <p>",
"    The baby was then returned to exclusive-breastfeeding, until one feeding with a cow&rsquo;s milk-based formula at 12 weeks of age. Approximately 90 minutes after that feeding, she developed repetitive vomiting and became lethargic (acute FPIES episode). A full sepsis workup, toxicology, and metabolic screening were done in the emergency department. She received intravenous fluid resuscitation and antibiotics and was observed in the hospital for three days. Blood-tinged diarrhea was noted only the first hospital day. She tolerated an extensively hydrolyzed casein formula and was discharged after three days when cultures were negative.",
"   </p>",
"   <p>",
"    She avoided cow&rsquo;s milk strictly and tolerated several solid foods introduced from five to seven months of age without symptoms, until an infant jar food containing cheese was given. Similar to the previous episode, she developed repetitive vomiting and lethargy 90 minutes after ingestion, and required intravenous fluid resuscitation (acute FPIES episode).",
"   </p>",
"   <p>",
"    Nearly all patients present with vomiting, which is repetitive in the acute presentation and intermittent in the chronic setting, and are commonly ill-appearing [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4-6,18,29,30\">",
"     4-6,18,29,30",
"    </a>",
"    ]. Overall, approximately 75 percent of infants with FPIES appear seriously ill, and 15 percent develop hypotension and require hospitalization, particularly with acute episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4\">",
"     4",
"    </a>",
"    ]. Other symptoms that can occur in both the chronic and acute presentations include diarrhea, abdominal distention, dehydration, and lethargy. In acute FPIES, repetitive emesis usually begins within one to three hours and diarrhea within 2 to 10 hours (mean onset five hours) of ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/30\">",
"     30",
"    </a>",
"    ]. Patients with acute presentations tend to be sicker and may develop pallor,",
"    <span class=\"nowrap\">",
"     hypotension/shock,",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypothermia. Failure to",
"    <span class=\"nowrap\">",
"     thrive/poor",
"    </span>",
"    weight gain (&lt;10",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    in young infants) and weight loss are seen in patients with chronic FPIES.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25142072\">",
"    <span class=\"h2\">",
"     Atypical FPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with FPIES have mixed immunologic reactions to the food(s) that causes their FPIES symptoms. A small subset of infants and children fulfilling the clinical diagnostic criteria for FPIES has or develops IgE antibodies to the trigger food. These patients are referred to as having atypical FPIES because the disorder is primarily considered a cell-mediated allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4,33\">",
"     4,33",
"    </a>",
"    ]. They tend to have a more protracted course of FPIES and have the potential for developing symptoms of IgE-mediated allergy, eg, anaphylaxis, in addition to FPIES. (See",
"    <a class=\"local\" href=\"#H7592457\">",
"     'Allergy testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H923782\">",
"    <span class=\"h2\">",
"     Atopic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 30 percent of infants with FPIES develop atopic diseases, such as atopic dermatitis (25 to 65 percent), asthma (3 to 20 percent), or allergic rhinitis (20 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. Family history of atopic diseases is present in 40 to 80 percent of patients, including a family history of food allergy in about 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10430961\">",
"    <span class=\"h2\">",
"     Laboratory and radiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common laboratory and radiographic findings are reviewed below and summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef87555 \" href=\"UTD.htm?25/54/26476\">",
"     table 1",
"    </a>",
"    ). Most of these studies are not performed as part of the initial diagnostic evaluation for FPIES, although some may have been performed as part of the evaluation for the patient&rsquo;s presenting symptoms (eg, vomiting and diarrhea, failure to thrive). (See",
"    <a class=\"local\" href=\"#H15042708\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10431376\">",
"    <span class=\"h3\">",
"     Blood tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies reveal anemia, hypoalbuminemia, and an elevated white blood cell count with a left shift and eosinophilia in patients with chronic FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/34\">",
"     34",
"    </a>",
"    ]. Thrombocytosis (platelets &gt;500",
"    <span class=\"nowrap\">",
"     x10",
"     <sup>",
"      9",
"     </sup>",
"     /L)",
"    </span>",
"    was found in 65 percent of acute FPIES episodes with a recorded white blood cell count in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/6\">",
"     6",
"    </a>",
"    ]. Peripheral blood neutrophil counts are usually elevated in positive challenges (acute FPIES) and peak at six hours. Metabolic acidosis (mean pH 7.03 in one series) and methemoglobinemia have been reported in both acute and chronic FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/29\">",
"     29",
"    </a>",
"    ]. Transient methemoglobinemia was reported in about one-third of infants with severe reactions and acidemia in one series, with some requiring",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/61/20438?source=see_link\">",
"     methylene blue",
"    </a>",
"    and bicarbonate treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/29\">",
"     29",
"    </a>",
"    ]. Methemoglobinemia may be caused by severe intestinal inflammation and reduced catalase activity resulting in increased nitrites. Food-specific IgE testing is discussed below. (See",
"    <a class=\"local\" href=\"#H7592457\">",
"     'Allergy testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10431384\">",
"    <span class=\"h3\">",
"     Stool studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;In young infants with chronic FPIES with diarrhea, results from stool examination were non-specific, showing occult blood, polymorphonuclear neutrophils, eosinophils, Charcot-Leyden crystals, and reducing substances [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/34\">",
"     34",
"    </a>",
"    ]. Stool contained frank or occult blood, mucus, sheets of leukocytes and eosinophils, and increased carbohydrate content in patients with diarrhea from acute FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18924706\">",
"    <span class=\"h3\">",
"     Gastric juice studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms such as severe vomiting and bloody diarrhea and results of intestinal biopsies both indicate the presence of gastrointestinal inflammation in FPIES. Thus, gastric juice analysis was performed in infants with suspected cow&rsquo;s milk FPIES at baseline and three hours after an OFC in one series to look for early signs of inflammation occurring with OFC [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/35\">",
"     35",
"    </a>",
"    ]. An elevated level of gastric juice leukocytes, with &gt;10",
"    <span class=\"nowrap\">",
"     leukocytes/hpf,",
"    </span>",
"    was seen in 15 of 16 positive challenges after three hours, including two infants without early symptoms of emesis or lethargy, and was not seen in eight control infants with negative challenges.",
"   </p>",
"   <p>",
"    Gastric juice is obtained by placing a nasogastric tube and aspirating gastric fluid. Gastric juice analysis is a research test that is a potential confirmatory test in patients with equivocal OFC results. However, it needs further validation in larger groups of patients and may not be a practical test in every setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10431392\">",
"    <span class=\"h3\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopies with biopsies were more frequently performed in symptomatic infants with cow&rsquo;s milk",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    soy FPIES prior to the establishment of clinical diagnostic criteria. These endoscopies revealed friable mucosa with rectal ulceration and bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4\">",
"     4",
"    </a>",
"    ]. Biopsies showed varying degrees of villous atrophy, tissue edema, crypt abscesses, and an inflammatory cell infiltrated with increased lymphocytes, eosinophils, and mast cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/19,36-38\">",
"     19,36-38",
"    </a>",
"    ]. Immunohistochemical studies showed plasma cells displaying IgM and IgA [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10430969\">",
"    <span class=\"h3\">",
"     Radiographic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiologic studies are not part of the routine diagnostic workup for FPIES, but were performed in some older studies. In one series of infants with FPIES and chronic diarrhea, rectal bleeding,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    failure to thrive, abdominal radiographs showed air fluid levels, non-specific narrowing and thumb-printing of the rectum and sigmoid, and thickening of the plicae circulares in the duodenum and jejunum with excess luminal fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/41\">",
"     41",
"    </a>",
"    ]. Distension of small bowel loops and thickening of the wall of jejunum distal to Treitz&rsquo;s ligament with diffuse subserosal bleeding was reported in patients who underwent laparotomy for suspected ileus. Intramural gas seen on abdominal radiographs, may lead to the misdiagnosis of necrotizing enterocolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. Resolution of radiologic abnormalities after dietary restriction has been documented [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7592457\">",
"    <span class=\"h3\">",
"     Allergy testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Greater than 90 percent of patients have negative skin prick tests and undetectable serum food-specific IgE at diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/5,7,11,18\">",
"     5,7,11,18",
"    </a>",
"    ]. About 21 percent of patients with solid food FPIES, and 18 to 30 percent with cow&rsquo;s milk or soy FPIES, have detectable food-specific IgE to the same food and up to 30 percent of infants with FPIES have IgE-mediated allergy to different foods. (See",
"    <a class=\"local\" href=\"#H25142072\">",
"     'Atypical FPIES'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Atopy patch testing (APT) was evaluated in 19 infants aged 5 to 30 months with challenged-confirmed FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/42\">",
"     42",
"    </a>",
"    ]. APT correctly predicted 28 of 33 outcomes of OFCs. All positive OFCs had a positive APT, although five patients with positive APT did not react upon OFC. These results have not been confirmed by other studies. Thus, further evaluation is required to determine the role of APT in the diagnosis of FPIES.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042708\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of FPIES is based upon the history, constellation of typical clinical symptoms (",
"    <a class=\"graphic graphic_table graphicRef87555 \" href=\"UTD.htm?25/54/26476\">",
"     table 1",
"    </a>",
"    ) with clinical improvement following withdrawal of the suspected causal protein, exclusion of other etiologies, and, if necessary, results of an oral food challenge (OFC) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/30,43\">",
"     30,43",
"    </a>",
"    ]. There are no laboratory and radiographic findings specific to FPIES. However, obtaining a complete blood count with differential during an acute presentation may be useful in that an elevated white blood count with a left shift is suggestive of FPIES or sepsis. In addition, an elevated methemoglobin level in a child that appears ashen, grey, or cyanotic and very ill also suggests the diagnosis of FPIES. (See",
"    <a class=\"local\" href=\"#H10431376\">",
"     'Blood tests'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H15042827\">",
"     'Infections'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H7082543\">",
"     'Congenital methemoglobinemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Endoscopy and biopsy are not routinely performed, but may be indicated to rule out other pathology of the gastrointestinal tract in cases where symptoms are unusually severe and do not resolve with bowel rest or amino acid-based formula. Skin prick testing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serum food-specific IgE testing is usually performed as part of the evaluation to rule out sensitization to particular foods and possible concomitant IgE-mediated disease. (See",
"    <a class=\"local\" href=\"#H15042790\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H10430961\">",
"     'Laboratory and radiographic findings'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Infants often present with multiple reactions and extensive evaluations before the diagnosis of FPIES is considered, especially when FPIES is caused by solid foods [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Non-specific symptoms and lack of definitive diagnostic tests can contribute to the delay in diagnosis. Delayed diagnosis of solid food FPIES may also be due to the perception that grains (eg, rice and oats) and vegetables have low allergenic potential and are not usually suspected as triggers of allergic reactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042753\">",
"    <span class=\"h2\">",
"     Oral food challenge (OFC)",
"    </span>",
"    &nbsp;&mdash;&nbsp;OFC is the gold standard for diagnosis of FPIES. However, infants do not usually require confirmatory challenges for initial diagnosis if they have a classic history (",
"    <a class=\"graphic graphic_table graphicRef87555 \" href=\"UTD.htm?25/54/26476\">",
"     table 1",
"    </a>",
"    ) and symptoms resolve after removal of the offending food from the diet. Clinician-supervised OFCs are necessary, however, if the history is unclear and a specific food trigger has not been identified, if the time course symptoms is atypical (eg, severe emesis within minutes of food ingestion in the absence of food-specific IgE), or if the child has persistent symptoms on an allergen-restricted diet, with the goal in this case of identifying the relevant food(s) and avoiding unnecessary food restrictions.",
"   </p>",
"   <p>",
"    The protocol for conducting OFCs for FPIES is outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef87566 \" href=\"UTD.htm?22/57/23452\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/2,11,15,30,44-46\">",
"     2,11,15,30,44-46",
"    </a>",
"    ]. An OFC for FPIES is considered a high-risk procedure. It should be conducted in a setting where intravenous access can be secured, rapid fluid resuscitation given if a reaction occurs, and prolonged observation can occur if necessary. An inpatient setting is the most appropriate for FPIES OFCs, but outpatient settings equipped with resuscitation capabilities and with access to a laboratory (for neutrophil counts and stool analysis) can be used. Performing FPIES OFCs in an intensive care unit is unnecessary, unless the patient has a history of near fatality with an episode [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042790\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of FPIES is extensive and includes other allergic food disorders, infectious diseases, intestinal obstruction due to anatomic or functional etiologies, severe gastroesophageal reflux disease, and metabolic, neurologic, and cardiac diseases. A comprehensive differential diagnosis is presented in the table (",
"    <a class=\"graphic graphic_table graphicRef87565 \" href=\"UTD.htm?6/48/6924\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042798\">",
"    <span class=\"h2\">",
"     Gastrointestinal food allergy disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gastrointestinal disorders caused by food allergy that may have a presentation similar to FPIES include both IgE mediated (eg, anaphylaxis), mixed (eg, eosinophilic gastrointestinal disorders), and non-IgE mediated (eg, allergic proctocolitis) disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7082251\">",
"    <span class=\"h3\">",
"     Allergic proctocolitis and food protein-induced enteropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic proctocolitis is a benign transient condition that typically begins in the first few months of life with blood-streaked stools. These infants are well-appearing and thriving, unlike the typical infant with FPIES. Over half of infants with proctocolitis are exclusively breastfed. Mild anemia and, rarely, hypoalbuminemia may be present. Eosinophilic infiltration of colonic biopsies is prominent and peripheral blood eosinophilia is occasionally seen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link&amp;anchor=H2#H2\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\", section on 'Food protein-induced proctitis/proctocolitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Food protein-induced enteropathy is a syndrome of small bowel injury causing malabsorption, intermittent vomiting, diarrhea, failure to thrive, and rarely, bloody stools. It is similar to celiac disease, although less severe. These infants are usually formula-fed. Anemia and hypoalbuminemia may be present, but not methemoglobinemia or acidemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link&amp;anchor=H11#H11\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\", section on 'Food protein-induced enteropathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cow&rsquo;s milk and soy are the most common food proteins implicated in these non-IgE mediated gastrointestinal food hypersensitivities. Skin prick testing and serum food-specific IgE are usually negative in these conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042813\">",
"    <span class=\"h3\">",
"     Eosinophilic gastrointestinal disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis are mixed pathophysiology disorders. Sensitization to food allergens is more common in the eosinophilic GI disorders than in FPIES, with about half of patients having detectable food-specific IgE antibodies. Disease onset ranges from a few days of age to adulthood. Symptoms are usually chronic, evolving over days to weeks following food exposure, and may include nausea, vomiting, poor appetite, early satiety, abdominal pain, and diarrhea with blood or mucus. The course is insidious, chronic, and",
"    <strong>",
"     not",
"    </strong>",
"    characterized by acute episodes of severe, repetitive vomiting or lethargy. Difficulty swallowing and food impaction may be the presenting symptom in teenagers and adults with EoE. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43703?source=see_link\">",
"     \"Eosinophilic gastroenteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042820\">",
"    <span class=\"h3\">",
"     Anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylaxis may present with acute onset of repetitive vomiting, diarrhea,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lethargy, usually within minutes to one to two hours following food ingestion. However, these manifestations occur in association with other symptoms (",
"    <a class=\"graphic graphic_table graphicRef64957 \" href=\"UTD.htm?35/20/36172\">",
"     table 4",
"    </a>",
"    ) that are absent in FPIES. Cardiovascular shock may develop, but unlike in FPIES, it usually ensues within minutes of exposure and is mostly responsive to treatment with intramuscular epinephrine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9401?source=see_link\">",
"     \"Anaphylaxis: Confirming the diagnosis and determining the trigger(s)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38920?source=see_link\">",
"     \"Food-induced anaphylaxis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33625?source=see_link\">",
"     \"Unique aspects of anaphylaxis in infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042827\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal viral or bacterial (",
"    <em>",
"     Salmonella",
"    </em>",
"    ,",
"    <em>",
"     Shigella",
"    </em>",
"    ,",
"    <em>",
"     Campylobacter",
"    </em>",
"    ,",
"    <em>",
"     Yersinia",
"    </em>",
"    ) infections can also present with acute vomiting, diarrhea, and dehydration. Patients with FPIES will not have a history of fever or sick contacts. However, this history may also be absent in patients&rsquo; acute viral illness. Often it is the recurrence of repetitive emesis hours after ingestion of a particular food that points to food intolerance and not an acute microbial illness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14216?source=see_link\">",
"     \"Epidemiology, pathogenesis, clinical presentation and diagnosis of viral gastroenteritis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24521?source=see_link\">",
"     \"Approach to the infant or child with nausea and vomiting\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13529?source=see_link\">",
"     \"Evaluation of diarrhea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sepsis should be considered in patients who present with acute dehydration and lethargy. Hypotension",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an elevated white cell count with a left shift support this diagnosis (",
"    <a class=\"graphic graphic_table graphicRef86087 \" href=\"UTD.htm?26/36/27212\">",
"     table 5",
"    </a>",
"    ). Patients with FPIES do not present with a fever or respiratory symptoms and typically recover rapidly with vigorous rehydration alone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10346?source=see_link\">",
"     \"Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4634?source=see_link\">",
"     \"Septic shock: Rapid recognition and initial resuscitation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=see_link\">",
"     \"Clinical features and diagnosis of sepsis in term and late preterm infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H616500\">",
"    <span class=\"h2\">",
"     Necrotizing enterocolitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Necrotizing enterocolitis (NEC) shares a number of possible presenting features with FPIES, including lethargy, poor feeding, vomiting, diarrhea, shock, and intramural gas on abdominal radiograph. Systemic and abdominal signs and symptoms seen in patients with NEC that are not typical of FPIES include apnea, respiratory failure, temperature instability, abdominal distention, and gastric retention [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=see_link\">",
"     \"Clinical features and diagnosis of necrotizing enterocolitis in newborns\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042834\">",
"    <span class=\"h2\">",
"     Intestinal obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are reports of exploratory laparotomy performed when acute FPIES was mistaken for ileus [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/41\">",
"     41",
"    </a>",
"    ]. Both conditions improve with bowel rest and intravenous hydration and may be associated with an elevated white blood count, but in FPIES there is usually a history of recurrent episodes upon food re-exposures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link\">",
"     \"Causes of acute abdominal pain in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/61/22490?source=see_link\">",
"     \"Emergent evaluation of the child with acute abdominal pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=see_link\">",
"     \"Intussusception in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H889832239\">",
"    <span class=\"h2\">",
"     Other gastrointestinal disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other gastrointestinal conditions may lead to severe projectile emesis (eg, pyloric stenosis), chronic emesis with poor weight gain (eg, gastroesophageal reflux disease), or abdominal distension, severe emesis, and failure to thrive (eg, Hirschsprung disease). In contrast to FPIES, there is no history of recurrence of symptoms upon food re-exposure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/29/3545?source=see_link\">",
"     \"Infantile hypertrophic pyloric stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/41/41625?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/33/19994?source=see_link\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=see_link\">",
"     \"Congenital aganglionic megacolon (Hirschsprung disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042842\">",
"    <span class=\"h2\">",
"     Metabolic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic disorders can present acutely with episodic vomiting, dehydration, and lethargy and chronically with failure to thrive. They should be considered in the differential diagnosis if metabolic acidosis is present. Patients with metabolic disorders may have other associated features, such as hypoglycemia, hyperpnea, hematologic abnormalities (eg, anemia, neutropenia, thrombocytopenia), liver dysfunction (eg, organomegaly, jaundice), renal disease, and developmental delay. Hyperammonemia is a common finding in patients with a metabolic disorder, although the ammonia level can be normal in patients who are not acutely ill. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=see_link\">",
"     \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=see_link\">",
"     \"Inborn errors of metabolism: Metabolic emergencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7082543\">",
"    <span class=\"h2\">",
"     Congenital methemoglobinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital methemoglobinemia should be considered if methemoglobin levels are elevated. However, unlike patients with FPIES, most patients with congenital methemoglobinemia are asymptomatic or may only complain of headache and easy fatigability. Patients with the rarer type II disease have severe developmental abnormalities and failure to thrive. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of methemoglobinemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link&amp;anchor=H19#H19\">",
"     \"Genetics and pathogenesis of methemoglobinemia\", section on 'Cytochrome b5 reductase 3 deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042849\">",
"    <span class=\"h1\">",
"     INITIAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management consists of elimination of the offending food from the diet and an emergency treatment plan for acute episodes due to accidental exposures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H614774\">",
"    <span class=\"h2\">",
"     Dietary elimination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A casein hydrolysate-based (hypoallergenic) formula is recommended in the infant with cow&rsquo;s milk FPIES if breastfeeding is not possible or the infant is exclusively formula-fed, due to frequent concomitant cow&rsquo;s milk and soy FPIES. In the rare case of FPIES in the nursing infant, the mother should completely eliminate the triggering food(s) from her diet. Infants presenting with chronic symptoms usually improve within 3 to 10 days of switching to a casein hydrolysate-based formula with or without temporary intravenous fluids [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/4\">",
"     4",
"    </a>",
"    ]. About 10 to 20 percent may require an amino acid-based formula [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7993?source=see_link\">",
"     \"Nutritional issues in food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Introduction of yellow fruits and vegetables at six months of age instead of cereals is suggested, because about one-third of infants with cow&rsquo;s milk or soy FPIES develop solid food FPIES and reactions to rice and other grains represent the most common types of solid food FPIES [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/7,49\">",
"     7,49",
"    </a>",
"    ]. Delaying introduction of grains, legumes, and poultry until the first year of life is suggested in infants with solid food FPIES, because of the high rate of reactions to multiple foods [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/2\">",
"     2",
"    </a>",
"    ]. Introduction of cow&rsquo;s milk and soy in these infants may be attempted after one year of age (preferably under clinician supervision) if there is no prior history of reactivity to these foods. Tolerance to one food from each high-risk group, for example soy for legumes, chicken for poultry, or oat for grains, increases the likelihood of tolerance to other foods in the same group [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/2\">",
"     2",
"    </a>",
"    ]. These recommendations are based upon a single-center clinical experience and may change as more data become available.",
"   </p>",
"   <p>",
"    Many children with IgE-mediated cow&rsquo;s milk allergy can tolerate milk in baked goods. However, this approach has not been studied in FPIES. The concern is that baking does not alter sequential epitopes that would continue to be recognized by T cells, presumed to be the effector cells of allergic inflammation in FPIES. Thus, we suggest that patients with FPIES avoid all forms of cow&rsquo;s",
"    <span class=\"nowrap\">",
"     milk/dairy,",
"    </span>",
"    including products with advisory labeling for milk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H614781\">",
"    <span class=\"h2\">",
"     Emergency treatment plan",
"    </span>",
"    &nbsp;&mdash;&nbsp;An emergency treatment letter that outlines the clinical features and management of acute FPIES should be provided to the",
"    <span class=\"nowrap\">",
"     patient/caregivers",
"    </span>",
"    for presentation to an emergency department clinician. The emergency letter template can be accessed at the website of the",
"    <a class=\"external\" href=\"file://iaffpe.org/forms_list.html\">",
"     International Association for Food Protein Enterocolitis",
"    </a>",
"    as well as through the reference [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=see_link\">",
"     \"Initial management of shock in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17688?source=see_link\">",
"     \"Treatment of hypovolemia (dehydration) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The emergency treatment for acute FPIES is the same as the treatment for a reaction outlined in the oral food challenge protocol (",
"    <a class=\"graphic graphic_table graphicRef87566 \" href=\"UTD.htm?22/57/23452\">",
"     table 2",
"    </a>",
"    ). There are no studies to support a particular protocol. In general, the child should be taken to the emergency department (ED) for evaluation and intravenous fluid administration if the episode is severe, manifesting with multiple episodes of projectile emesis, lethargy, and a pale or ashen appearance.",
"   </p>",
"   <p>",
"    Children who develop dehydration, tachycardia, and hypotension should receive",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/63/17401?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    as well as any necessary supportive therapy, such as oxygen or vasopressors to maintain blood pressure. The use of glucocorticoids is based upon the presumption that a cellular inflammatory response is the primary etiology of the reaction, although no studies have been conducted to confirm the efficacy of glucocorticoids in this setting. Epinephrine is used in patients with shock, but anecdotally it has not been helpful in resolution of other acute FPIES symptoms. (See",
"    <a class=\"local\" href=\"#H15042632\">",
"     'Pathogenesis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients with mild reactions of one to two episodes of emesis may be rehydrated carefully at home. The exception is children who have had severe FPIES reactions in the past; these children should also be taken to the ED immediately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042857\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cow&rsquo;s milk and soy FPIES resolve in a majority of patients by age three years. However, patients with solid food FPIES",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    those with concomitant detectable food-specific IgE may have a more protracted course. An oral food challenge is used to determine if FPIES has resolved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042865\">",
"    <span class=\"h2\">",
"     Cow's milk and soy FPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resolution of FPIES appears to be population dependent, particularly for cow&rsquo;s milk and soy. Cow&rsquo;s milk FPIES resolved in about 60 percent by age three years in a referral allergy population at the author&rsquo;s institution in the United States (US), the Korean cohort showed over 60 percent resolution by 10 months, the Israeli birth cohort showed 90 percent resolution by age three years, and the mean age at resolution was 24 months in the Italian series [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/5,7,11,18,35\">",
"     5,7,11,18,35",
"    </a>",
"    ]. More striking, only 25 percent of soy FPIES resolved by age three years in the US study, while in the Korean cohort, over 90 percent of children showed resolution of soy FPIES by 10 months [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/7,35\">",
"     7,35",
"    </a>",
"    ]. This difference may be explained by the higher proportion of subjects with detectable food-specific IgE levels and atopic dermatitis in the US study compared with the Israeli and Korean studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042873\">",
"    <span class=\"h2\">",
"     Solid food FPIES natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the studies on solid food FPIES at the author&rsquo;s institution, resolution by age three years occurred in 67 percent for vegetables, 66 percent for oat, and 40 percent for rice [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The mean age of resolution for solid foods and soy in the Italian series was 53 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15983934\">",
"    <span class=\"h1\">",
"     FOLLOW-UP EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An oral food challenge (OFC) is also used to determine whether FPIES has resolved before the food is reintroduced into the diet. We conservatively recommend follow-up challenges every 18 to 24 months in patients without recent reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/2\">",
"     2",
"    </a>",
"    ]. However, in a study of 27 Korean infants with cow&rsquo;s milk FPIES, 64 percent tolerated cow&rsquo;s milk at 10 months and 92 percent tolerated soy at 10 months [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/35\">",
"     35",
"    </a>",
"    ]. The investigators recommended follow-up challenge be undertaken sooner; after 12 months of age for cow&rsquo;s milk and between six to eight months of age for soy. Further studies are needed to establish the optimal timing of follow-up challenges.",
"   </p>",
"   <p>",
"    The follow-up evaluation should include testing for food-specific IgE prior to the OFC, because patients initially presenting with or later developing food-specific IgE antibodies are at risk for persistent FPIES. Determination of when and how to perform a follow-up OFC in the small proportion of patients that develop positive skin prick tests",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    detectable food-specific IgE levels should also take into consideration the possibility of an acute IgE-mediated reaction. A modified OFC protocol with more incremental food dose administration and availability of appropriate medications such as epinephrine and an antihistamine is recommended in these cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/12/2250/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/59/20409?source=see_link\">",
"     \"Oral food challenges for diagnosis and management of food allergies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15042881\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE mediated food allergy that primarily presents in infancy. The most common food triggers are cow&rsquo;s milk and soy formulas, although FPIES can also be caused by solid foods. (See",
"      <a class=\"local\" href=\"#H15042624\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15042632\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      FPIES manifests as profuse, repetitive vomiting, often with diarrhea, leading to dehydration and lethargy in the acute setting, or weight loss and failure to thrive in a chronic form. The common laboratory and radiographic findings are reviewed in the table (",
"      <a class=\"graphic graphic_table graphicRef87555 \" href=\"UTD.htm?25/54/26476\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15042663\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of FPIES is based upon the history, constellation of typical clinical symptoms (",
"      <a class=\"graphic graphic_table graphicRef87555 \" href=\"UTD.htm?25/54/26476\">",
"       table 1",
"      </a>",
"      ) with clinical improvement following withdrawal of the suspected causal protein, exclusion of other etiologies, and, if necessary, results of an oral food challenge (OFC) (",
"      <a class=\"graphic graphic_table graphicRef87566 \" href=\"UTD.htm?22/57/23452\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15042708\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of FPIES includes other allergic food disorders, infectious diseases, intestinal obstruction due to anatomic or functional etiologies, severe gastroesophageal reflux disease, and metabolic, neurologic, and cardiac diseases (",
"      <a class=\"graphic graphic_table graphicRef87565 \" href=\"UTD.htm?6/48/6924\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15042790\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial management consists of elimination of the offending food from the diet and an emergency treatment plan for acute episodes due to accidental exposures. (See",
"      <a class=\"local\" href=\"#H15042849\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cow&rsquo;s milk and soy FPIES resolve in a majority of patients by age three years. However, patients with solid food FPIES",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      those with concomitant detectable food-specific IgE may have a more protracted course. The recommended frequency of oral rechallenges to determine resolution of disease is uncertain, but we perform these OFCs about every 18 to 24 months. (See",
"      <a class=\"local\" href=\"#H15042857\">",
"       'Natural history'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15983934\">",
"       'Follow-up evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/1\">",
"      NIAID-Sponsored Expert Panel, Boyce JA, Assa'ad A, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010; 126:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/2\">",
"      Sicherer SH. Food protein-induced enterocolitis syndrome: case presentations and management lessons. J Allergy Clin Immunol 2005; 115:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/3\">",
"      Lake AM. Dietary Protein Enterocolitis. Immunol Allergy Clin North Am 1999; 19:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/4\">",
"      Nowak-Wegrzyn A, Muraro A. Food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol 2009; 9:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/5\">",
"      Katz Y, Goldberg MR, Rajuan N, et al. The prevalence and natural course of food protein-induced enterocolitis syndrome to cow's milk: a large-scale, prospective population-based study. J Allergy Clin Immunol 2011; 127:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/6\">",
"      Mehr S, Kakakios A, Frith K, Kemp AS. Food protein-induced enterocolitis syndrome: 16-year experience. Pediatrics 2009; 123:e459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/7\">",
"      Nowak-Wegrzyn A, Sampson HA, Wood RA, Sicherer SH. Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics 2003; 111:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/8\">",
"      Caubet JC, Nowak-W��grzyn A. Food protein-induced enterocolitis to hen's egg. J Allergy Clin Immunol 2011; 128:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/9\">",
"      Caubet JC, Nowak-W��grzyn A. Current understanding of the immune mechanisms of food protein-induced enterocolitis syndrome. Expert Rev Clin Immunol 2011; 7:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/10\">",
"      Powell GK, McDonald PJ, Van Sickle GJ, Goldblum RM. Absorption of food protein antigen in infants with food protein-induced enterocolitis. Dig Dis Sci 1989; 34:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/11\">",
"      Sicherer SH, Eigenmann PA, Sampson HA. Clinical features of food protein-induced enterocolitis syndrome. J Pediatr 1998; 133:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/12\">",
"      Burks AW, Casteel HB, Fiedorek SC, et al. Prospective oral food challenge study of two soybean protein isolates in patients with possible milk or soy protein enterocolitis. Pediatr Allergy Immunol 1994; 5:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/13\">",
"      Berin MC. Mucosal antibodies in the regulation of tolerance and allergy to foods. Semin Immunopathol 2012; 34:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/14\">",
"      Shek LP, Soderstrom L, Ahlstedt S, et al. Determination of food specific IgE levels over time can predict the development of tolerance in cow's milk and hen's egg allergy. J Allergy Clin Immunol 2004; 114:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/15\">",
"      McDonald PJ, Goldblum RM, Van Sickle GJ, Powell GK. Food protein-induced enterocolitis: altered antibody response to ingested antigen. Pediatr Res 1984; 18:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/16\">",
"      Monti G, Castagno E, Liguori SA, et al. Food protein-induced enterocolitis syndrome by cow's milk proteins passed through breast milk. J Allergy Clin Immunol 2011; 127:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/17\">",
"      Nomura I, Morita H, Hosokawa S, et al. Four distinct subtypes of non-IgE-mediated gastrointestinal food allergies in neonates and infants, distinguished by their initial symptoms. J Allergy Clin Immunol 2011; 127:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/18\">",
"      Sopo SM, Giorgio V, Dello Iacono I, et al. A multicentre retrospective study of 66 Italian children with food protein-induced enterocolitis syndrome: different management for different phenotypes. Clin Exp Allergy 2012; 42:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/19\">",
"      Jenkins HR, Pincott JR, Soothill JF, et al. Food allergy: the major cause of infantile colitis. Arch Dis Child 1984; 59:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/20\">",
"      Levy Y, Danon YL. Food protein-induced enterocolitis syndrome--not only due to cow's milk and soy. Pediatr Allergy Immunol 2003; 14:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/21\">",
"      Hojsak I, Kljai��-Turkalj M, Misak Z, Kolacek S. Rice protein-induced enterocolitis syndrome. Clin Nutr 2006; 25:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/22\">",
"      Zapatero Rem&oacute;n L, Alonso Lebrero E, Mart&iacute;n Fern&aacute;ndez E, Mart&iacute;nez Molero MI. Food-protein-induced enterocolitis syndrome caused by fish. Allergol Immunopathol (Madr) 2005; 33:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/23\">",
"      Hwang JB, Kang KJ, Kang YN, Kim AS. Probiotic gastrointestinal allergic reaction caused by Saccharomyces boulardii. Ann Allergy Asthma Immunol 2009; 103:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/24\">",
"      Bruni F, Peroni DG, Piacentini GL, et al. Fruit proteins: another cause of food protein-induced enterocolitis syndrome. Allergy 2008; 63:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/25\">",
"      Monti G, Viola S, Tarasco V, et al. A case of severe allergic reaction to cooked potato. Acta Paediatr 2011; 100:e236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/26\">",
"      Coates RW, Weaver KR, Lloyd R, et al. Food protein-induced enterocolitis syndrome as a cause for infant hypotension. West J Emerg Med 2011; 12:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/27\">",
"      Mehr SS, Kakakios AM, Kemp AS. Rice: a common and severe cause of food protein-induced enterocolitis syndrome. Arch Dis Child 2009; 94:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/28\">",
"      Hsu P, Mehr S. Egg: a frequent trigger of food protein-induced enterocolitis syndrome. J Allergy Clin Immunol 2013; 131:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/29\">",
"      Murray KF, Christie DL. Dietary protein intolerance in infants with transient methemoglobinemia and diarrhea. J Pediatr 1993; 122:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/30\">",
"      Powell GK. Milk- and soy-induced enterocolitis of infancy. Clinical features and standardization of challenge. J Pediatr 1978; 93:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/31\">",
"      Sampson HA, Anderson JA. Summary and recommendations: Classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children. J Pediatr Gastroenterol Nutr 2000; 30 Suppl:S87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/32\">",
"      Fernandes BN, Boyle RJ, Gore C, et al. Food protein-induced enterocolitis syndrome can occur in adults. J Allergy Clin Immunol 2012; 130:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/33\">",
"      Onesimo R, Dello Iacono I, Giorgio V, et al. Can food protein induced enterocolitis syndrome shift to immediate gastrointestinal hypersensitivity? A report of two cases. Eur Ann Allergy Clin Immunol 2011; 43:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/34\">",
"      Hwang JB, Lee SH, Kang YN, et al. Indexes of suspicion of typical cow's milk protein-induced enterocolitis. J Korean Med Sci 2007; 22:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/35\">",
"      Hwang JB, Sohn SM, Kim AS. Prospective follow-up oral food challenge in food protein-induced enterocolitis syndrome. Arch Dis Child 2009; 94:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/36\">",
"      Goldman H, Proujansky R. Allergic proctitis and gastroenteritis in children. Clinical and mucosal biopsy features in 53 cases. Am J Surg Pathol 1986; 10:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/37\">",
"      Gryboski JD. Gastrointestinal milk allergy in infants. Pediatrics 1967; 40:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/38\">",
"      Halpin TC, Byrne WJ, Ament ME. Colitis, persistent diarrhea, and soy protein intolerance. J Pediatr 1977; 91:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/39\">",
"      Fontaine JL, Navarro J. Small intestinal biopsy in cows milk protein allergy in infancy. Arch Dis Child 1975; 50:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/40\">",
"      Chung HL, Hwang JB, Kwon YD, et al. Deposition of eosinophil-granule major basic protein and expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the mucosa of the small intestine in infants with cow's milk-sensitive enteropathy. J Allergy Clin Immunol 1999; 103:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/41\">",
"      Jayasooriya S, Fox AT, Murch SH. Do not laparotomize food-protein-induced enterocolitis syndrome. Pediatr Emerg Care 2007; 23:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/42\">",
"      Fogg MI, Brown-Whitehorn TA, Pawlowski NA, Spergel JM. Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol 2006; 17:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/43\">",
"      Powell GK. Enterocolitis in low-birth-weight infants associated with milk and soy protein intolerance. J Pediatr 1976; 88:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/44\">",
"      Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, et al. Work Group report: oral food challenge testing. J Allergy Clin Immunol 2009; 123:S365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/45\">",
"      Hwang JB, Song JY, Kang YN, et al. The significance of gastric juice analysis for a positive challenge by a standard oral challenge test in typical cow's milk protein-induced enterocolitis. J Korean Med Sci 2008; 23:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/46\">",
"      Powell GK. Food protein-induced enterocolitis of infancy: differential diagnosis and management. Compr Ther 1986; 12:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/47\">",
"      Murch SH. Cow's-milk protein as a specific immunological trigger of necrotising enterocolitis--or food protein-induced enterocolitis syndrome in disguise? J Pediatr Gastroenterol Nutr 2013; 56:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/48\">",
"      de Boissieu D, Matarazzo P, Dupont C. Allergy to extensively hydrolyzed cow milk proteins in infants: identification and treatment with an amino acid-based formula. J Pediatr 1997; 131:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/12/2250/abstract/49\">",
"      Liu AH, Jaramillo R, Sicherer SH, et al. National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 2010; 126:798.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16528 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-5088ACF45B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2250=[""].join("\n");
var outline_f2_12_2250=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15042881\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042616\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042624\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042632\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042640\">",
"      Food triggers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15042910\">",
"      - Cow's milk and soy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15042648\">",
"      - Solid foods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042663\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042671\">",
"      Age of onset",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042686\">",
"      Chronic versus acute presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25142072\">",
"      Atypical FPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H923782\">",
"      Atopic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10430961\">",
"      Laboratory and radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10431376\">",
"      - Blood tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10431384\">",
"      - Stool studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18924706\">",
"      - Gastric juice studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10431392\">",
"      - Histology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10430969\">",
"      - Radiographic features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7592457\">",
"      - Allergy testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042708\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042753\">",
"      Oral food challenge (OFC)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042790\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042798\">",
"      Gastrointestinal food allergy disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7082251\">",
"      - Allergic proctocolitis and food protein-induced enteropathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15042813\">",
"      - Eosinophilic gastrointestinal disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15042820\">",
"      - Anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042827\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H616500\">",
"      Necrotizing enterocolitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042834\">",
"      Intestinal obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H889832239\">",
"      Other gastrointestinal disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042842\">",
"      Metabolic disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7082543\">",
"      Congenital methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042849\">",
"      INITIAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H614774\">",
"      Dietary elimination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H614781\">",
"      Emergency treatment plan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042857\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042865\">",
"      Cow's milk and soy FPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15042873\">",
"      Solid food FPIES natural history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15983934\">",
"      FOLLOW-UP EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15042881\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/16528\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/16528|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/54/26476\" title=\"table 1\">",
"      Clinical features of FPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/57/23452\" title=\"table 2\">",
"      FPIES oral food challenge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/48/6924\" title=\"table 3\">",
"      Differential diagnosis of FPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/20/36172\" title=\"table 4\">",
"      Symptoms and signs of anaphylaxis in infants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/36/27212\" title=\"table 5\">",
"      Pediatric systemic inflammatory response syndrome criteria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9401?source=related_link\">",
"      Anaphylaxis: Confirming the diagnosis and determining the trigger(s)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24521?source=related_link\">",
"      Approach to the infant or child with nausea and vomiting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=related_link\">",
"      Causes of acute abdominal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=related_link\">",
"      Clinical features and diagnosis of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=related_link\">",
"      Clinical features and diagnosis of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/41/41625?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=related_link\">",
"      Congenital aganglionic megacolon (Hirschsprung disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/61/22490?source=related_link\">",
"      Emergent evaluation of the child with acute abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43703?source=related_link\">",
"      Eosinophilic gastroenteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14216?source=related_link\">",
"      Epidemiology, pathogenesis, clinical presentation and diagnosis of viral gastroenteritis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13529?source=related_link\">",
"      Evaluation of diarrhea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38920?source=related_link\">",
"      Food-induced anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=related_link\">",
"      Genetics and pathogenesis of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=related_link\">",
"      Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=related_link\">",
"      Inborn errors of metabolism: Metabolic emergencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/29/3545?source=related_link\">",
"      Infantile hypertrophic pyloric stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=related_link\">",
"      Initial management of shock in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35145?source=related_link\">",
"      Intussusception in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=related_link\">",
"      Management of food allergy: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/33/19994?source=related_link\">",
"      Management of gastroesophageal reflux disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7993?source=related_link\">",
"      Nutritional issues in food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/59/20409?source=related_link\">",
"      Oral food challenges for diagnosis and management of food allergies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4634?source=related_link\">",
"      Septic shock: Rapid recognition and initial resuscitation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10346?source=related_link\">",
"      Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17688?source=related_link\">",
"      Treatment of hypovolemia (dehydration) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33625?source=related_link\">",
"      Unique aspects of anaphylaxis in infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_12_2251="MR spectroscopy brain tumors";
var content_f2_12_2251=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F79098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F79098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    MR spectroscopy parameters",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Brain process",
"       </td>",
"       <td class=\"subtitle1\">",
"        N-Acetylaspartate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Choline",
"       </td>",
"       <td class=\"subtitle1\">",
"        Lactate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neoplasm",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infarction",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infection",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2251=[""].join("\n");
var outline_f2_12_2251=null;
var title_f2_12_2252="RT plus ADT versus ADT in clinical T3 prostate cancer";
var content_f2_12_2252=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F54425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F54425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Phase III trials of radiation therapy plus ADT versus ADT alone in clinical stage T3 prostate cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Trial:",
"       </td>",
"       <td class=\"subtitle1\">",
"        No. of patients",
"       </td>",
"       <td class=\"subtitle1\">",
"        Median follow-up",
"        <br/>",
"        (years)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Outcomes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Intergroup - NCIC",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        1205",
"       </td>",
"       <td rowspan=\"2\">",
"        6.0",
"       </td>",
"       <td>",
"        7-year overall survival:",
"        <br/>",
"        74 versus 66 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7-year cancer-specific survival:",
"        <br/>",
"        90 versus 79 percent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Scandinavian Prostate Cancer Group",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        875",
"       </td>",
"       <td rowspan=\"2\">",
"        7.6",
"       </td>",
"       <td>",
"        10-year cancer-specific mortality:",
"        <br/>",
"        12 versus 24 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10-year biochemical recurrence:",
"        <br/>",
"        25 versus 75 percent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        French",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        263",
"       </td>",
"       <td rowspan=\"2\">",
"        5.6",
"       </td>",
"       <td>",
"        5-year locoregional recurrence:",
"        <br/>",
"        10 versus 29 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5-year distant metastases:",
"        <br/>",
"        3 versus 11 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Lancet 2011: 378:2104.",
"      </li>",
"      <li>",
"       Lancet 2009; 373:301.",
"      </li>",
"      <li>",
"       J Clin Oncol 2010; 28:343s (abstract 4505).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2252=[""].join("\n");
var outline_f2_12_2252=null;
var title_f2_12_2253="Congenital anomalies associated with stridor";
var content_f2_12_2253=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Congenital anomalies associated with stridor",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Malformation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Characteristics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Nose*",
"       </td>",
"       <td>",
"        Nasal deformities",
"       </td>",
"       <td>",
"        Choanal atresia or agenesis, septum deformities, turbinate hypertrophy, vestibular atresia or stenosis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        Pharynx*",
"       </td>",
"       <td>",
"        Craniofacial anomalies",
"       </td>",
"       <td>",
"        Anomalies causing facial retrusion are associated with upper airway obstruction, including Crouzon's, Pierre Robin, and Apert's syndrome.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tongue",
"       </td>",
"       <td>",
"        Macroglossia and glossoptosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"6\">",
"        Larynx&nbsp;",
"       </td>",
"       <td>",
"        Laryngomalacia",
"       </td>",
"       <td>",
"        Most common cause of chronic stridor in infants. Almost all patients present by&nbsp;six weeks of age. Symptoms are more pronounced after upper respiratory infections.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laryngeal webs",
"       </td>",
"       <td>",
"        75 percent located in the glottic area. Complete webs cause respiratory distress at birth, partial webs produce stridor, weak cry, and different degrees of respiratory distress.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laryngeal cysts",
"       </td>",
"       <td>",
"        Located in supraglottic area may cause respiratory distress and stridor.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laryngeal clefts",
"       </td>",
"       <td>",
"        Characterized by abnormal communication between the larynx and pharynx, sometimes extending downward between the trachea and esophagus. Patients may present with aspiration, cough, swallowing difficulties, respiratory distress, hoarse cry,&nbsp;or&nbsp;occasionally with&nbsp;stridor; often associated with other congenital anomalies.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subglottic hemangioma",
"       </td>",
"       <td>",
"        Presents as progressive loud stridor with increased respiratory distress. Associated with hemangiomas in other parts of the body.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subglottic stenosis",
"       </td>",
"       <td>",
"        May be congenital but more often acquired secondary to intubation. Usually located 2 to 3 mm below the glottis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"3\">",
"        Trachea",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Tracheal stenosis",
"       </td>",
"       <td>",
"        Usually present with stridor or both stridor and wheezing. If stenosis is significant, respiratory distress occurs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular rings or slings",
"       </td>",
"       <td>",
"        74 percent of vascular rings are symptomatic.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tracheomalacia",
"       </td>",
"       <td>",
"        Associated with other congenital anomalies. May be secondary to a vascular ring or cysts. Worsens with upper respiratory infections, crying, coughing or feeding. May cause severe spells with cyanosis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Bronchi and distal airways",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Bronchogenic cyst&nbsp;",
"       </td>",
"       <td>",
"        May occur at any point throughout the tracheobronchial tree. Typically present during childhood with recurrent coughing, wheezing, or pneumonia, but may become symptomatic during infancy or adulthood, or present as an incidental finding on chest radiographs.&nbsp;&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Noise generated from the nose or pharynx is typically low in pitch and is referred to as snoring or stertor.",
"     <br>",
"      &bull; Noise generated from the trachea, bronchi or distal airways is mostly wheezing.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2253=[""].join("\n");
var outline_f2_12_2253=null;
var title_f2_12_2254="PEFR in men";
var content_f2_12_2254=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57257%7EPULM%2F62839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57257%7EPULM%2F62839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Predicted average peak expiratory flow for normal males (L/min)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"6\">",
"        Height",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        60 inches/152 cm",
"       </td>",
"       <td class=\"subtitle2\">",
"        65 inches/165 cm",
"       </td>",
"       <td class=\"subtitle2\">",
"        70 inches/178 cm",
"       </td>",
"       <td class=\"subtitle2\">",
"        75 inches/191 cm",
"       </td>",
"       <td class=\"subtitle2\">",
"        80 inches/203 cm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        554",
"       </td>",
"       <td>",
"        602",
"       </td>",
"       <td>",
"        649",
"       </td>",
"       <td>",
"        693",
"       </td>",
"       <td>",
"        740",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        543",
"       </td>",
"       <td>",
"        590",
"       </td>",
"       <td>",
"        636",
"       </td>",
"       <td>",
"        679",
"       </td>",
"       <td>",
"        725",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        532",
"       </td>",
"       <td>",
"        577",
"       </td>",
"       <td>",
"        622",
"       </td>",
"       <td>",
"        664",
"       </td>",
"       <td>",
"        710",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        521",
"       </td>",
"       <td>",
"        565",
"       </td>",
"       <td>",
"        609",
"       </td>",
"       <td>",
"        651",
"       </td>",
"       <td>",
"        695",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        509",
"       </td>",
"       <td>",
"        552",
"       </td>",
"       <td>",
"        596",
"       </td>",
"       <td>",
"        636",
"       </td>",
"       <td>",
"        680",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        45",
"       </td>",
"       <td>",
"        498",
"       </td>",
"       <td>",
"        540",
"       </td>",
"       <td>",
"        583",
"       </td>",
"       <td>",
"        622",
"       </td>",
"       <td>",
"        665",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        486",
"       </td>",
"       <td>",
"        527",
"       </td>",
"       <td>",
"        569",
"       </td>",
"       <td>",
"        607",
"       </td>",
"       <td>",
"        649",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        55",
"       </td>",
"       <td>",
"        475",
"       </td>",
"       <td>",
"        515",
"       </td>",
"       <td>",
"        556",
"       </td>",
"       <td>",
"        593",
"       </td>",
"       <td>",
"        634",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        463",
"       </td>",
"       <td>",
"        502",
"       </td>",
"       <td>",
"        542",
"       </td>",
"       <td>",
"        578",
"       </td>",
"       <td>",
"        618",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        65",
"       </td>",
"       <td>",
"        452",
"       </td>",
"       <td>",
"        490",
"       </td>",
"       <td>",
"        529",
"       </td>",
"       <td>",
"        564",
"       </td>",
"       <td>",
"        603",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        440",
"       </td>",
"       <td>",
"        477",
"       </td>",
"       <td>",
"        515",
"       </td>",
"       <td>",
"        550",
"       </td>",
"       <td>",
"        587",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    These values represent average normal values within 100 L/min. Predicted values for African American and Hispanic minorities are approximately 10 percent lower.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Leiner GC, et al, Am Rev Respir Dis 1963; 88:644.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Predicted average peak expiratory flow for normal females (L/min)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"6\">",
"        Height",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        55 inches/140 cm",
"       </td>",
"       <td class=\"subtitle2\">",
"        60 inches/152 cm",
"       </td>",
"       <td class=\"subtitle2\">",
"        65 inches/165 cm",
"       </td>",
"       <td class=\"subtitle2\">",
"        70 inches/178 cm",
"       </td>",
"       <td class=\"subtitle2\">",
"        75 inches/190 cm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        390",
"       </td>",
"       <td>",
"        423",
"       </td>",
"       <td>",
"        460",
"       </td>",
"       <td>",
"        496",
"       </td>",
"       <td>",
"        529",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        385",
"       </td>",
"       <td>",
"        418",
"       </td>",
"       <td>",
"        454",
"       </td>",
"       <td>",
"        490",
"       </td>",
"       <td>",
"        523",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        380",
"       </td>",
"       <td>",
"        413",
"       </td>",
"       <td>",
"        448",
"       </td>",
"       <td>",
"        483",
"       </td>",
"       <td>",
"        516",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        375",
"       </td>",
"       <td>",
"        408",
"       </td>",
"       <td>",
"        442",
"       </td>",
"       <td>",
"        476",
"       </td>",
"       <td>",
"        509",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        370",
"       </td>",
"       <td>",
"        402",
"       </td>",
"       <td>",
"        436",
"       </td>",
"       <td>",
"        470",
"       </td>",
"       <td>",
"        502",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        45",
"       </td>",
"       <td>",
"        365",
"       </td>",
"       <td>",
"        397",
"       </td>",
"       <td>",
"        430",
"       </td>",
"       <td>",
"        464",
"       </td>",
"       <td>",
"        495",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        360",
"       </td>",
"       <td>",
"        391",
"       </td>",
"       <td>",
"        424",
"       </td>",
"       <td>",
"        457",
"       </td>",
"       <td>",
"        488",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        55",
"       </td>",
"       <td>",
"        355",
"       </td>",
"       <td>",
"        386",
"       </td>",
"       <td>",
"        418",
"       </td>",
"       <td>",
"        451",
"       </td>",
"       <td>",
"        482",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        350",
"       </td>",
"       <td>",
"        380",
"       </td>",
"       <td>",
"        412",
"       </td>",
"       <td>",
"        445",
"       </td>",
"       <td>",
"        475",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        65",
"       </td>",
"       <td>",
"        345",
"       </td>",
"       <td>",
"        375",
"       </td>",
"       <td>",
"        406",
"       </td>",
"       <td>",
"        439",
"       </td>",
"       <td>",
"        468",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        340",
"       </td>",
"       <td>",
"        369",
"       </td>",
"       <td>",
"        400",
"       </td>",
"       <td>",
"        432",
"       </td>",
"       <td>",
"        461",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    These values represent average normal values within 80 L/min. Predicted values for African American and Hispanic minorities are approximately 10 percent lower.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Leiner GC, et al, Am Rev Respir Dis 1963; 88:644.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2254=[""].join("\n");
var outline_f2_12_2254=null;
var title_f2_12_2255="Telogen and anagen hairs";
var content_f2_12_2255=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Telogen and anagen hairs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 188px; height: 382px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Telogen club hairs have a cornified, depigmented, rounded-up bulb without an attached root sheath (left). Normal anagen hairs have pigmented, distorted bulbs and an attached root sheath (right).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wolff K, Goldsmith LA, Katz S, et al. Fitzpatrick's Dermatology in General Medicine, 7th ed, McGraw-Hill Professional 2008. Copyright &copy; 2008 The McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_12_2255=[""].join("\n");
var outline_f2_12_2255=null;
